Tag: Russia

Pandora Report 12.13.2024

by dkellogg97, posted in Pandora Report

This week’s Pandora Report covers the rush to find the former Assad regime’s hidden chemical weapons, a recent study on H5N1’s potential to become an efficient human pathogen, Nobel laureates’ call for the Senate to block RFK Jr. from becoming HHS Secretary, and more.

Assad Regime Falls

On Sunday, Syrian rebels continued their advance, taking the capital city of Damascus and forcing the country’s long-time leader, President Bashar al-Assad, to flee to Moscow. This ended the country’s 13-year-long civil war and toppled a brutal dictatorship known to have, among other things, used chemical weapons against its own civilians. Now, the country is strapped for cash and being led by opposition forces with limited experience in governance.

Adding to the chaos is the mad dash to locate the former Assad regime’s chemical weapons it hid from inspectors. Among the list of missing weapons are more than 360 tons of mustard gas that the Assad regime admitted to making, but never fully accounted for. There are also five missing tons of precursors for sarin that the Assad regime claimed were “Lost during transportation, due to traffic accidents.”

The OPCW said it is monitoring the situation, reaffirming its commitment to “clarifying gaps, discrepancies, and inconsistencies in Syrian chemical weapons declaration amidst political transition.” Rebels in the south of the country have reached out to the OPCW for support in safely disposing of a cache of CW they found. One US official told the press the US is working with other countries in the Middle East to prevent these weapons from falling into the wrong hands. Meanwhile, Israel reported that it has destroyed CW and other weapons caches while seizing areas along its shared border with the country it claims are part of a demilitarized buffer zone.

Further Reading and Listening:

New Study Finds Single Mutation in Bovine Influenza H5N1 Hemagglutinin Switches Specificity to Human Receptors

A recent study in Science found that a single glutamine to leucine mutation in clade 2.3.4.4b-an H5N1 virus widespread in US dairy cattle that has caused a few mild human cases-at residue 226 of the virus hemagglutinin “was sufficient to enact the change from avian to human specificity.” This means that this virus that currently cannot infect humans very easily could be just one mutation away from being able to do so much more effectively. This finding alone does not mean that this mutation in nature would be guaranteed to make this virus an efficient human pathogen, but it might mean that this version of the virus has a higher zoonotic potential than other H5N1 viruses.

Further Reading:

Investigation Launched into Queensland Lab Incident

An investigation has been launched by Australian authorities into the “major breach” of biosafety protocols that occurred at a state-run laboratory in Queensland in 2021. It was revealed that 323 virus samples-nearly 100 of which were live samples of Hendra virus-were missing. According to Health Minister Tim Nicholls, the incident was only discovered in August of 2023, and the lab is unable to confirm whether the materials were removed or destroyed, though there is no suggestion that they were taken or stolen from the lab.

Top Wuhan Virologist Says WIV Holds No Close Relatives to SARS-CoV-2

Shi Zhengli, the virologist leading coronavirus research at the Wuhan Institute of Virology (WIV) when the COVID-19 pandemic began, presented data on dozens of new coronaviruses collected from bats in southern China at a conference in Japan last week. Shi has said repeatedly that SARS-CoV-2 was never seen nor studied in her lab, but some have continued to insist that one of the bat coronaviruses collected by her team was closely related to it. As a result, Shi promised to sequence the genomes of the viruses stored in her freezers and release the resulting data.

The analysis presented at the conference has not been peer reviewed and includes data from the whole genomes of 56 new betacoronaviruses in addition to some partial sequences. All of these viruses were collected between 2004 and 2021. Shi explained at the conference that none of the viruses she has sequenced are the most recent ancestors of SARS-CoV-2 and that “We didn’t find any new sequences which are more closely related to SARS-CoV-1 and SARS-CoV-2.”

The known viruses that are closest to SARS-CoV-2 were found in bats in Laos and southern China. However, years (or decades) have passed since these viruses split from their common ancestor with SARS-CoV-2. Shi has long since collaborated with EcoHealth Alliance, which previously received US federal funding that was suspended because of inadequate oversight of research activities at the WIV. This collaboration has produced a larger analysis of more than 230 sequences that EcoHealth Alliance’s Peter Daszak says will be submitted for peer review and publication in the coming weeks.

Further Reading: “PLA Looks into China-US Collaboration in Biosecurity Research,” Stephen Chen, SCMP

75+ Nobel Laureates Urge Senate Not to Confirm RFK Jr.

77 winners of the Nobel Prize in Medicine, Chemistry, Physics, and Economics have signed a letter (below) urging the Senate not to confirm President-Elect Trump’s pick to lead HHS-Robert F. Kennedy Jr.. This is a rare example of Nobel laureates coming together against a US Cabinet choice, according to Sir Richard Roberts, winner of the 1993 Nobel Prize in Medicine and a drafter of the letter. The letter criticizes Kennedy’s lack of experience in public health in addition to his widely criticized opinions on topics like drinking water fluoridation and vaccines for measles and polio. The letter reads in part, “In view of his record, placing Mr. Kennedy in charge of DHHS would put the public’s health in jeopardy and undermine America’s global leadership in the health sciences, in both the public and commercial sectors…We strongly urge you to vote against the confirmation of his appointment as Secretary of the DHHS.”

81adbc30-fullDownload

Further Reading:

“2024 ABSA Conference Summary”

Biodefense MS Student Lena Kropke discusses her experience at the 67th Annual Biosafety and Biosecurity Conference in this Pandora Report event summary, writing in part “Attending this conference not only reaffirmed that biosafety and biosecurity are vital components of international security, but also showcased the incredible dedication of professionals who work tirelessly toward this mission. Moreover, it offered an introduction to an amazing network of biosafety and security professionals.”

Read more about Lena’s time attending the conference in Phoenix here.

“Disincentivizing Bioweapons: Theory and Policy Approaches”

This NTI essay collection is “…designed to encourage the exploration and identification of potential solutions to disincentivize states from developing or using biological weapons,” and aims to “bridge theory and practical policy-relevant approaches to develop new approaches to invigorate international efforts to reduce biological threats.” Its fifth essay, “Two Competing Bioweapons Nonproliferation Policies: Deterrence by Denial and Discussion,” was authored by Sonia Ben Ouagrham-Gormley, Associate Professor at the Schar School.

Mitigating Arboviral Threat and Strengthening Public Health Preparedness: Proceedings of a Workshop

From NASEM: “Arboviruses, or viruses carried by arthropods like mosquitoes or ticks, are responsible for hundreds of thousands of deaths worldwide each year. As the climate changes globally, the geographic distribution of these diseases, including Zika, dengue, chikungunya, West Nile, and yellow fever, are steadily expanding. The National Academies Forum on Microbial Threats hosted a public workshop in December 2023 to explore avenues of threat reduction from known and emerging arboviral diseases in the context of public health preparedness and capacity building. The workshop featured talks from experts in entomology, public health, ecology, virology, immunology, disease modeling, and urban planning.”

Read this Proceedings of a Workshop for free here.

“The Current Pathogenicity and Potential Risk Assessment of Nipah Virus as Potential Cause of “Disease X”: A Narrative Review”

Mehnaz et al. recently published this article in Health Science Reports: “Background and Aims…The World Health Organization (WHO) recognized the potential for a severe international epidemic and introduced the term “Disease X” to classify pathogens that not yet identified. The Nipah virus (NiV) is highly dangerous due to its zoonotic nature, high mortality rate, and ability to cause severe clinical symptoms in humans. In this review, we gather the latest information on the NiV and its potential to become a significant candidate for Disease X.”

“Methods…We performed a thorough review of articles published in PubMed, Scopus, and Google Scholar using appropriate MeSH terms and keywords. Studies reported NiV infection were considered for this review.”

“Results…The NiV exhibits different epidemiological patterns in different countries that calls for customized prevention and control strategies. Genetic analysis highlights NiV’s ability to mutate that alters possible treatment options. Transmission typically involves bats as the primary reservoir, with humans becoming infected either through intermediate hosts or food. This shows NiV’s complex nature, including its ability to reach the central nervous system through the olfactory nerve. Promising treatment options, such as monoclonal antibodies, antivirals, and ongoing vaccine research, provide hope. However, the virus’s adaptability, human-to-human transmission, and the lack of specific antiviral therapy raise concerns about its potential to cause a global pandemic. The interconnection between animals, humans, and the environment stresses the need for a One Health approach to tackle emerging infectious disease by NiV.”

“Conclusion…Global collaboration, surveillance, and research investments are imperative for the preparation of future pandemics. The ongoing COVID-19 challenges underscoring the critical need for sustained scientific endeavors, global leadership, and recognition of the prominence of NiV as a candidate for the potential Disease X.”

“Engineering Biology Public Trust Survey Findings”

From the UK’s Department for Science, Innovation and Technology, these findings are the result of a survey on public perceptions of engineering biology in relation to five application areas: health, agriculture and food, low carbon fuels, chemicals and materials, and waste and environment. Key findings from this survey include “The majority of respondents felt comfortable with using new and emerging technologies on a day-to-day basis, but relatively few could explain what engineering biology is,” “There was a strong belief amongst respondents that applications of engineering biology could be useful. Similarly, the majority were comfortable with each of the specific applications and believe that they will be positive for society,” “There was broad agreement that the government is well placed to make decisions about the use of engineering biology but the public should also be involved in decision making,” and more.

“CSR Biodefense Scorecard: Winter 2024 Update”

From the Council on Strategic Risks: “In the fall of 2023, we kicked off our Biodefense Scorecard series to help inform the public on the progress and implementation status of past CSR recommendations on reducing biological risks. This update captures several areas of sustained positive action across pathogen early warning, diplomacy, and biomanufacturing.”

“Ignoring the Real Biowarfare Threat”

David Heslop and Joel Keep discuss the potential implications of recent renovations at Sergiev Posad-6 in this piece from the Lowy Institute, writing in part “While much attention has been paid to nuclear arms, Washington and Moscow must also address biological weapons, which both nations claimed to renounce many years ago. The fate of such programs is not only a matter for Russia and the United States, but for global health security at large.”

“Instrumentalising Biological Weapons-Related Allegations: Russia’s Compliance Politics and the Norms Against Biological Weapons”

Una Jakob recently published this working paper with CBWNet discussing Russia’s use of BWC compliance procedures and their effect on norms against BW. Jakob explains in part of the paper’s executive summary, “Seen in this light, the Russian activities may counterintuitively have contributed to strengthening the norms against biological weapons at the discursive level, as no actor has called them into question and as their validity has been reaffirmed repeatedly in the process, including by Russia itself. This stands in contrast, however, to Russia’s policy which may contest biological weapons norms at the action level. This discrepancy between the discursive and practical level and its implications for norm strength merit further theoretical attention. On a policy level, it will be important to increase transparency, counter disinformation, and strengthen the means to demonstrate, verify and enhance confidence in compliance with the BWC. This would also strengthen the possibilities to address biological weapons-related allegations, including those made in bad faith, and help sustain the norms against biological weapons comprehensively and in the long term.”

“Workshop on S&T Developments with Relevance for the CWC and BWC”

Anna Krin and Gunnar Jeremias edited this CBWNet working paper detailing a workshop hosted in June at Hamburg University focused on challenges and opportunities facing biological and chemical arms control. Jeremias explains in the introduction, “Throughout the workshop, four panels delved into key topics: the general concept and application of scientific and technological advice in arms control in general and particularly in chemical and biological arms control; current developments in science and technology that may necessitate attention; potential frameworks for organizing verification under the CWC and the prospects for institution building for S&T advice and verification within the BWC; and the technologies and governance methods that could be employed to enhance the efficacy of arms control measures…The insights gathered during these discussions aim to contribute to the ongoing discourse on arms control, ensuring that both the BWC and CWC remain vital in a landscape marked by rapid scientific change. This compendium encapsulates the collaborative efforts and perspectives of workshop participants, reflecting a shared commitment to advancing arms control in an increasingly complex world.”

“High-Impact, Low-Probability: NATO-EUROPOL Cooperation in Countering the CBRN Terrorist Threat to Europe”

This JCBRN Defence COE report by Mathias Katsuya “…draws on secondary-source research and insights provided by JCBRN Defence COE personnel as well as Europol’s CBRN-E Team Leader. An initial threat assessment is followed by a review of Europol’s CBRN capabilities, centring on the role of its European Counter-Terrorism Centre and inhouse CBRN-E Team as key nodes in law enforcement information-sharing, capacity-building, and operational coordination. Having identified key doctrinal and capability overlaps with NATO in addition to a stated commitment by Europol’s CBRN-E Team to enhance its civil-military relations, the report outlines a three-pillar approach to deepening connections between NATO and Europol: short-term measures to foster staff-level contacts in both organisations, a formalised relationship between Europol’s CBRN-E Team and NATO’s JCBRN Defence COE, and deeper institutional linkages to effectively confront current and emerging CBRN threats.”

“Hybrid Threats in the CBRN Environment: Challenges and Implications”

This JCBRN Defence COE paper by Paulina Frederike Gogacz discusses hybrid CBRN threats and their use by actors like Russia. Gogacz explains in the paper’s summary that “An analysis of the six strategic enablers outlined in NATO’s Chemical, Biological, Radiological and Nuclear (CBRN) Defence Policy (2022) indicates important steps to ameliorate current defences and prepare NATO and its member states for future hybrid CBRN threats, thereby increasing overall resilience. They include important aspects: robust intelligence-sharing mechanisms to ensure timely and accurate threat information; comprehensive exercises to simulate and prepare for various CBRN scenarios; strong partnerships both within the alliance and with external entities to foster cooperation and resource sharing; effective strategic communication to manage information and public perception; collaborative scientific research to advance technological capabilities and countermeasures; and the resilience of medical infrastructure to ensure a rapid and effective response to CBRN incidents. These steps collectively aim to bolster NATO’s preparedness and adaptability in the face of evolving hybrid CBRN threats.”

“Securing a Strategic Advantage in Biosecurity for NATO”

Max Breet and Lauren Ross recently authored this commentary for RUSI, writing in their summary “NATO should recognise the importance of biosecurity by understanding it as a new domain. This would allow the Alliance to more effectively leverage existing structures to defend itself against hybrid biological threats.”

“The Rise of Mpox in a Post-Smallpox World”

McQuiston et al. recently published this article in Emerging Infectious Diseases: “Reports of mpox are rising in Africa where the disease is endemic and in new countries where the disease has not been previously seen. The 2022 global outbreak of clade II mpox and an ongoing outbreak of the more lethal clade I mpox highlight the pandemic potential for monkeypox virus. Waning population immunity after the cessation of routine immunization for smallpox plays a key role in the changing epidemiologic patterns of mpox. Sustained human-to-human transmission of mpox is occurring widely in the context of insufficient population immunity, fueling genetic mutations that affect the accuracy of some diagnostic tests and that could lead to changing virulence. Additional research should address complex challenges for control of mpox, including improved diagnostics and medical countermeasures. The availability of vaccines should be expanded not only for outbreak response but also for broader routine use for persons in mpox-endemic countries.”

“Confronting Risks of Mirror Life”

Adamala et al. recently published this Science Policy Forum piece, writing in part, “All known life is homochiral. DNA and RNA are made from “right-handed” nucleotides, and proteins are made from “left-handed” amino acids. Driven by curiosity and plausible applications, some researchers had begun work toward creating lifeforms composed entirely of mirror-image biological molecules. Such mirror organisms would constitute a radical departure from known life, and their creation warrants careful consideration. The capability to create mirror life is likely at least a decade away and would require large investments and major technical advances; we thus have an opportunity to consider and preempt risks before they are realized. Here, we draw on an in-depth analysis of current technical barriers, how they might be eroded by technological progress, and what we deem to be unprecedented and largely overlooked risks (1). We call for broader discussion among the global research community, policy-makers, research funders, industry, civil society, and the public to chart an appropriate path forward.”

Bonus: Read Carl Zimmer’s discussion of this warning in The New York Times here.

NEW: OneLab Network Webinar

“Clinical laboratories must be alert for unusual and potentially infectious agents and immediately notify their Laboratory Response Network (LRN) reference laboratory if routine diagnostic testing results in the potential identification of rare and unusual infectious agents that may be used in a bioterrorist attack or other bio-agent incident. This webinar will describe the LRN and highlight the clinical laboratory’s role and responsibilities in initiating contact with their LRN. Join us as we share an example of a response, new tools, and valuable resources to aid in the clinical laboratory’s response.”

This event will take place on December 17 at 12 pm ET. Register for this event here.

NEW: Understanding the Introduction of Pathogens into Humans- Preventing Patient Zero: A Workshop

“The past few decades have seen the emergence of several diseases with drastic public health and economic consequences. Understanding routes of pathogen emergence and transmission is critical to preventing and mitigating disease spillover and amplification. The National Academies Forum on Microbial Threats will host a hybrid public workshop to address gaps in understanding of disease emergence, with a focus on human-animal interaction and laboratory biosafety. The workshop will explore how applications of existing policy structures, emerging technologies, and actionable research can improve biosecurity measures and prevention of future disease emergence.”

This event will take place on January 15 and 16. Learn more and register here.

NEW: Rise of the Zombie Bugs: The Surprising Science of Parasitic Mind-Control

Johns Hopkins APL’s colloquium will feature Mindy Weisberger, author of the upcoming book Rise of the Zombie Bugs: The Surprising Science of Parasitic Mind-Control: “Zombies are all around us—insect zombies, that is. In Rise of the Zombie Bugs, Mindy Weisberger explores the eerie yet fascinating phenomenon of real-life zombification in the insect class and among other invertebrates. Zombifying parasites reproduce by rewriting their victims’ neurochemistry, transforming them into the “walking dead”: armies of cicadas, spiders, and other hosts that helplessly follow a zombifier’s commands, living only to serve the parasite’s needs until death’s sweet release (and often beyond).”

Learn more about this January 31 event here.

How to Avoid Human-Made Pandemics

From the Asia Centre for Health Security: “Studying viruses that could potentially cause outbreaks is one of the most effective ways to reduce the risk of pandemics. However, this type of research—especially when it involves collecting samples from the field and manipulating pathogens—can unintentionally lead to a pandemic if not managed carefully. Dr Lentzos will discuss her findings from the Pathogen Project, which brought together an international taskforce of scientists, biosecurity and public health experts, ethicists, and civil society leaders to seek consensus on this question: Can we agree on ways to manage research that carries pandemic risk as safely, securely and responsibly as possible?”

This event will take place on January 23 at 8 pm (GMT +8:00) via Zoom. RSVP here.

Preparedness in Rural Communities: National and State/Local Perspectives and Plans

From Penn State: “The COVID-19 pandemic and recent hurricanes have thrust the preparedness of rural communities into the national spotlight. At the federal level, the Administration for Strategic Preparedness and Response and the Centers for Disease Control and Prevention have recently released national goals and plans for preparedness of rural communities. The overall objective of this virtual, 2-day mini-symposium is to identify opportunities in public health and agricultural preparedness and response in rural communities. The mini-symposium will focus upon national perspectives on Thursday, January 30 and the state/local perspectives on Friday, January 31. Speakers include representatives of the Administration for Strategic Preparedness and Response, the Department of Homeland Security, US Department of Agriculture, the USA Center for Rural Public Health Preparedness, and state/local leaders.”

This event will take place on January 30 and 31, from 11 am to 2 pm ET each day. Learn more and register here.

Cyberbiosecurity Summit

From Johns Hopkins APL and Bio-ISAC: “Advancements in biomanufacturing and biotechnology drive the science we need to thrive, everything from apples to vaccines. The Cyberbiosecurity Summit 2025 convenes leading experts in biotechnology, biosecurity, and cybersecurity to explore the intersection of these fields and discuss the strategies to create a safe, secure future for us all.”
This event will take place February 25-26 in Laurel, MD. Register here and review the call for sessions here (closes 12/12).

NEW: The Independent Panel Solicits Views and Insights on Pandemic Prevention, and Response Efforts

“The Independent Panel for Pandemic Preparedness and Response, co-chaired by HE Ellen Johnson Sirleaf and RH Helen Clark, welcomes you to share your insights and expertise on the status of international and regional pandemic-related reform processes and initiatives, and how progress can be continued and accelerated in the months and years ahead.”

Learn more about this survey and submit by December 20 here.

Pandora Report 11.8.2024

by dkellogg97, posted in Pandora Report

This week’s Pandora Report discusses one Biodefense MS student’s research on malaria, the UK’s recently-announced sanctions against 56 people and entities linked to Russia, the CDC’s call for more avian influenza testing, and what a second Trump administration likely means for US public health and global health security.

Biodefense MS Student Presents at Malaria Research Symposium

Zachary Berliner, a Biodefense MS student, is presenting a poster at the 10th Annual Future of Malaria Research Symposium in Baltimore, MD, on November 8. This conference, jointly run by the Johns Hopkins Malaria Research Institute and the University of Maryland School of Medicine, provides “a platform for early-career scientists to share their research with peers, emerging leaders, and established investigators.” In 2023, nine cases of locally acquired malaria occurred in the United States, the first such cases in twenty years. Zak’s project, Public Opinions Toward Malaria Control Interventions in the National Capital Region, featured a survey of adults in the National Capital Region about their opinions toward various malaria control interventions. His study serves as an indicator of preliminary opinions among a small group of Americans to better inform politicians. His poster can be found here, and the full paper can be found here. The poster is based on the capstone paper that Zak wrote as a culmination of his experience in the Biodefense program. Zak is graduating with his MS in Biodefense in December and is looking for policy and analysis opportunities focused on biodefense and health security.

United Kingdom Announces Sanctions on 56 People and Entities Linked to Russia

The UK announced its largest sanctions package against Russia since May of last year this week, in a series of actions the government hopes “disrupts the supply of vital equipment for Putin’s war machine and bears down on Russian malign activity globally, exposing the corrupt activities of Russian proxy military groups in Africa.” Those sanctioned include Denis Sergeev (who was charged by the Met Police in the attempted murder of Sergei Skripal), entities in China, Turkey, and Central Asia, Africa Corps and other private mercenary groups linked to the Kremlin, and others. The UK is the first G7 country to directly sanction Africa Corps, which has directly threatened peace and security in Libya, Mali, and the Central African Republic.

CDC Calls for Expanded Bird Flu Testing as California and Washington Report More Cases

Officials at the CDC called for more testing on farms with avian influenza cases after a recent study found some dairy workers have shown signs of infection even though they did not report feeling sick. The study that 7% of the 115 farmworkers whose blood was tested (eight) had antibodies consistent with previous H5N1 infection, pointing to more infections than the 46 identified so far. More cases in farmworkers have also been reported in recent days, including at least four in California and three in Washington. The California Department of Public Health also recently reported one other probable case in a dairy worker who met the case definition, though CDC’s confirmation test was negative.

What Lies Ahead in Trump’s Second Term

President-Elect Trump’s recent victory likely will have severe implications for both domestic health policy and global health security. The first Trump administration largely failed in its response to the COVID-19 pandemic, despite the US ranking very well in pre-pandemic preparedness assessments like the Global Health Security Index and the Trump administration being handed a pandemic playbook by the preceding Obama administration that specifically flagged novel coronaviruses as a potential pandemic threat. The upcoming second Trump administration looks ready to fair just as poorly in terms of not just pandemic preparedness, but in general public health and global health engagement as well.

The president-elect, who has repeatedly and falsely claimed that climate change is a hoax, has promised to rollback federal regulations on the oil and gas industry that are aimed at slowing climate change. Trump pulled the United States out of the 2015 Paris Climate Accord in 2017, and his campaign has indicated it intends to do the same again once he is back in office. Trump is also expected to target the EPA during his second term. Changes like this are especially concerning as the effects of climate change, such as increased extreme weather and easier spread of infectious diseases, pose a growing threat globally.

Trump does plan to involve at least one environmental lawyer in his administration-Robert F. Kennedy Jr., an environmental lawyer who Trump has suggested may play a large role in public health in his administration. Unfortunately, Kennedy has no training in public health or medicine, and he has repeatedly peddled anti-vaccine conspiracy theories over the years. Kennedy also faced backlash for comments suggesting COVID-19 was “ethnically targeted,” saying “COVID-19 is targeted to attack Caucasians and Black people. The people who are most immune are Ashkenazi Jews and Chinese…We don’t know whether it was deliberately targeted or not but there are papers out there that show the racial or ethnic differential and impact.” Kennedy has also voiced criticism of the childhood vaccine schedule and public water fluoridation, claiming the latter is “lowering IQ in our children,” in contrast to what numerous studies over multiple decades show about its safety and efficacy.

Trump has promised to allow Kennedy to “go wild on” health, medicines, and food policy, with Kennedy saying he believes entire departments at the FDA “have to go.” Kennedy has also said he wants an eight-year-long “break” in NIH funding for infectious disease research, and that he would move that money to chronic disease research. Congressional Republicans have targeted the NIH in recent years, including efforts to strip its authority over gain of function research and repeatedly attacking former NIAID Director, Anthony Fauci.

Trump’s second term also may pose threats to global health security more directly. For example, in 2020, the Trump administration formally notified the United Nations that it intended to withdraw the country from the World Health Organization. This move would have cut off one of the largest funding sources to the WHO in the middle of the COVID-19 pandemic. Furthermore, some experts argue the attempt was unlawful, in addition to the threat it posed to domestic and global health and security. While the Trump campaign mentioned few specifics about foreign policy for a second term, the United Nations is bracing itself for this incoming administration.

This week’s election results have many experts deeply concerned about what this administration will bring. Saskia Popescu, an alumna of the Schar School’s Biodefense PhD Program and current adjunct professor at the school made this statement to The Bulletin of the Atomic Scientists about the election result’s implications for public health: Right now, I think you’d be hard-pressed to find many in public health, healthcare, and pandemic preparedness/response, who are not deeply concerned. The recent notion that Robert F. Kennedy Jr. could be in charge of public health for the United States poses a real danger. From his claims that vaccines are harmful or unnecessary to his proposed efforts to remove fluoride from public water systems, Kennedy continuously pushes anti-science rhetoric and dis/misinformation.

History has shown us what might happen under another Trump administration during times of crises, from extreme weather events to a pandemic. We have seen how an administration that pits itself against science and dedicated public service officials reacts. As we face an ongoing H5N1 outbreak, persistent outbreaks of emerging infectious diseases, an erosion of trust in public health, a rise in dis/misinformation, and widening social disparities, we need leadership that will unite rather than divide.

We are at a critical time in forming effective and pragmatic policies to address complex issues such as the ways in which developments in artificial intelligence (AI) will affect biosecurity, the safety and security around critical research of dangerous pathogens, the effects of climate change on infectious diseases, and the need to strengthen global health through equity and partnership.

Developing policies in these areas will require strategies based on collaboration and evidence-based measures–not inflammatory, inaccurate, and harmful rhetoric that furthers partisan divides and enflames social discourse. It’s our responsibility to find a path that ensures the protection of public health and global health security. We’ve got a lot of work to do, and I fear a hard road ahead of us.

Others have voiced concerns about a return to US isolationism in global health, Trump not seeking out quality scientific advice, policies regarding vaccines, and more that can be read in this piece from The Bulletin of the Atomic Scientists.

“HHS’ ASPR Playing ‘Quarterback’ for Cyber Response, Resilience”

Jason Miller discusses ASPR’s cyber efforts with Biodefense PhD Program alumnus, Schar School adjunct professor, and current Deputy Director of ASPR’s Office of Preparedness in this piece for Federal News Network: “Just a little over a year ago, that coordination was occurring, but not as smooth as it needed to be. We took some steps, and actually now have a Public Health Service, captain, or an 06 officer, permanently embedded within the National Cyber Investigative Joint Task Force, that the FBI leads. We have a HHS ASPR person embedded full time with the FBI agents and other law enforcement folks who work in that task force and really are dealing with very sensitive information and responding to cyber incidents in the healthcare sector every day,” said Mazanec on Ask the CIO. “That’s just another example where we’ve really tightened up and continue to mature our partnership with the FBI. We do work with the other health focused entities like the Veterans Affairs Department, the Defense Health Agency, certainly within HHS, with the Indian Health Service  and with the Centers for Medicaid and Medicare Services.”

Read more here.

“GHSD Five-year Strategy 2024-2028 (October 2024)”

The State Department’s Bureau of Global Health Security and Diplomacy recently released its strategic plan for 2024-2028: “The COVID-19 pandemic underscored the importance of preventing, detecting, and responding to health crises to safeguard American lives and the global economy. Building on the successes of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), which has saved more than 25 million lives from HIV/AIDS, and to address the growing challenges posed by health threats, the State Department established the Bureau of Global Health Security and Diplomacy in August 2023.”

“Building on decades of leadership on global health within the State Department, the Bureau of Global Health Security and Diplomacy’s mission is to lead U.S. diplomatic engagement, help coordinate foreign assistance, and promote international cooperation against health threats, integrating global health security as a core component of national security and foreign policy. The bureau’s first ever five-year Strategy for 2024-2028 outlines the State Department’s role in ending HIV/AIDS as a public health threat and advancing global health security and pandemic prevention, preparedness, and response efforts for the U.S. government.”

“The goals of the Strategy are to:

  • End HIV/AIDS as a public health threat by 2030
  • Catalyze the political will, financing, and leadership necessary to achieve heath security and address public health threats, including HIV/AIDS
  • Improve global multisectoral preparedness and response through diplomacy to protect against health security threats
  • Empower the diplomatic workforce to prioritize and integrate global health security as a key pillar of U.S. foreign policy.”

Read the strategy here.

“Chemical Weapons Policymakers Must Act to Balance the Prospects and Perils of AI”

Patrick Norén recently published this CBNW article covering a conference organized by the OPCW and Kingdom of Morocco focused on the role of AI in advancing implementation of the CWC. Norén covers general trends in speakers’ comments, the dual use nature of AI, challenges in legislation, regulation, and cooperation, and issues with misinformation and disinformation.

“MATCH 2.0 Enters Demonstration and Live Testing Phase”

From Stimson: “Behind every chemical transfer is a story, and too often, that story includes discrepancies in reported data. The Stimson Center’s MATCH project team has completed development of an updated DLT prototype and is demonstrating to CWC National Authorities and other stakeholders how it traces these narratives and creates a clear, immutable record of each transaction, aligning records of national authorities and industry while maintaining data confidentiality, reducing risks of misreporting, and enhancing nonproliferation by enabling faster reconciliation of discrepancies in the annual reporting of chemicals covered by the Chemical Weapons Convention (CWC).”

Read more here.

“THE NEXUS BETWEEN SCIENCE AND NATIONAL SECURITY IN CANADA: THE CASE OF THE NATIONAL MICROBIOLOGY LABORATORY IN WINNIPEG”

The Canadian House of Commons’ Special Committee on the Canada-People’s Republic of China Relationship recently released this interim report. Among other things, the report reveals that CSIS “issued a direct and unheeded warning to senior health officials in August 2018, raising concerns about “insider threat activities” linked to Dr. Xiangguo Qiu and her husband, Keding Cheng.” The report explains in its conclusion “The events at the Winnipeg NML facility revealed, as outlined in this report, the fundamentally open and collaborative nature of Canadian scientific research as a means of contributing to the common good, on the one hand, and, on the other, the need for a cultural shift within the scientific field in terms of its vigilance over national security risks and the need to reconsider how we collaborate with entities or states that may not share the same interests as Canada. For example, with regard to the PRC, Mr. Vigneault said that “[i]t is sometimes in our own national interest to collaborate with Chinese entities, but we need to do it with our eyes wide open and make sure that we protect our own base.”’

Read Sam Cooper’s coverage of this report in The Bureau here.

NEW: Developing Guardrails for AI Biodesign Tools

From NTI: “Join us for a virtual webinar releasing the findings of NTI | bio’s new report, Developing Guardrails for AI Biodesign Tools, followed by a moderated discussion and Q+A with distinguished guest Claire Quereshi.”

“Artificial intelligence (AI) promises to revolutionize not only aspects of daily life but cutting-edge scientific research and development. Within the life sciences, AI biodesign tools (BDTs) have improved significantly in their ability to design biological molecules and make predictions about living systems, displaying potential for beneficial applications and posing significant potential risks if misused.”

“Authors Sarah R. Carter, Ph.D., Nicole E. Wheeler, Ph.D., Christopher R. Isaac, M.Sc., and Jaime M. Yassif, Ph.D. conducted interviews with experts with deep experience creating bioinformatic tools, developing BDTs, and crafting biosecurity policies. The report outlines several proposed measures that could be deployed to design governance approaches to reduce biological risks without unduly hindering scientific advances.”

This event will take place virtually on November 14 at 11 am ET. Learn more and register here.

NEW: A Year-End Review, Recapping Global AI Governance Efforts

From CSET: “This time last year seemed to herald a landmark period in establishing AI governance regimes around the world. After ChatGPT and other AI tools burst onto the scene, U.S. policymakers issued new executive orders, hosted hearings and high-profile learning sessions, and developed new frameworks and standards to support the safe and secure development of AI. Elsewhere, the European Union worked to finalize its AI Act, and China announced its Global AI Governance Initiative. One year later, where do the promises and commitments to govern AI stand?”

“Join us on November 14, as we look back on the last year of global AI governance efforts and evaluate what progress has been made, what work remains to be done, and what the actions of global partners and competitors alike mean for U.S. strategy going forward. CSET Associate Director of Analysis Owen J. Daniels will moderate a conversation with CSET researchers Mia Hoffmann, Mina Narayanan, and Cole McFaul as we survey governance developments around the world over the past year. The moderated discussion will be followed by audience Q&A.”

This event will take place at 1 pm ET on November 14. Learn more and RSVP here.

NEW: Enhancing the Resilience of Healthcare and Public Health Critical Infrastructure

From NASEM: “Healthcare and public health infrastructure, technology, and operations are rapidly changing and are increasingly interdependent and interconnected. Threats to the nation’s critical social and physical infrastructure systems are also rapidly evolving and highly complex—posing potentially new or growing risks of disruption and challenging the assumptions used to design and protect these systems.”

“The National Academies Forum on Medical and Public Health Preparedness for Disasters and Emergencies will host a hybrid public workshop to explore strategies, policies, and innovative actions to improve the resilience of healthcare and public health (HPH) critical infrastructure to impacts from disasters and other emergencies.”

This event will take place in DC on December 9 and 10. Register here.

NEW: Resilience in the Face of Global Risks

From CSR: “The Council on Strategic Risks (CSR) cordially invites you to our first annual CSR symposium, Resilience in the Face of Global Risks, scheduled for Tuesday, December 10, 2024. This is the first event bringing together all three of CSR’s institutions—the Center for Climate & Security, the Converging Risks Lab, and the Janne E. Nolan Center on Strategic Weapons—to engage with leaders across our mission sets.”

“The United States and its allies face a complex global security landscape where systemic risks like climate and ecological crisis, nuclear proliferation, and biological threats are blending with war, geopolitical competition, and human insecurity in new and profound ways. While there has been tremendous leadership—and meaningful progress—across these overlapping risk areas, they require persistent innovation in community building to meet the modern risk landscape.”

“The symposium will dive into the progress our communities have made—and how our passionate communities can better work together to help shape the future.”

“In addition to a keynote address, guests will hear from panels, take part in breakout sessions showcasing important issues and new ideas, plus engage with thought leaders between sessions. It will be a widely attended gathering, free to attendees.”

“As we enter a new year with an exceptionally dynamic security environment, we hope CSR’s December event will inspire and build a stronger community across professionals dedicated to anticipating and addressing the world’s greatest risks. We appreciate your consideration and hope you will be able to join us on the 10th of December.”

RSVP here.

Preparing for the Next Outbreak: Designing Closer Collaboration between Healthcare and Public Health to Deploy Pathogen-Agnostic Testing as an Early Warning System

From PNNL: “Please join us in welcoming Dr. Adi V. Gundlapalli, Senior Advisor for Data Readiness and Response in the Office of Public Health Data, Surveillance, and Technology at the CDC for his talk titled “Preparing for the Next Outbreak: Designing Closer Collaboration between Healthcare and Public Health to Deploy Pathogen-Agnostic Testing as an Early Warning System”. This webinar will take place Wednesday, November 13th, at noon PT.”

Learn more and register here.

Developing Guardrails for AI Biodesign Tools

From NTI: “Join us for a virtual webinar releasing the findings of NTI | bio’s new report, Developing Guardrails for AI Biodesign Tools, followed by a moderated discussion and Q+A with distinguished guest Claire Quereshi.”

“Artificial intelligence (AI) promises to revolutionize not only aspects of daily life but cutting-edge scientific research and development. Within the life sciences, AI biodesign tools (BDTs) have improved significantly in their ability to design biological molecules and make predictions about living systems, displaying potential for beneficial applications and posing significant potential risks if misused.”

This virtual event will take place on November 14 at 11 am EST. Learn more and register here.

13th Annual Jonathan Tucker Symposium

“The James Martin Center for Nonproliferation Studies cordially invites you to the 13th annual Jonathan Tucker Symposium on chemical and biological weapons issues on November 13th and 14th, 2024.”

Among this year’s speakers are Dr. Yong-Bee Lim, an alumnus of the Biodefense PhD Program and Deputy Director of the Converging Risks Lab and Biosecurity Projects Manager at the Council on Strategic Risks, who will give a talk titled “Technology Democratization and its Implications for CBW Safety and Security: Lessons Learned from Engagement with Non-Traditional Communities.”

Learn more and register here.

One Health and the Politics of COVID-19 Book Launch

The Writer’s Center is hosting a book launch for Dr. Laura Kahn’s new book, One Health and the Politics of COVID-19 (blurb below) on November 23 at 2 pm EST in Bethesda, MD. Learn more and RSVP here.

“One Health and the Politics of COVID-19 unpacks the mysteries of COVID-19’s origins to impart important lessons for future outbreaks. The One Health concept recognizes the interconnected links among the health of humans, animals, plants, and the environment. By comparing the history, science, and clinical presentations of three different coronaviruses—SARS-CoV-1, MERS, and SARS-CoV-2 (COVID-19)—Kahn uncovers insights with important repercussions for how to prepare and avoid future pandemics. The One Health approach provides a useful framework for examining the COVID-19 pandemic. Understanding the origins of this zoonotic disease requires investigating the environmental and molecular biological factors that allowed the virus to spread to humans. The book explores the many ways in which the wild animal trade, wet markets, and the camel industry contributed to the spread of the earlier SARS-CoV-1 and MERS coronaviruses. For SARS-CoV-2 (COVID-19), Kahn examines the biosafety, biosecurity, and bioethics implications of gain-of-function research on pandemic potential pathogens. This book is a must read to understand the geopolitics of the COVID-19 pandemic.”

2024 CBD S&T Conference

From DTRA: “The CBD S&T Conference brings together the most innovative and influential chemical and biological defense community members from around the globe to share insights and collaborate on the emerging chem-bio threats of tomorrow.”

“Join the Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department in its role as the Joint Science and Technology Office (JSTO) for Chemical and Biological Defense, an integral component of the Chemical and Biological Defense Program, as we Focus Forward to uncover novel concepts and examine groundbreaking discoveries within the chem-bio defense landscape.”

“The 2024 CBD S&T Conference will be held at the Broward County Convention Center, December 2–5, 2024.”

Learn more and register here.

Health Security Intelligence: Managing Threats Risks and Hazards Post-Covid 19
“As  the acute impact of the COVID-19 pandemic recedes, many unaddressed questions remain for Australia about how to better prepare for the next likely health threat, risk or hazard.”

“In addition to how we enhance national public health capacity, what are the important lessons we can learn from the pandemic from national security and biosecurity perspectives?”

“Given the likelihood of another pandemic at some point, an increasingly uncertain geo-political order and the potential exploitation of biotechnology by bad actors how does Australia and its allies better prepare for a future of increasingly complex health security and biological security threats, risks and hazards?”

“This event is for all health security intelligence stakeholders (policy-makers, national security staff, scientists, researchers and clinicians) who work across the one health continuum and national security agencies.”

“It will introduce participants to Charles Sturt’s extensive research agenda across the one health biosecurity, health and biological security and discuss both their national security and scientific implications.  You will hear briefings from key researchers across both STEM and social sciences disciplines working on assessing key health security threats, risks and hazards relevant to your work.”

This event will take place in-person and over livestream on December 4 from 2-4 pm AEDT. Learn more and register here.

US AI Safety Institute Issues RFI on Responsible Development of Chem-Bio Models

From AISI: “The U.S. Artificial Intelligence Safety Institute (U.S. AISI), housed within the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST), released a Request for Information seeking insight from stakeholders regarding the responsible development and use of chemical and biological (chem-bio) AI models.”

“Input from a broad range of experts in this field will help the U.S. AISI to develop well-informed approaches to assess and mitigate the potential risks of chem-bio AI models, while enabling safe and responsible innovation.”

“Respondents are encouraged to provide concrete examples, best practices, case studies, and actionable recommendations where possible. The full RFI can be found here.”

“The comment period is now open and will close on December 3, 2024, at 11:59PM Eastern Time. Comments can be submitted online at www.regulations.gov, under docket no. 240920-0247.”

Pandora Report 10.19.2024

by dkellogg97, posted in Pandora Report

This week’s Pandora Report covers updates from the Biodefense Graduate Program, a new biosecurity and biosafety declaration from ASEAN leadership, the United States’ IV fluid shortage, new publications and upcoming events, and more.

Upcoming Virtual Information Sessions on the Biodefense Graduate Program

If you are interested in a career in biodefense or global health security or want to develop the knowledge and skills necessary to work at the nexus of health, science, and security, find out what the Schar School of Policy and Government has to offer. 

The Schar School PhD programs will be holding a virtual open house on Wednesday, October 30 from 6-7:30 PM. Please join Dr. Gregory Koblentz, director of the Biodefense Graduate Program, to learn more about the Biodefense PhD program and ask any questions you may have. Register here.

Biodefense MS Grads Starts at National Security Commission on Emerging Biotechnology as Policy Advisor

Olivia Parker, a recent graduate of the Biodefense MS program, recently joined the National Security Commission on Emerging Biotechnology (NSCEB) as a policy advisor. NSCEB is a legislative branch advisory entity charged with conducting a thorough review of how advancements in emerging biotechnology and related technologies will shape current and future activities of the Department of Defense. To learn more about NSCEB, visit their website here: https://www.biotech.senate.gov.

Establishing a National Biosafety and Biosecurity Agency for the United States
Professor Gregory Koblentz, director of the Biodefense Graduate Program, along with co-authors David Gillum and Rebecca Moritz, past presidents of the American Biosafety Association (ABSA), have published an article proposing the establishment of an independent Federal agency to oversee a unified national biorisk management system in the United States called the National Biosafety and Biosecurity Agency (NBBA). The current fragmented regulatory landscape needs to be refocused to address the complexities of modern biological research, including risks associated with accidental, inadvertent, and deliberate biological incidents. The NBBA would consolidate various regulatory functions, streamline processes, and enhance oversight. This oversight would encompass life sciences research in the United States, regardless of the source of funding or level of classification. The agency could also contribute to the bioeconomy by streamlining requirements to safeguard public health and the environment while fostering scientific and commercial progress. The proposed agency would govern high-risk biological pathogens, manage the Federal Select Agent Program, enforce policies related to dual use research of concern, pathogens with enhanced pandemic potential, and nucleic acid synthesis screening, administer regulations on the use and care of laboratory animals, as well as regulate other relevant biosafety and biosecurity activities. The goal would be to provide one-stop shopping for the biomedical research and biotechnology sectors subject to oversight by the Federal government. To ensure leadership in global biosafety and biosecurity, the agency’s mission would include international collaboration, applied research, education, workforce development, and coordination with national security initiatives. Creating an agency like the NBBA will be politically challenging but presenting a comprehensive vision and engaging stakeholders early and frequently, and being transparent in the process, will be essential for garnering support. Creating a unified biosafety and biosecurity governance system in the United States will ensure the safe and secure advancement of biological research while sustaining innovation and maintaining international competitiveness.  The article is open access and can be downloaded here.

George Mason Scientist Secures $1.4 Million from DTRA to Study Viruses’ Impacts on Organ Health

George Mason University researcher Aarthi Narayanan recently secured a $1.4M grant from the Defense Threat Reduction Agency (DTRA) to investigate how an infection spreads between organs, and how a therapeutic will impact connected organs. The work will initially focus on mosquito-transmitted viruses while Narayanan hopes to expand the implications from these studies to other human disease states. Read more here.

ASEAN Leaders Make Declaration on Strengthening Regional Biosafety and Biosecurity

Leaders of the nations comprising the Association of Southeast Asian Nations (ASEAN) made a declaration on biosafety and security earlier this month during the 44th and 45th ASEAN Summits in Vientiane, Lao PDR. Their declaration includes an agreement to strengthen biosafety and biosecurity in the region by committing to strengthening multi-sectoral and multi-stakeholder coordination at the national level on these issues, establishing the ASEAN Biosafety and Biosecurity Network, establishing or strengthening relevant national legal frameworks, upholding commitments around responsible and ethical research using high-risk pathogens and toxins and related data to prevent DURC issues, enhancing protocols and procedures for the safe storage and transport of high-risk pathogens and toxins, ensuring the provision of necessary relevant human resources, supporting efforts to develop sustainable lab infrastructure, and tasking ASEAN Health Ministers to cooperate with relevant ministries to begin consultation, coordinate, and monitor efforts to meet the declaration’s deliverables.

Amid IV Fluid Shortage, Biden Administration Invokes Defense Production Action

The Biden administration told news outlets this week that it has invoked the Defense Production Act (DPA) in order to quicken the reconstruction of a Baxter facility in North Cove, North Carolina that was heavily damaged by Hurricane Helene. The plant was responsible for about 60% of the nation’s IV solutions, so the damage done to it by the storm has left many hospitals postponing surgeries and other procedures. Several products are affected, including multiple concentrations of dextrose IV solution, lactated ringers IV solution, peritoneal dialysis solution, sodium chloride 0.9% IV solution and for irrigation, and sterile water for injection and irrigation.

The DPA was passed in response to the Korean War and is historically based on the War Powers Acts of World War II. Over the years, Congress has expanded the term “national defense” as defined in the DPA so its scope includes things like enhancing and supporting “domestic preparedness, response, and recovery from natural hazards, terrorist attacks, and other national emergencies.” The DPA can be used to compel companies to prioritize government contracts and to help the federal government incentivize expansion of productive capacity and supply. The DPA was similarly invoked by both the Trump and Biden administrations in response to the COVID-19 pandemic.

Baxter said this week that 450 truckloads of undamaged products were removed from the site and that it is working with seven of its plants around the world to help address the shortage. The company is working with the FDA to import nearly 18,000 tons of product from Europe and Asia through the end of the year. Shipments from Baxter plants in Mexico and Spain began arriving last week, and the FDA has already authorized temporary importation from five sites in Canada, China, Ireland, and the United Kingdom. The company is also looking into other strategies, such as expiration date extension requests.

While this recent escalation of IV solution shortage is concerning, it is part of a broader problem that has existed in the US for years. Many of the products listed above were already in shortage prior to Hurricane Helene damaging the North Cove facility. For example, sterile water for injection was placed on the FDA shortage list in November of 2021, and multiple types of dextrose IV solution were added in early 2022. Perhaps most shockingly, saline solution has been on the list since June of 2018.

The reason the US has been grappling with this shortage for years, unsurprisingly, comes down to their lack of profitability. There is a high barrier to entry in that companies must invest substantial time and money in meeting regulatory requirements and setting up a manufacturing facility. At the same time, they are pressured to keep the prices of these products low. There are also issues with managing storage and transportation of these products, as a single bag of saline is about a foot long and weighs more than two pounds. Maintaining the sterility needed to safely make these products further complicates matters as well. Erin Fox, Senior Pharmacy Director at the University of Utah Health, told NBC that “These are life-saving products, but at the same times these are absolutely treated as kind of commodities.”

This situation is mirrored in an even more threatening issue-the dearth of antibiotic research amid rising antimicrobial resistance. While the WHO firmly warned last year that “We have arrived in the post-antibiotic era,” research and development of new antibiotics are still falling flat. Similarly, much of the issue comes down to reliance on private companies for innovations when those companies no longer have enough incentive to try and bring new antibiotics to market. By the 1980s, pharmaceutical companies knew they were unlikely to develop broad-spectrum antibiotics, and it is not very profitable to treat specific types of infections. This hurt private sector research greatly and, by 2021, just four major US pharmaceutical companies had dedicated antibiotic divisions. The FDA and its EU equivalent, the European Medicines Agency, have approved just 12 new antibiotics since 2017, 10 of which were similar to existing drugs.

There are some measures in work to help address this issue, including ARPA-H’s recently announced Defeating Antibiotic Resistance through Transformative Solutions (DARTS) project. Another example is the proposed Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act, or PASTEUR Act. The bipartisan bill failed to pass the Senate in 2021, but a revamped version (albeit with less funding) was introduced last year. The bill calls for the creation of a Committee on Critical Need Antimicrobials, requirements for HHS to award grants that support appropriate stewardship of antimicrobial drugs, and authorization of HHS to enter into subscription contracts for critical-need antimicrobial drugs.

No one potential law will address the lack of antibiotic research in the US, let alone the broader challenge of AMR and superbugs. Similarly, using the DPA once to help hasten the rebuilding of the North Cove Baxter facility will not get the country completely out of trouble in maintaining adequate IV solution supply. These kinds of challenges are long games that are only going to get worse amid economic and supply chain challenges, in addition to problems like climate change. Addressing these kinds of problems requires long-term thinking and sustained funding, rather than relying on reacting to issues as they worsen.

“Public Health Departments Face a Post-COVID Funding Crash”

Jazmin Orozco Rodriguez tackles the newest iteration of the public health boom-and-bust funding cycle in this article for KFF Health News: “But public health leaders quickly identified a familiar boom-and-bust funding cycle as they warned about an incoming fiscal cliff once the federal grants sunset. Now, more than a year since the federal Department of Health and Human Services declared the end of the coronavirus emergency, states — such as Montana, California and Washington — face tough decisions about laying off workers and limiting public health services…Public health experts warn that losing staff who perform functions like disease investigation, immunization, family planning, restaurant inspection and more could send communities into crisis.”

“Mitigating Risks from Gene Editing and Synthetic Biology: Global Governance Priorities”

Stewart Patrick and Josie Barton authored this report for the Carnegie Endowment for International Peace: “Rapid advances in bioscience and bioengineering hold immense promise for human betterment. But as these disruptive technologies become more widely distributed, their inherently dual-use nature and susceptibility to unintended consequences could create unprecedented dangers.”

“AI Scans RNA ‘Dark Matter’ and Uncovers 70,000 New Viruses”

Smriti Mallapaty breaks down recent AI-powered research in this article for Nature News, explaining in part “Researchers have used artificial intelligence (AI) to uncover 70,500 viruses previously unknown to science, many of them weird and nothing like known species. The RNA viruses were identified using metagenomics, in which scientists sample all the genomes present in the environment without having to culture individual viruses. The method shows the potential of AI to explore the ‘dark matter’ of the RNA virus universe.”

“Tackling AMR: A Call for Global Action to Preserve Medical Progress”

Paul Murray, CEO of Life and Health Reinsurance at Swiss Re, discusses AMR and compounding factors like climate change in this piece for the World Economic Forum, writing in part “More such efforts are needed. Ultimately, stewardship programmes that promote the appropriate use of antimicrobials will be critical to preserving the effectiveness of existing medications. In addition, renewed drug development efforts to invent novel antibiotics are necessary, with resistant species emerging more quickly after a new drug’s introduction.”

“The Changing Face of Pandemic Risk: 2024 Report”

From GPMB, this report is a “…call to action for global leaders, policy-makers, health professionals, and communities to build a safer, more resilient future. It outlines the key drivers of pandemic risk and provides a roadmap for strengthening our defences.”

“Emerging Trends in Chemical Weapons Usage in the Middle East”

Natasha Hall discusses multiple issues regarding CW in the Middle East in this CSIS Brief, including the international community’s failure to address the Assad regime’s use of these weapons, challenges in multipolarity, and how actors are most likely to challenge existing norms by escalating from using RCAs to TICs and PBAs while spreading disinformation and slowing evidence collection.

“Putin Ordered Novichok Attack, Double Agent Skripal Tells UK Inquiry”

This reporting from Reuters details Sergei Skripal’s statement to the public inquiry into the death of Dawn Sturgess, and the poisoning of Yulia and Sergei Skripal in addition to a police officer who responded to the incident. In it, Skripal says “I believe Putin makes all important decisions himself. I therefore think he must have at least given permission for the attack on Yulia and me.”

Read more here.

“Russia’s Chemical Weapons Lies”

John V. Parachini and Svitlana Slipchenko discuss Russia’s CW-focused disinformation in this piece for the National Interest, writing in part “State parties should demand that Russia stop weakening the global ban on chemical weapons use with its torrent of falsehoods about others, disclose its own secret chemical weapons activities, and lay out a plan for coming into compliance with an accord it helped negotiate.”

“Russia’s Latest Target in Africa: U.S.-Funded Anti-Malaria Programs”

The New York Times‘ Elian Peltier discusses Russia’s use of African influencers to discredit US-funded anti-malaria programs on the continent amid to help stoke distrust and fear of the West in this article: “Western-backed health initiatives in Africa are one of Russia’s latest targets, a scenario reminiscent of the Cold War, when the Soviet Union accused the United States of spreading AIDS on the continent. The State Department says that African Initiative, a news outlet backed by Russia’s intelligence services, has spun similar accounts, including “disinformation regarding an outbreak of a mosquito-borne viral disease.”’

“Fueling China’s Innovation: The Chinese Academy of Sciences and Its Role in the PRC’s S&T Ecosystem”

Cole McFaul, Hanna Dohmen, Sam Bresnick, and Emily S. Weinstein recently published this CSET Issue Brief: “The Chinese Academy of Sciences is among the most important S&T organizations in the world and plays a key role in advancing Beijing’s S&T objectives. This report provides an in-depth look into the organization and its various functions within China’s S&T ecosystem, including advancing S&T research, fostering the commercialization of critical and emerging technologies, and contributing to S&T policymaking.”

What We’re Listening To 🎧

The BWC Global Forum: Biotech, Biosecurity & Beyond, Episode 15-Open-Source Intelligence

This episode features Yong-Bee Lim, an alumnus of the Biodefense PhD Program and the current Deputy Director of the Converging Risks Lab and Biosecurity Projects Manager at the Council on Strategic Risks.

“In this episode, we discuss the availability and use of open-source data to monitor BWC-related activities. Dr. Lim is leading a study to identify tools, techniques, and sources to support the ability to identify, track, and evaluate biological activities using publicly available information. Open-source analysis of biological activities, facilities, programs, and capabilities has been revolutionized through the convergence of radically expanded public access to data previosuly only available to state-level intelligence agencies and the emergence of advanced analytic tools, such as machine learning and artificial intelligence (AI). These new capabilities potentially offer civil society experts—or state governments without advanced intelligence programs—the opportunity to identify trends and patterns in data that can provide insight into the nature of biological activities.”

New: 13th Annual Jonathan Tucker Symposium

“The James Martin Center for Nonproliferation Studies cordially invites you to the 13th annual Jonathan Tucker Symposium on chemical and biological weapons issues on November 13th and 14th, 2024.”

Among this year’s speakers are Dr. Yong-Bee Lim, an alumnus of the Biodefense PhD Program and Deputy Director of the Converging Risks Lab and Biosecurity Projects Manager at the Council on Strategic Risks, who will give a talk titled “Technology Democratization and its Implications for CBW Safety and Security: Lessons Learned from Engagement with Non-Traditional Communities.”

Learn more and register here.

NEW: 2024 CBD S&T Conference

From DTRA: “The CBD S&T Conference brings together the most innovative and influential chemical and biological defense community members from around the globe to share insights and collaborate on the emerging chem-bio threats of tomorrow.”

“Join the Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department in its role as the Joint Science and Technology Office (JSTO) for Chemical and Biological Defense, an integral component of the Chemical and Biological Defense Program, as we Focus Forward to uncover novel concepts and examine groundbreaking discoveries within the chem-bio defense landscape.”

“The 2024 CBD S&T Conference will be held at the Broward County Convention Center, December 2–5, 2024.”

Learn more and register here.

Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1)

“The National Academies will host a 2-day virtual public workshop, October 22-23, to explore research priorities for the ongoing H5N1 outbreak in the U.S. Recognizing the interconnection between people, animals, and their shared environment, this workshop will take a One Health approach to bring together federal government agencies, the academic community, and the private sector, as well as other relevant stakeholders across the health, agriculture, and food safety sectors.”

“Workshop discussions will focus on basic science and research areas of concern and may help inform future research that could provide local, national, and global communities with information about virus transmission, mitigation of risks, and appropriate measures to prevent the spread of disease.”

Learn more and register here.

The Advancing Threat Agnostic Biodefense Webinar Series

From PNNL: “Please join us in welcoming Drs. Matthew Kasper and Lindsay Morton from the Department of Defense (DoD) Global Emerging Infections Surveillance (GEIS) program for their talk titled “Challenges and Opportunities in Pathogen Agnostic Sequencing for Public Health Surveillance: Lessons Learned From the Global Emerging Infections Surveillance Program.” This webinar will take place Tuesday, October 29th, at noon PT.”

Learn more and register here.

One Health and the Politics of COVID-19 Book Launch

The Writer’s Center is hosting a book launch for Dr. Laura Kahn’s new book, One Health and the Politics of COVID-19 (blurb below) on November 23 at 2 pm EST in Bethesda, MD. Learn more and RSVP here.

“One Health and the Politics of COVID-19 unpacks the mysteries of COVID-19’s origins to impart important lessons for future outbreaks. The One Health concept recognizes the interconnected links among the health of humans, animals, plants, and the environment. By comparing the history, science, and clinical presentations of three different coronaviruses—SARS-CoV-1, MERS, and SARS-CoV-2 (COVID-19)—Kahn uncovers insights with important repercussions for how to prepare and avoid future pandemics. The One Health approach provides a useful framework for examining the COVID-19 pandemic. Understanding the origins of this zoonotic disease requires investigating the environmental and molecular biological factors that allowed the virus to spread to humans. The book explores the many ways in which the wild animal trade, wet markets, and the camel industry contributed to the spread of the earlier SARS-CoV-1 and MERS coronaviruses. For SARS-CoV-2 (COVID-19), Kahn examines the biosafety, biosecurity, and bioethics implications of gain-of-function research on pandemic potential pathogens. This book is a must read to understand the geopolitics of the COVID-19 pandemic.”

NEW: BID2025 Stakeholder Input Request
“From BARDA: We are excited to host our next BARDA Industry Day (BID) conference on June 30 – July 1, 2025, in Washington, D.C.! BID2025 will delve into the critical intersection of health security and sustainability with experts from various sectors to discuss cutting-edge medical countermeasure (MCM) innovations and strategies.”

“We want to make sure that the event reflects the interests of our attendees. Your feedback will help us curate sessions, speakers, and topics that are relevant and engaging for you. This short questionnaire should take no more than three minutes to complete. Please share your thoughts on what you would like to see at the conference by October 30, 2024.“

Share thoughts here.

US AI Safety Institute Issues RFI on Responsible Development of Chem-Bio Models

From AISI: “The U.S. Artificial Intelligence Safety Institute (U.S. AISI), housed within the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST), released a Request for Information seeking insight from stakeholders regarding the responsible development and use of chemical and biological (chem-bio) AI models.”

“Input from a broad range of experts in this field will help the U.S. AISI to develop well-informed approaches to assess and mitigate the potential risks of chem-bio AI models, while enabling safe and responsible innovation.”

“Respondents are encouraged to provide concrete examples, best practices, case studies, and actionable recommendations where possible. The full RFI can be found here.”

“The comment period is now open and will close on December 3, 2024, at 11:59PM Eastern Time. Comments can be submitted online at www.regulations.gov, under docket no. 240920-0247.”

ACHS Fellowship Program 2025

From the Asia Centre for Health Security: “The ACHS Fellowship Program aims to inspire and connect the next generation of biosecurity leaders and innovators.”

“Newly launched in 2025, ACHS Fellowship is a highly competitive, part-time program that provides an opportunity for talented graduate students and professionals to deepen their expertise, expand their network, and build their leadership skills through a series of training and project work coordinated by the Asia Centre for Health Security based at the Saw Swee Hock School of Public Health, National University of Singapore (NUS).”

“This 12-month fellowship does not require relocation to Singapore and can be completed alongside full-time employment or an academic schedule.”

Learn more and apply here.

Pandora Report 8.16.2024

by dkellogg97, posted in Pandora Report

This week’s Pandora Report discusses the recent mpox PHEIC declaration, updates on H5N1, and more.

World Health Organization Declares Mpox PHEIC

Mpox (formerly known as monkeypox) is a viral illness caused by the monkeypox virus, which is part of the genus Orthopoxvirus. Two clades exist (clade I and clade II). Clade IIb caused a global outbreak of mpox in 2022-23 that also resulted in a PHEIC (public health emergency of international concern) declaration. Now, the WHO has declared an outbreak of clade I mpox a PHEIC as case counts in the Democratic Republic of the Congo (DRC) and neighboring countries swell. 548 people have been killed by the disease in 2024, according to the DRC government.

WHO Director-General Tedros Adhanom Ghebreyesus made the declaration “on the advice of an IHR Emergency Committee of independent experts who met earlier in the day to review data presented by experts from WHO and affected countries. The Committee informed the Director-General that it considers the upsurge of mpox to be a PHEIC, with potential to spread further across countries in Africa and possibly outside the continent.”

Tedros said in a statement, “The emergence of a new clade of mpox, its rapid spread in eastern DRC, and the reporting of cases in several neighbouring countries are very worrying. On top of outbreaks of other mpox clades in DRC and other countries in Africa, it’s clear that a coordinated international response is needed to stop these outbreaks and save lives.”

According to WHO “The monkeypox virus was discovered in Denmark (1958) in monkeys kept for research and the first reported human case of mpox was a nine-month-old boy in the Democratic Republic of the Congo (DRC, 1970). Mpox can spread from person to person or occasionally from animals to people. Following eradication of smallpox in 1980 and the end of smallpox vaccination worldwide, mpox steadily emerged in central, east and west Africa.”

Image Credit: CDC PHIL| “This is a colorized transmission electron microscopic image of mpox virus particles (purple), which were found within an infected cell (brown), having been cultured in the laboratory. The image was captured and color-enhanced at the National Institute of Allergy and Infectious Diseases (NIAID), Integrated Research Facility (IRF), located in Fort Detrick, Maryland.”

Sweden Reports First Clade I Case Outside Africa, ECDC Raises Risk Alert Level

The Public Health Agency of Sweden reported on Thursday that the country has recorded the first case of mpox caused by clade I outside of Africa. Health and Social Affairs Minister Jakob Forssmed said in a news conference, “We have now also during the afternoon had confirmation that we have one case in Sweden of the more grave type of mpox, the one called clade 1.” State Epidemiologist Masnus Gisslen said in an official statement that the patient was infected while visiting “the part of Africa where there is a major outbreak of mpox clade 1.”

Following Sweden’s announcement, the European Centre for Disease Prevention and Control (ECDC) raised its risk level for mpox from ‘low’ to ‘moderate,’ for sporadic cases appearing in the EU. The agency also asked countries to maintain high levels of awareness regarding those traveling from affected areas. The ECDC says the overall risk to the EU population has gone up from “very low” to “low” and that it expects there will be more imported cases in the coming weeks.

United States Announces Further $424 Million in Assistance for the DRC

This week the US, through the United States Agency for International Development, announced “…nearly $424 million in humanitarian and health assistance to address the ongoing catastrophe in the Democratic Republic of the Congo (DRC). This includes $414 million in humanitarian assistance to support people experiencing persistent humanitarian needs resulting from conflict and displacement. This announcement, made in Kinshasa by the U.S. Ambassador to the DRC Lucy Tamlyn and U.S. Representative to the United Nations Agencies for Food and Agriculture Jeffrey Prescott, also includes an additional $10 million in health assistance to respond to the current mpox outbreak in the DRC and in other affected countries in the region. USAID is also donating 50,000 mpox vaccines to the DRC, which is the country most impacted by this outbreak.”

The statement later explained that “The United States is the largest provider of humanitarian assistance to the DRC and the largest bilateral donor to DRC’s health sector. This Fiscal Year, the U.S. provided more than $256 million in health assistance through bilateral programs including the President’s Emergency Plan for AIDS Relief (PEPFAR), the President’s Malaria Initiative (PMI), and the Global Health Security program, which enabled more than seven million people to receive lifesaving treatment for diseases including TB, HIV, and malaria.”

European Commission Coordinates Procurement and Donation of 215,000 Bavarian Nordic Doses to Africa CDC

The European Commission’s Health Emergency Preparedness and Respons Authority (HERA) announced on Wednesday that it “will procure and donate 175,420 doses of the MVA-BN® vaccine, the only FDA and EMA-approved mpox vaccine, as an immediate response to the mpox outbreak in Africa. In addition, the pharmaceutical company Bavarian Nordic will donate 40,000 doses to HERA. The Africa CDC will distribute the vaccines according to regional needs.”

The announcement came in response to Africa CDC’s call for the international community to assist in mobilizing two million vaccines to stop this outbreak. The Commission said in its statement that “Through the Africa CDC, these vaccines will be distributed to affected countries. Furthermore, HERA is in collaboration with the Africa CDC with the aim to expand access to mpox diagnostics and sequencing in the region, with a €3.5 million grant foreseen for early autumn.”

Bavarian Nordic Wins $157 Million Contract to Replenish US JYNNEOS Vaccine Supply

The Biomedical Advanced Research and Development Authority (BARDA) has reached an agreement with the Danish company Bavarian Nordic to “partly replenish” its stockpile of JYNNEOS vaccine following the 2022 mpox outbreak. This $156.8 million deal follows a similar one made last year by the US government totaling $120 million.

Further Reading

H5N1 Threat Persists but Remains Low

Despite the renewed focus on mpox, concern still remains about the spread of avian influenza globally, particularly H5N1, which has infected thirteen farmworkers in the United States so far this year. Despite the relatively low risk, Seqirus has begun producing and storing doses of its new vaccine targeting H5N1 in its facility outside of Raleigh, NC. In total, the company has agreed to produce 4.8 million doses in exchange for $22 million from the federal government. The government has also given Moderna $176 million to develop mRNA vaccines for influenza, including H5N1.

The CDC explained in a recent summary about its Influenza Risk Assessment Tool that “The current overall individual and population health risk to the general public posed by the avian influenza A(H5N1) virus presently spreading in cows, poultry, and other mammals remains low. Systematic comparisons of data related to this avian influenza A(H5N1) virus using the Influenza Risk Assessment Tool (IRAT) to data from other influenza A viruses has scored this virus’s future pandemic potential as “moderate risk” based on information through June 26, 2024. This is similar to previous assessments of earlier avian influenza A(H5N1) viruses.”

Furthermore, the WHO released an updated assessment on recent H5N1 events in collaboration with the Food and Agriculture Organization of the United Nations and the World Organisation for Animal Health. The assessment found that “At the present time, based on available information, FAO-WHO-WOAH assess the global public health risk of influenza A(H5N1) viruses to be low, while the risk of infection for occupationally exposed persons is low to moderate depending on the risk mitigation measures in place. Transmission between animals continues to occur and, to date, a limited number of human infections have been reported. Although additional human infections associated with exposure to infected animals or contaminated environments are likely to continue to occur, the overall public health impact of such infections at a global level is minor.”

DOD, NNSA Inaugurate New Supercomputing System Dedicated to Biological Defense

Earlier this month, the Department of Defense (DOD) and the National Nuclear Security Administration (NNSA) announced a new supercomputing system that is dedicated to biological defense at Lawrence Livermore National Laboratory. According to DOD, the Department “…is working with NNSA to significantly increase the computing capability available to our national biodefense programs. The collaboration has enabled expanding systems of the same system architecture as LLNL’s upcoming exascale supercomputer, El Capitan, which is projected to be the world’s most powerful supercomputer when it becomes operational later this year.”

“The biodefense-focused system will provide unique capabilities for large-scale simulation and AI-based modeling for a variety of defensive activities, including bio surveillance, threat characterization, advanced materials development, and accelerated medical countermeasures. DoD and NNSA intend to allow the U.S. Government interagency, International Allies and partners, and academia and industry to access the supercomputing capability.”

Learn more here.

Schumer Pledges to Block Any Senate Effort to Significantly Cut CDC Budget

Senate Majority Leader Chuck Schumer (D-NY) told The Associated Press this week that he would block any legislation from passing the Senate that proposes significant cuts to the budget of the Centers for Disease Control and Prevention (CDC). Schumer further said that such cuts “would wreak havoc and chaos on food safety funding mechanisms and tracking operations at a core level.” As the AP explains, “Democrats said the proposal in a House bill includes a reduction of the CDC’s proposed budget by $1.8 billion, or about 22%, that would harm public health. The Republican-led effort also would mean a major cut in programs designed to address firearm injuries and opioid overdose prevention.”

The House Appropriations Committee passed the measure on a party-line vote last month.

“AIxBio: Opportunities to Strengthen Health Security”

Aurelia Attal-Juncqua, Anita Cicero, Alex Zhu, and Thomas Inglesby recently authored this published this preprint on SSRN: “Artificial Intelligence (AI) has the potential to revolutionize biosecurity, health security, biodefense, and pandemic preparedness by offering groundbreaking solutions for managing biological threats. This landscape review explores recent advancements in AI across these fields, drawing from both grey literature and peer-reviewed studies published between January 2019 and February 2024. AI has demonstrated potential in predicting viral mutations, which could enable earlier detection of outbreaks, and streamlining resource allocation by analyzing diverse data sources. It could also play a crucial role in accelerating the development and deployment of medical countermeasures, such as vaccines and therapeutics. Additionally, use of AI may enhance laboratory automation, reducing human error and increasing biosafety. Despite these promising advancements, significant challenges and risks related to the potential misuse of AI, data security, and privacy concerns necessitate careful implementation and robust governance. This paper highlights the rapid progress and vast potential of AI in biosecurity, and provides key recommendations for U.S. policymakers to effectively harness AI’s capabilities while ensuring safety and security. These recommendations include expanding access to advanced computing resources, fostering collaboration across sectors, and establishing clear regulatory frameworks to support the safe and ethical deployment of AI technologies.”

“Emerging Biosecurity Threats in the Age of AI”

Suryesh K Namdeo and Pawan Dhar recently published this piece with IndiaBioscience: “As artificial intelligence (AI) enables the transformation of biology into an engineering discipline, an effective governance model that uses threat forecasting, real-time evaluation, and response strategies is urgently needed to address accidental or deliberate misuse. This article talks about the risks at the interface of AI and biosecurity and what could India do to better prepare for potential AI-biorisks.”

“2023 Biorisks, Biosecurity and Biological Disarmament Conference Report”

From UNIDIR: “To facilitate multi-stakeholder engagement around biological risks, biological security and biological disarmament, the United Nations Institute for Disarmament Research (UNIDIR), the United Nations Office for Disarmament Affairs (UNODA) and the World Health Organization (WHO) co-organized a stakeholder conference designed to bring together actors from civil society, academia and industry, as well as diplomats, to stimulate the exchange of ideas and thinking around how to build biosecurity and bolster biological disarmament.”

“The Biorisks, Biosecurity and Biological Disarmament Conference took place in Geneva, Switzerland, on 4–5 July 2023. The event provided an opportunity to discuss ongoing diplomatic processes and current and upcoming issues in the areas of biorisk, biosecurity and biological disarmament.”

“More than 80 individuals from 30 countries, representing 60 institutions, participated in the discussion in person, and a further 334 individuals joined the discussion virtually from around the world. The participants included diplomats, public health professionals, security experts and scientists from a wide range of organizations.”

“The Conference consisted of seven substantive panels, which explored a range of topics, centred on advances in science and technology and their related risks and benefits, biosecurity implementation, dual-use governance, disease response, international cooperation, and verification technologies. The discussions that took place during all seven panels are summarized in this conference report.”

“Launching the Global Biosecurity Accelerator at the Helsinki Biosecurity Dialogue”

Christopher East covers the launch of the Global Biosecurity Accelerator in this post from the Council on Strategic Risks, writing in part “This is a core driver of why CSR launched the Global Biosecurity Accelerator, of which the Helsinki Biosecurity Dialogue was the first multinational convening. The Global Biosecurity Accelerator’s mission is to accelerate global resilience to the full spectrum of biological threats— natural, accidental, or deliberate. In addition to promoting strong biosecurity strategies across nations, Accelerator events will raise insights from the range of actions that nations take—from enhancing biodefense, to embedding biosecurity in a whole-of-society approach, to One Health initiatives. Designed with interoperability and depth of defense in mind, CSR aims for the Global Biosecurity Accelerator to help jumpstart a ‘whole-of-globe’ approach to resilience against biological threats.”

“Russian Influence in Eastern Europe is Aggravating HIV Epidemic, Say Experts”

The Guardian‘s Kat Lay discusses the role of Russian propaganda in deterring people in eastern Europe from accessing necessary healthcare as AIDS deaths are up 34% compared to 2010. Lay writes in part, “Efforts to improve treatment and prevent infections are being hampered by Russian-linked propaganda against targets including opioid replacement therapy services, which reduce the risk of HIV infection among people using drugs, and the LGBTQ+ community…Meanwhile, “foreign agent” laws in a number of countries, following a pattern established in Russia, require charities and organisations receiving overseas funding to register and impose onerous reporting requirements. This has forced some charities to withdraw, a media briefing at the 25th international Aids conference was told.”

“Ebola: Ten Years Later – Lessons Learned and Future Pandemic Preparedness”

Krutika Kuppalli recently authored this post for PLOS Global Public Health‘s Speaking of Medicine and Health blog, writing in part “In early December 2013, a 2-year-old boy in the remote village of Meliandou, Guinea fell ill with a mysterious disease and succumbed to the illness a few days later.1 The disease spread rapidly, resulting in 49 cases and 29 deaths before being identified as the Zaire strain of the Ebola virus and officially declared an outbreak on March 23, 2014.2 Over the ensuing months, the outbreak spread to neighboring Liberia and Sierra Leone, with cases also emerging in Senegal, Nigeria, Mali, the United States and Europe.3 On August 8, 2014, the World Health Organization (WHO) Director-General declared the outbreak a Public Health Emergency of International Concern (PHEIC), the highest global health alert, signifying the outbreak posed a public health risk to other Member States and necessitated a coordinated international response.4 Despite global efforts to control the outbreak, it lasted for over two years, resulting in over 28,000 cases and more than 11,000 deaths by the time it was declared over on June 9, 2016.3 This crisis exposed significant weaknesses in global health systems, prompting a re-evaluation of pandemic preparedness and response strategies. A decade later, it is essential to reflect on the lessons learned from the West Africa Ebola crisis and their impact on current and future pandemic preparedness efforts. These lessons are outlined using the Health Emergency Preparedness and Response (HEPR) architecture developed by WHO, focusing on strengthening five core health emergency components: collaborative surveillance, safe and scalable care, community protection, access to countermeasures, and emergency coordination.”

“Déjà Vu All Over Again — Refusing to Learn the Lessons of Covid-19”

Michael S. Sinha, Wendy E. Parmet, and Gregg S. Gonsalves recently published this perspective piece in the New England Journal of Medicine, in which they explain “The spread of H5N1 avian influenza among cattle and other farm animals as well as to agricultural workers in the United States has raised concerns about the potential for an influenza pandemic. Although the threat of pandemic H5N1 doesn’t appear to be imminent — this variant has yet to show the potential to be transmitted from human to human — the federal government’s initial response suggests that, rather than heeding the lessons from Covid-19, elected officials and other key decision makers may be relying on a dangerous type of revisionism that could lead to more deaths, should H5N1 cause a pandemic.”

“The World Is Not Ready for the Next Pandemic”

Michael Osterholm and Mark Olshaker call for greater government investment in new and better vaccines in this Foreign Affairs article: “It is impossible to know when a new pandemic will arise, or which specific pathogen will be its cause. H5N1 is just one of the viruses that could mutate into something that will start a pandemic. But eventually, one will happen. It is therefore time to move away from vague recommendations and best practices to a far larger-scale program aimed at producing new and better vaccines, antiviral drugs and other countermeasures, and building the infrastructure at the scale needed to protect entire populations. Although such efforts will be costly, failing to take these steps could be catastrophic.”

NEW: AI and the Evolution of Biological National Security Risks

“In the wake of a global pandemic and rapidly advancing AI technologies, scientists and government leaders from around the world have sounded alarms about a changing biothreat landscape. Between dire warnings of more widely accessible bioterrorism capabilities, novel superviruses, and next generation bioweapons, how should policymakers and weigh the impacts of AI on biosecurity? Where are risks really changing, and where have they been overblown? What actions need to be taken now, and what emerging capabilities need to be monitored for future threats?”

“Please join the Center for a New American Security on Wednesday, August 21, from 10:30–11:30 a.m. ET for a panel discussion on these questions and more. Bill Drexel, Fellow in CNAS’s Technology and National Security Team, will be joined by leading biosecurity experts inside and outside government grappling with the nexus of AI and emerging biotechnologies.”

“This panel is part of CNAS’s AI Safety and Stability project, which aims to better understand AI risks and identify specific steps to improve AI safety and stability in national security applications. The event will build upon the project’s new report, AI and the Evolution of Biological National Security Risks: Capabilities, Thresholds, and Interventions in which Bill Drexel and Caleb Withers provide a clear-eyed overview of the emerging effects of AI on the biothreat landscape and propose actionable solutions to avoid the worst outcomes.”

This panel will feature Sonia Ben Ouagrham-Gormley, Associate Professor and Deputy Director of George Mason’s Biodefense Graduate Program, who reviewed and provided interviews to the report’s authors.

NEW-Safeguarding the Food Supply: Integrating Diverse Risks, Connecting with Consumers, and Protecting Vulnerable Populations – A Workshop

From the National Academies: “On September 4-5, the Food Forum will host a workshop that explores the state of the science around hazard- and risk-based approaches to safeguarding both domestic and global food systems. Workshop presenters will examine nutrition, economic, and equity implications in food safety decision-making, and considerations and strategies for communicating hazard and risk across sectors. The workshop will also include national and international perspectives on risk assessment and tools to mitigate risk, as well as opportunities for the future of risk management and assessment, food safety, and public health.”

Learn more and register for this virtual event here.

Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences – August Information Gathering Meeting
From the National Academies: “This is the first in-person meeting of the consensus study, Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences. The open session of this information gathering meeting will include initial briefings containing information relevant to study issues. The committee will also meet in closed session for project planning and review of topics and speakers for remaining meetings.”

This event will take place on August 13 and 14. Learn more and register here.

Call for Experts-Enhancing the Resilience of Healthcare and Public Health Critical Infrastructure

From the National Academies: The National Academies Forum on Medical and Public Health Preparedness for Disasters and Emergencies is seeking experts to participate in an upcoming workshop that will examine strategies, policies, and innovative actions to improve the resilience of health care and public health critical infrastructure to impacts from disasters and other emergencies.

Approximately 8-10 volunteer experts are needed to serve on the workshop planning committee. Expertise in the following areas is desired:

  • Healthcare operations and management
  • Public health, emergency management, and environmental health
  • IT, data science, and cybersecurity
  • Infrastructure systems, engineering, and supply chain
  • Risk assessment and mitigation
  • Insurances, cost management, and health economics
  • Community resilience and lived experience
  • Public policy

We are also collecting information for potential speakers, participants, and peer reviewers for any publications resulting from the activity.

Please submit nominations by August 23, 2024. For any additional questions regarding the workshop, please view the project page or email Shalini Singaravelu at SSingaravelu@nas.edu.

Learn more and submit nominations here.

Call for Experts-Potential Research Priorities to Inform Readiness and Response to Highly Pathogenic Avian Influenza A (H5N1): A Workshop

From the National Academies: The National Academies is seeking suggestions for experts to participate in a new workshop exploring research priorities to inform readiness and response to the ongoing Highly Pathogenic Avian Influenza (HPAI) A (H5N1) outbreak in the United States. Recognizing the interconnection between people, animals, and their shared environment, the workshop will take a One Health approach to bring together federal government agencies, the academic community, and the private sector, as well as other relevant stakeholders across the health, agriculture, and food safety sectors and will focus primarily on basic science and research questions of specific concern. 

Approximately 8-10 volunteer experts are needed to build a committee for a future workshop and any publications resulting from this activity. Expertise in the following areas is desired:

  • One Health and emerging infectious diseases
  • National, state, and/or local public health and medical readiness and response
  • Epidemiology and surveillance
  • Medical countermeasures (diagnostics, vaccines, therapeutics)
  • Agricultural and veterinary health and sciences
  • Food safety
  • Social sciences, risk communication, and community engagement
  • Modeling, risk assessment, and strategic foresight
  • Regulatory issues

Please submit nominations by August 30, 2024. For any additional questions regarding the forum, please view the project page or email Shalini Singaravelu at SSingaravelu@nas.edu.

Learn more and submit nominations here.

Pandora Report 5.10.2024

by dkellogg97, posted in Pandora Report

This week’s Pandora Report covers a new interim staff report from the House Select Subcommittee on the Coronavirus Pandemic, the new United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential, the OPCW’s statement on Russia’s alleged use of toxic chemicals as weapons in Ukraine, and more.

GMU Biodefense Students Visit National Museum of Health and Medicine

“Late last month a cadre of students from the Schar School of Policy and Government’s biodefense graduate program visited the National Museum of Health and Medicine in Silver Spring, Maryland, not far from the George Mason University campuses.”

“The 150-year-old museum is known for its collections that depict the human anatomy and everything that can befall it, in sometimes stark and gory detail. What else would you expect from a museum with a pathology guide with listings for “bilateral nephrolithiasis (kidney stones),” “liver, hydatid cyst from tape worm,” and an all-time-favorite, “trichobezoar (human hairball from stomach).”’

Read more about this visit here on the Schar School’s website.

GMU Biodefense students at the National Museum of Health and Medicine

Select Subcommittee on the Coronavirus Pandemic Interim Staff Report Calls for Daszak, EcoHealth Alliance Debarment

Earlier this month, the House Select Subcommittee on the Coronavirus Pandemic’s chairman, Rep. Brad Wenstrup (R-OH), released an interim staff report-“An Evaluation of the Evidence Surrounding EcoHealth Alliance, Inc.’s Research Activities”. The press release explains in part, “This report details the Select Subcommittee’s comprehensive investigation into the U.S. government’s funding and lack of oversight of gain-of-function research, EcoHealth Alliance (EcoHealth), and the Wuhan Institute of Virology (WIV). The report reveals serious, systemic weaknesses in the National Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Health’s (NIH) grant procedures and examines how these failures enabled EcoHealth President Dr. Peter Daszak to fund dangerous gain-of-function research in Wuhan, China without sufficient oversight.”

The select subcommittee’s recommendations include:

  • “The Select Subcommittee on the Coronavirus Pandemic recommends that EcoHealth Alliance and Dr. Peter Daszak are formally debarred and cut off from receiving any future U.S. taxpayer funding.”
  • “The Select Subcommittee also recommends that the U.S. Department of Justice conduct a formal investigation into Dr. Daszak.”
  • “Further, the Select Subcommittee recommends eight improvements to NIAID and NIH procedures that will improve grant compliance, increase biosafety and biosecurity of high-risk research, and advance transparency and accountability in America’s federal health agencies.”

Daszak testified before the select subcommittee on the day the report was released, which was covered by Matt Field in The Bulletin of the Atomic Scientists. Field explains in his coverage that Daszak was grilled by members of both major political parties during the subcommittee’s hearing on May 1, writing “On Wednesday, however, members of both US political parties came armed with blistering criticism for Peter Daszak, the head of the nonprofit EcoHealth Alliance, questioning his honesty in dealing with federal agencies and skewering his alleged conflicts of interests as he attempted to assume the role of a leading scientific voice on the pandemic’s origins. Beginning in 2014, EcoHealth ran a US-funded, multimillion-dollar project to identify hotspots where patterns of interaction between humans and animals could spark disease outbreaks.”

He later writes, “They hammered away on one of the plot points in the origins debate, EcoHealth’s transparency in reporting on its studies to the National Institutes of Health (NIH). Over the course of one five-year grant, EcoHealth was supposed to submit annual reports. One of those, covering 2018-2019, came two years late. Daszak claimed that EcoHealth had tried to submit the report, but the NIH had a problem with its computerized reporting platform. According to a report by the subcommittee’s Democrats, however, a forensic audit found no evidence for this assertion.”

Chairman Wenstrup said in a statement, ““EcoHealth Alliance President Dr. Peter Daszak is not a good steward of U.S. taxpayer dollars and should never again receive funding from the U.S. taxpayer. Dr. Daszak and his organization conducted dangerous gain-of-function research at the WIV, willfully violated the terms of a multi-million-dollar NIH grant, and placed U.S. national security at risk. This blatant contempt for the American people is reprehensible. It is imperative to establish higher standards of oversight at the NIH. The Select Subcommittee’s detailed and comprehensive report today holds Dr. Daszak and EcoHealth Alliance accountable and sheds light on severe shortcomings in our public health systems.”

US Agencies Set to Tighten Gain-of-Function Research Oversight

This White House announced this week the new United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential and accompanying implementation guidance, following years of public debate and recommendations made by the National Science Advisory Board for Biosecurity. As the New York Times explains, “The new policy, which applies to research funded by the federal government, strengthens the government’s oversight by replacing a short list of dangerous pathogens with broad categories into which more pathogens might fall. The policy pays attention not only to human pathogens, but also those that could threaten crops and livestock. And it provides more details about the kinds of experiments that would draw the attention of government regulators.”

Read Max Kozlov’s summary and discussion of this new policy in Nature.

Emergent BioSolutions Announces Layoff Plans, Plant Closures

Emergent BioSolutions, the Gaithersburg-based company best known for producing Narcan, has announced it is shuttering its Maryland manufacturing facilities and laying off about 300 employees. This includes its Baltimore-Bayview Drug Substance manufacturing facility and its Rockville Drug Product facility, according to The Baltimore Banner. The company has also said it will eliminate 85 currently vacant positions. This is all on top of the more than 230 Maryland employees Emergent laid off last year.

Emergent drew national attention in the summer of 2021 after the company, which had secured a government contract to produce COVID-19 vaccines on behalf of Johnson & Johnson and AstraZeneca, came under Congressional scrutiny for potentially contaminating at least 75 million vaccine doses. Furthermore, as The New York Times highlighted at the time, “With its stock price cut in half, Emergent faces several shareholder lawsuits accusing it of securities fraud, and a pension fund filed a complaint last Tuesday claiming that some executives and board members — including several former federal officials — had engaged in insider trading by unloading more than $20 million worth of stock over the past 15 months.”

An investigation found that Emergent was forced to destroy or discard up to 400 million doses’ worth of ingredients for COVID-19 vaccines. ABC News explained in a piece about the report that “Congressional investigators probing the Maryland-based biotech company found that Emergent executives had privately raised urgent quality-control concerns even before the company began manufacturing the vaccines’ key ingredient — despite publicly expressing confidence in their ability to deliver on their multimillion-dollar government contract.”

‘”Despite major red flags at its vaccine manufacturing facility, Emergent’s executives swept these problems under the rug and continued to rake in taxpayer dollars,” House Oversight and Reform Committee Chairwoman Carolyn Maloney, D-N.Y., said of the report, which determined that the company’s “manufacturing failures and deceptive tactics” led to the large-scale waste of ingredients that could have helped make millions of vaccine doses.”

Emergent’s stock price did jump following the announcement of the layoffs, finishing yesterday at $4.37 up from $1.93 on May 1, a far cry from the $130 its shares were traded for in August 2020. According to The Baltimore Banner, “The company estimated that the restructuring will cost up to $21 million this year and save the company about $80 million annually. In a filing with the U.S. Securities and Exchange Commission, Emergent said most of those initial costs will be related to severance and benefits.”

OPCW Releases Statement on Ukraine

The OPCW released this week a statement about Russia’s alleged use of toxic chemicals as weapons in Ukraine. It reads in part “The Secretariat of the Organisation for the Prohibition of Chemical Weapons (OPCW) has been monitoring the situation on the territory of Ukraine since the start of the war in February 2022 in relation to allegations of use of toxic chemicals as weapons…The information provided to the Organisation so far by both sides, together with the information available to the Secretariat, is insufficiently substantiated.”

Read more here.

Mason Biodefense Graduate Program Director Discusses AI, Biological Weapons Risks with CNN

Biodefense Graduate Program Director Gregory Koblentz was recently interviewed in this May 5 CNN Newsroom segment covering AI and biological weapons proliferation risks. It was filmed ahead of the release of an episode of CNN’s “How It Really Happened” focused on the 2001 Amerithrax attacks.

“2024 U.S. Department of State Report on North Korea’s ‘Genetic Scissors’ Technology and Capabilities and Its National Security Implications”

This report from the Institute for National Security Strategy was co-authored by Biodefense PhD Program alumnus Hyun Jung Kim: “The recent U.S. State Department’s report, titled “2024 Adherence to and Compliance with Arms Control, Nonproliferation, and Disarmament Agreements and Commitments,” articulates that North Korea has acquired the capability to genetically engineer biological products utilizing CRISPR. This report raises alarms over the potential transformation of this genetic engineering technology into an offensive biological weapons program. CRISPR, often referred to as ‘genetic scissor’ technology, renowned for its ability to precisely cut and replace sections of the genome, holds promise for groundbreaking developments in medicine, agriculture, and energy sectors. However, this technology also faces several challenges, including ethical and institutional issues and safety concerns. The national security threats posed by the advancement of North Korea’s genetic engineering technology include unconventional warfare tactics such as terrorism and targeted assassinations, the potential leakage of genetically modified bioagents due to laboratory accidents, and the proliferation of weapons of mass destruction. Furthermore, the same report notes the development of ‘dual-use marine toxins’ by the Chinese People’s Liberation Army, which may imply possible strategic cooperation and coordination between China and North Korea in the development of biological toxins, posing a significant challenge to the international security landscape.”

“China, Biotechnology, and BGI: How China’s Hybrid Economy Skews Competition”

Anna Puglisi and Chryssa Rask recently published this issue brief with Georgetown’s Center for Security and Emerging Technology: “As the U.S. government considers banning genomics companies from China, it opens a broader question about how the United States and other market economies should deal with China’s “national champions.” This paper provides an overview of one such company—BGI—and how China’s industrial policy impacts technology development in China and around the world.”

“The National Blueprint for Biodefense: Immediate Action Needed to Defend Against Biological Threats”

This latest report from the Bipartisan Commission on Biodefense urges policymakers to adopt several measures to help sustain and grow US biodefense, including establishing a congressional working group focused on biodefense at the start of each Congress, making amendments to the Public Health Service Act in order to “produce a research and development plan for reducing pathogen transmission in built environments,” and replacing BioWatch.

In addition to the report linked above, Axios’ Alison Snyder has summarized the report and provided context to its recommendations here.

“Twenty Years of Preparedness: Reflecting on the Legacy of the Project BioShield Act of 2004”

Adey Pierce-Watkins and Tanima Sinha recently published this report for BDO: “This July 2, 2024, marks the 20th anniversary of The Project BioShield Act of 2004 (P.L. 108-276); legislation enacted in response to the anthrax attacks of September 2001, which revealed the need for development and acquisition of medical countermeasures (vaccines, therapeutics, and diagnostics) to protect the U.S. population from chemical, biological, radiological, and nuclear (CBRN) threats. This Act, and associated Congressional Appropriations, established a Special Reserve Fund (SRF) of $5.593B advanced funding available over a 10-year period for the advanced development and procurement of medical countermeasures with the intent of initiating a new posture of national preparedness.1 Simultaneously, this legislation created new market incentives for pharmaceutical and biotech companies to engage in the development of CBRN medical countermeasures and transformed the partnership between the federal government and industry into a shared responsibility for increasing preparedness against CBRN threats. As a result, this legislation and the SRF created a “guaranteed market” for pharmaceutical companies to produce CBRN medical countermeasures for which there previously was no commercial demand…In recognition of the 20th Anniversary of The Project BioShield Act, it is fitting to highlight the impact and milestones of this legislation based on its intended purpose and outcomes to date.”

“It Shouldn’t Be Easy to Buy Synthetic DNA Fragments to Recreate the 1918 Flu Virus”

Kevin M. Esvelt recently authored this piece for STAT News, writing in part “It should be hard — exceedingly hard — to obtain the synthetic DNA needed to recreate the virus that caused the deadly 1918 influenza pandemic without authorization. But my lab found that it’s surprisingly easy, even when ordering gene fragments from companies that check customers’ orders to detect hazardous sequences…Our experiment demonstrates that the immense potential benefits of biotechnology are profoundly vulnerable to misuse. A pandemic caused by a virus made from synthetic DNA — or even a lesser instance of synthetic bioterrorism — would not only generate a public health crisis but also trigger crippling restrictions on research.”

Applied Biosafety Special Issues on Biosafety and Biosecurity for Synthetic Genomics

Applied Biosafety‘s first and second special issues focused on biosafety and biosecurity for synthetic genomics is now available online. Articles include “Enhancing Gene Synthesis Security: An Updated Framework for Synthetic Nucleic Acid Screening and the Responsible Use of Synthetic Biological Materials,” “Developing a Common Global Baseline for Nucleic Acid Synthesis Screening,” Biosecurity Risk Assessment for the Use of Artificial Intelligence in Synthetic Biology,” “Biosecurity Assessments for Emerging Transdisciplinary Biotechnologies: Revisiting Biodefense in an Age of Synthetic Biology,” and more.

“Supporting Follow-Up Screening for Flagged Nucleic Acid Synthesis Orders”

Tessa Alexanian and Sella Nevo recently published this briefer with CSR’s Nolan Center, writing in part “Medical diagnostics, biomanufacturing, and many other parts of the bioeconomy rely on synthetic DNA and RNA purchases, which are ordered from commercial providers and shipped to laboratories around the globe. In addition to enabling beneficial biotechnology, affordable and accessible nucleic acid synthesis raises biosecurity concerns: some sequences can be used to reconstruct pathogen genomes or engineer dangerous biological agents, and it’s necessary to ensure those sequences are not misused by actors seeking to cause harm.”

“Most commercial synthesis providers screen the orders they receive to identify sequences of concern that could facilitate the construction of dangerous biological agents. When sequences in an order are flagged, follow-up screening determines whether the order is fulfilled. This screening centers on the customer: do they have a legitimate, peaceful purpose for obtaining the flagged sequences of concern?”

“This follow-up screening is the subject of this briefer. Between July and August 2023, we interviewed industry contacts and other policy and biosecurity experts. In the subsequent months, we conducted independent research and solicited expert feedback on report drafts. This process made clear that today, the follow-up screening process is ad-hoc. The customer service representatives, bioinformaticians, and security experts conducting follow-up screening often lack support for handling ambiguous cases, and there is little infrastructure to support information-sharing with other synthesis providers or law enforcement…”

“Developing a Customer Screening Framework for the Life Sciences”

A new report from Blueprint Biosecurity: “Since the 1970’s and the advent of recombinant DNA, biology has consistently become easier to engineer, and the pace of these advances is increasing. Many tools and capabilities for engineering biology are becoming more powerful, more affordable, and more widely available. These capabilities are critical for basic scientific research as well as advances in health, agriculture, and a wide range of applications in the burgeoning bioeconomy. However, access to these tools also raises the possibility that they could be accidentally or deliberately misused to cause harm by enabling development of toxins, pathogens, or other dangerous biological agents, including some not found in nature. Potential biological harms include high-consequence events such as the development and release of an engineered pathogen that causes a global catastrophe as well as a wide range of lower-consequence, higher-likelihood events. To prevent this type of misuse, policy experts have recommended expanding customer screening practices and policy frameworks to include a broad range of life sciences products, services, and infrastructure (Carter and DiEuliis, 2019a). Recent advances in artificial intelligence (AI) have increased this type of risk and have intensified these calls for action (Carter, et al., 2023; Helena, 2023).”

“To Combat Cow Flu Outbreak, Scientists Plan to Infect Cattle with Influenza in High-Security Labs”

Science’s Kai Kupferschmidt discusses current efforts to better understand H5N1 in this piece, writing in part “The avian influenza virus that has been infecting dairy cows and spreading alarm in the United States was expected to reach Germany this week. But that’s actually good news. A shipment of samples of the H5N1 virus from Cornell University virologist Diego Diel is destined for the Federal Research Institute for Animal Health in Riems, which has one of the rare high-security labs worldwide that are equipped to handle such dangerous pathogens in cattle and other large animals. There, veterinarian Martin Beer will use the samples to infect dairy cows, in search of a fuller picture of the threat the virus poses, to both cattle and people, than researchers have been able to glean from spotty data collected in the field.”

“Biodiversity Loss is Biggest Driver of Infectious Disease Outbreaks, Says Study”

This piece from The Guardian discusses the findings of a recent Nature meta-analysis: “New infectious diseases are on the rise and they often originate in wildlife. In meta-analysis published in the journal Nature, researchers found that of all the “global change drivers” that are destroying ecosystems, loss of species was the greatest in increasing the risk of outbreaks. Biodiversity loss was followed by climate change and introduction of non-native species.”

“Washington Accuses Russia of Chemical Weapons Attacks in Ukraine”

Andrea Stricker and Anthony Ruggiero recently authored this piece for the Foundation for Defense of Democracies that summarizes the United States’ claim that Russia has used CW in Ukraine, writing in part “The United States last week accused Russia of using chemical weapons against Ukrainian troops and sanctioned 12 Russian entities and individuals associated with Vladimir Putin’s ongoing chemical weapons program. The finding points to yet another instance of Moscow’s violation of international norms and conventions through the continued possession, stockpiling, and use of chemical weapons.”

“The Alleged Use of Chemical Weapons in Ukraine: How the International Community Can Investigate”

Ahmet Üzümcü recently authored this commentary piece for the European Leadership Network, explaining in part “I have summarised above the different mechanisms employed in the recent past to investigate allegations of the use of chemical weapons. I believe that one of them might be activated to investigate reported incidents in Ukraine. Whichever is selected may not enjoy the support of the whole membership; however, if one of the options is chosen, it needs to be practical and produce concrete results despite the challenges associated with the ongoing conflict. One of the strengths of the OPCW’s robust verification and compliance regime has always been its level of expertise and objectivity in the area of chemical weapons. The international community could leverage these strengths to test the veracity of the allegations that have been levelled against Russia about chemical weapons use during the armed conflict in Ukraine. The States Parties to the Chemical Weapons Convention should support such an initiative for two reasons: first, to provide a deterrent effect against further alleged uses of chemical weapons, and second, to uphold the integrity and credibility of the Chemical Weapons Convention, which is one of the pillars of the rules-based international order.”

ICYMI: Biological Weapons Convention Scientific and Technological Advisory Mechanism

From the UN Institute for Disarmament Research: “The Friends of the Chair, together with UNIDIR and @unitednations_disarmament, organized this informal webinar on a BWC scientific and technological advisory mechanism. This webinar was designed to support ongoing activities of the BWC Working Group and to stimulate thinking and discussion around a mechanism during the intersessional period. The event consisted of an expert panel followed by a moderated question-and-answer session with the audience.”

Watch here.

NEW-Slaves to the Bomb: The Role & Fate of N. Korea’s Nuclear Scientists

“The Committee for Human Rights in North Korea (HRNK) is delighted to invite you to the rollout of its latest report, Slaves to the Bomb: The Role & Fate of North Korea’s Nuclear Scientists by Robert Collins. The event will be open to the press and on the record. The report will be published on HRNK’s website on the day of the report rollout.”

This event will take place on May 17, at 3 pm EST. Learn more and RSVP here.

NEW-Getting Ahead of Avian Influenza: Why Organizations Need to Prepare Today

From Bluedot: “Highly Pathogenic Avian Influenza A(H5N1), commonly referred to as bird flu, has been making headlines around the world, as the virus rapidly spreads to new animal species. Already the cause of a panzootic (global animal pandemic), last month a human H5N1 case was reported in the U.S. after likely contracting it from infected dairy cattle. The virus has now been detected in dairy herds across multiple states, with evidence to suggest it has been spreading more widely than previously thought — begging the question: Are we at risk for an avian influenza-instigated pandemic?”

“Join us for a deep dive into avian influenza as we explore why and how organizations should prepare to safeguard against bird flu. Together, through collaborative efforts and informed decision-making, we can mitigate the risk of increased transmission to humans. BlueDot’s experts have been closely monitoring the situation and potential risks, issuing multiple alerts on H5N1 — and other avian influenzas — over the past 15 months.”

This event will take place on May 23, at 11 am ET. Learn more and register here.

Biosafety and the Origin of the COVID-19 Pandemic: Evidence and Policy Implications

From Brookings: “The world just lived through the COVID-19 pandemic, with more than 7 million reported direct deaths globally, more than 775 million reported cases, more than 14 million indirect excess deaths, and likely millions more unreported deaths. Despite the devastating effects on people and economies around the world, we still do not know with certainty how the pandemic originated, with the two most likely hypotheses either a natural spillover from an animal host or a research lab leak. Finding an answer to this question is not just a matter of doing justice to the millions of victims of COVID-19—it will have significant ramifications for policy implementation to help prevent the next pandemic.”

“Importantly, the catastrophic impact of the COVID-19 disease has shown us that preventing the next pandemic and biosafety in general should be top of mind for researchers, regulators, policymakers and public health officials, and it will likely require an array of measures by private, public, and nongovernmental organizations. This includes reconsidering our early warning systems for emergent diseases from the natural world, and taking a closer look at research with dangerous pathogens in biolabs. Identifying the origins of the recent pandemic can help target those efforts.”

“On May 14, the Brookings Center on Regulation and Markets will address these complex questions. First, Alina Chan, scientific advisor at the Broad Institute, and Alison Young, Curtis B. Hurley chair in public affairs reporting at the University of Missouri School of Journalism, will explain why the origin of the SARS-CoV-2 virus matters for public policy. Then, a balanced expert panel will debate the two most likely origins: natural spillover or a leak from a lab. A final panel of biosafety experts will discuss what measures would be best suited to improve biosafety and reduce the risks for research-related lab incidents as well as future pandemics. This event is a part of the CRM series on Reimagining Modern-day Markets and Regulations.”

This online event will take place on May 14 at 1:30 pm EDT. Learn more and access the event here.

Addressing the Challenges Posed by Chemical and Biological Weapons: Intensive Online Introductory Course for Students of Technical Disciplines

“SIPRI and the European Union Non-Proliferation and Disarmament Consortium (EUNPDC) invite graduate and postgraduate students of the technical or natural science disciplines to apply for an intensive online introductory course on chemical and biological weapons—their proliferation, the efforts to eliminate them, the various mechanisms used to control their spread—and endeavours underway to reduce the risk of chemical or biological agents in terrorist attacks. The course will take place online, during four half-days on 28–31 May 2024, 14:00 to 18:00 Central European Summer Time (CEST).”

“The course will cover the fundamentals of chemical and biological weapons as well as of missiles and other means of delivery; the history of chemical and biological warfare; the evolution of international norms against these weapons; the threats associated with potential terrorist uses of chemical and biological material; bioweapons and other related scientific advances; the current challenges posed by chemical weapons; arms control treaties; and mechanisms to curb the spread of dangerous substances, including export controls.”

“The course will also discuss the role of the EU institutions and industry to address the challenges mentioned above. The course will be instructed by renowned experts on non-proliferation, arms control, disarmament, export controls, verification and related subjects from SIPRI, other European research centres, think tanks and international organizations.”

Learn more and apply here.

Registration for GHS 2024 Now Open

Registration is now open for the Global Health Security 2024 conference in Sydney, Australia. This iteration will take place 18-21 June, 2024. The call for abstracts is also still open. “The mission of the Global Health Security conference is to provide a forum where leaders, researchers, policy-makers, and representatives from government, international organisations, civil society, and private industry from around the world can engage with each other, review the latest research and policy innovations, and agree solutions for making the world safer and healthier. To that end, our mission is to help foster a genuinely multidisciplinary community of practice that is committed to working collaboratively to enhance global health security and eliminate disease, irrespective of its origin or source.”

SBA.3 International Synthetic Biology, and Biosecurity Conference in Africa

“Join us for the SBA.3 International Synthetic Biology and Biosecurity Conference in Africa, a groundbreaking event that brings together experts, researchers, and enthusiasts in the field of synthetic biology. This in-person conference will take place at the Laico Regency Hotel from Wed, Jul 17, 2024 to Friday, Jul 19, 2024.”

“Get ready to dive into the exciting world of synthetic biology and explore its potential applications in Africa. From cutting-edge research to innovative solutions, this conference offers a unique opportunity to learn, network, and collaborate with like-minded individuals.”

“Discover the latest advancements, trends, and challenges in synthetic biology through engaging keynote speeches, interactive workshops, and thought-provoking panel discussions. Immerse yourself in a vibrant atmosphere where ideas flow freely and new connections are made.”

“Whether you’re a seasoned professional or just starting your journey in synthetic biology, this conference provides a platform to expand your knowledge, exchange ideas, and contribute to the growth of the field in Africa.”

“Don’t miss out on this extraordinary event that promises to shape the future of synthetic biology and biosecurity in Africa. Mark your calendars and join us at the SBA.3 International Synthetic Biology and Biosecurity Conference in Africa!”

Learn more and register here.

IBBIS Announces The Common Mechanism

The International Biosecurity and Biosafety Initiative for Science (IBBIS) recently launched The Common Mechanism, “An open-source, globally available tool for DNA synthesis screening.” The organization explains on its website that “The Common Mechanism helps providers of synthetic DNA and RNA to effectively screen orders to prevent synthesis technology from being exploited. We provide free, distributed, open-source, automated software for screening sequences of nucleic acids (including DNA and RNA) as well as resources to facilitate customer screening.”

Learn more and access the tool here.

Pandora Report 5.3.2024

by dkellogg97, posted in Pandora Report

This edition of the Pandora Report covers the United States’ accusations against the Russian Federation regarding the use of chloropicrin and riot control agents “as a method of warfare” in Ukraine, the Biden administration’s new framework for nucleic acid synthesis screening, DHS’ new guidelines on preventing AI threats to critical infrastructure and CBRN weapons design, and more.

United States Accuses Russia of Violating Chemical Weapons Convention, Announces Further Sanctions

On Wednesday, the US officially accused Russia of violating the CWC by deploying chloropicrin weapons against Ukrainian forces and using riot control agents “as a method of warfare” in Ukraine. Chloropicrin (PS), a choking agent, was first used during World War I, and it is explicitly banned under the CWC, as is the use of RCAs not included in the CWC’s schedules when used as a method of warfare. In a statement, the US Department of State said “The use of such chemicals is not an isolated incident, and is probably driven by Russian forces’ desire to dislodge Ukrainian forces from fortified positions and achieve tactical gains on the battlefield. Russia’s ongoing disregard for its obligations to the CWC comes from the same playbook as its operations to poison Aleksey Navalny and Sergei and Yulia Skripal with Novichok nerve agents.”

Credit: National Museum of Health and Medicine

The State Department and the Department of the Treasury have announced sanctions against more than 280 individuals and entities, including more than 80 known to be engaged in sanction evasion or that are related to Russia’s CBW and defense industrial base. In its statement, the Treasury said “Treasury is also targeting three Russia-based entities and two individuals involved in procuring items for military institutes involved in Russia’s chemical and biological weapons programs. In coordination, the Department of State is separately designating three Russian government entities associated with Russia’s chemical and biological weapons programs and four Russian companies contributing to such entities. These actions are being taken concurrent with the Department of State’s imposition of Chemical and Biological Weapons Control and Warfare Elimination Act of 1991 (the CBW Act) sanctions on Russia over its use of the chemical weapon chloropicrin against Ukrainian troops.”

White House Releases Framework for Nucleic Acid Synthesis Screening

On Monday, the White House Office of Science and Technology Policy (OSTP) announced the release of its Framework on Nucleic Acid Synthesis Screening, as directed by President Biden’s Executive Order on the Safe, Secure, and Trustworthy Development of Artificial Intelligence. The framework aims to help manage AI risks so that its benefits can be used in synthetic biology by encouraging “providers of synthetic nucleic acids to implement comprehensive, scalable, and verifiable screening mechanisms.”

In its statement, OSTP said “Through the AI executive order, President Biden has directed action on AI across the economy, including AI applied to biotechnology and synthetic biology. Nucleic acids serve as the critical building blocks for life science research and development (R&D) —including the development of new biomedical products, novel strategies for recycling and energy production, and the creation of new classes of materials. It is essential that nucleic acid synthesis technologies are appropriately managed to promote positive outcomes and prevent nefarious uses. Nucleic acid synthesis screening is an effective, targeted measure to mitigate the potential for misuse of AI-enabled biotechnologies.”

“This framework recommends that providers of synthetic nucleic acids screen purchases to prevent misuse, building on recent guidance from the Department of Health and Human Services. The National Institute of Standards and Technology will further support implementation of this framework by engaging with industry to develop technical standards for screening, as directed by the Executive Order.”

“As directed by the Executive Order, within 180 days of the release of this framework, federal research funding agencies will require recipients of federal R&D funds to procure synthetic nucleic acids only from providers that implement these best practices. While this framework establishes requirements for federally funded research, it is anticipated that these requirements may be adopted more broadly by other research funders.”

DHS Warns AI Could Be Used to Design WMD

This week, the Department of Homeland Security released a new report discussing potential ways that artificial intelligence could be used to help design chemical, biological, radiological, and nuclear weapons as well as guidelines addressing this threat. DHS also released guidelines on securing critical infrastructure in light of advancements in AI, as required by President Biden’s Executive Order (EO) 14110, “Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (AI)”.

The report on CBRN weapons and AI risks, which was submitted to President Biden, “…identifies trends within the growing AI field along with distinct types of AI and machine learning models that might enable or exacerbate biological or chemical threats to the U.S. It also includes national security threat mitigation techniques through oversight of the training, deployment, publication and use of AI models and the data used to create them — particularly regarding how safety evaluations and guardrails can be leveraged in these instances.”

Meanwhile, the guidance on protecting critical infrastructure focuses its attention on water treatment facilities and supplies, telecom operations, and power grids in light of recent cyber attacks targeting these kinds of facilities. “AI can present transformative solutions for U.S. critical infrastructure, and it also carries the risk of making those systems vulnerable in new ways to critical failures, physical attacks, and cyber attacks. Our Department is taking steps to identify and mitigate those threats,” said Secretary of Homeland Security Alejandro Mayorkas in a press release. 

Asia Centre for Health Security Opens in Singapore

Recently, the Asia Centre for Health Security (ACHS) opened its doors at the National University of Singapore’s Saw Swee Hock School of Public Health, marking an important development for health security research in the region. In a statement about ACHS, the Centre’s Director and Vice Dean of Saw Swee Hock SPH, Hsu Li Yang, told The Straits Times “The focus includes all manner of catastrophic biological threats, rather than just zoonoses. So laboratory biosafety and deliberately released or man-made biological agents are also a part of our work…Rather than hardcore biomedical science and technology, we work on health systems, global health law and regulations, and global relations where it pertains to health security issues.”

Joyce Teo explains in the same piece that “Established with the help of generous philanthropic funding, ACHS is steered by a multidisciplinary team with expertise in areas from public health and clinical practice to global health law and policymaking. It will work closely with the S. Rajaratnam School of International Studies at Nanyang Technological University in areas such as research and training.”

“National Intelligence Estimate: Dynamics Shaping Global Health Security In the Next Decade”

The Office of the Director of National Intelligence recently approved for release this December 2023 National Intelligence Estimate (NIE) from the National Intelligence Council. The estimate’s key takeaway is that “During the next decade, the global health security landscape will be stressed by climate and societal changes, strained health infrastructure and capacity, and eroding global health governance. Regardless of the severity and scope, global health emergencies are likely to continue to strain national health systems, particularly disadvantaging poorer countries, as well as encourage and result in responses that are constrained by major power competition. Nonetheless, promising health initiatives utilized during the COVID-19 pandemic, coupled with burgeoning technological advances, are likely to help fill some shortfalls, but will require overcoming competitive approaches and geopolitical rivalry.”

“Public Health Preparedness: HHS Should Address Strategic National Stockpile Coordination Challenges”

From the Government Accountability Office: “The federal government coordinates with states, localities, territories, and Tribes to distribute life-saving medicines and supplies from the Strategic National Stockpile during public health emergencies…But during recent public health responses, such as COVID-19 and mpox, jurisdictions weren’t clear on how and from whom to request supplies, causing confusion and delays. Additionally, some Tribal officials cited challenges with having the facilities needed to receive and store delivered supplies…Our recommendations address this and other issues we found.”

“Who Could Catch Bird Flu First? These Experts Have an Idea, and a Way to Help.”

Erin M. Sorrell, Monica Schoch-Spana and Meghan F. Davis recently published this opinion piece in The New York Times discussing the need to improve protections for those working in the farming industry. They write in part “So far, bird flu testing of this cohort has been woefully inadequate. Testing is usually under the purview of state authorities following federal Centers for Disease Control and Prevention guidelines. Tests are recommended for symptomatic workers. The exact number of dairy workers and other people who have so far been tested for H5N1 is not publicly available at the federal level. There is no excuse to continue only limited testing of this vulnerable population. Any serious surveillance efforts of H5N1 demand that the country do better to ensure proper testing and health care is provided to these workers now, lest we risk being caught flat-footed by a new pandemic so soon after Covid.”

“WHO Overturns Dogma on Airborne Disease Spread. The CDC Might Not Act on It.”

Amy Maxmen discusses the CDC’s potential response to recent changes in how the WHO defines airborne disease spread in this piece for KFF Health News: “However, the WHO report stops short of prescribing actions that governments, hospitals, and the public should take in response. It remains to be seen how the Centers for Disease Control and Prevention will act on this information in its own guidance for infection control in health care settings.”

“A Pandemic Agreement Is Within Reach”

Anita Cicero and Alexandra Phelan recently authored this editorial piece for Science, explaining their introduction “At the end of May, 194 member states of the World Health Organization (WHO) will meet for the World Health Assembly. Negotiations underway now will determine whether they vote then to adopt a pandemic agreement. For the past 2 years, discussions have focused on articulating essential components of a robust and equitable architecture for pandemic preparedness and response. Despite this, talks have failed to produce sufficient consensus on a detailed draft, prompting the intergovernmental negotiating body to propose a “streamlined” version. The new text, released on 16 April, consolidates provisions for research and development, technology transfer, pathogen access and benefit sharing (including pandemic products such as medicines and vaccines), with many particulars deferred to future procedures. Ultimately, success of the agreement will depend on these details and implementation. Nevertheless, member states shouldn’t bypass the consensus reached to date, but continue progress to adopt this agreement.”

CARB-X 2023 Annual Report

Boston University’s Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) recently released its 2023 Annual Report, which identifies several trends, including:

  • “Rapid diagnostics expanded during the COVID-19 pandemic, leaving product developers poised to capitalize on their investments by embracing new sample types and pathogens;
  • More than half of therapeutics applicants were in the hit-to-lead stage, reinforcing the evident dearth of oral therapeutics in the clinical and preclinical pipelines; and 
  • CARB-X received expressions of interest from the vaccine community in response to the lack of vaccines in development for K. pneumoniae, ExPEC, S. aureus, A baumannii, and N. gonorrhoeae.“

“Ralph Baric, Whose Virology Techniques Were Used in Wuhan, Testified That Lab Leak Was Possible”

Katherine Eban, co-author of the widely criticized Vanity Fair and ProPublica article discussing the possibility of a lab leak origin of the COVID-19 pandemic at the Wuhan Insitute of Virology, recently published this Vanity Fair piece, writing “The UNC coronavirologist who has collaborated on gain-of-function research with the Wuhan Institute of Virology’s Shi Zhengli, told congressional investigators that he has long worried about biosafety protocols inside China. Though he thinks it’s far more likely COVID-19 originated in nature, he said of a possible laboratory escape, “You can’t rule that out.”’

“A Virus Hunter’s Struggle for Respect in Post-COVID China”

In this piece for Think Global Health, Yanzhong Huang discusses how Zhang Yongzhen, the scientist who first published the genome sequence of SARS-CoV-2, has struggled with his employer-the Shanghai Public Health Clinical Center-as China moves on from COVID-19: “In a shocking turn of events, Zhang Yongzhen, PhD, the internationally renowned scientist credited with first publishing the genome sequence of the SARS-CoV-2 coronavirus, staged a sit-in protest outside his laboratory at the Shanghai Public Health Clinical Center (SPHCC). In a country that values stability and obedience, this dramatic action quickly captured the attention of both Chinese and international media. As Edward Holmes, a leading virologist at the University of Sydney, remarked in Nature, “it is unfathomable to me to have a scientist of that caliber sleeping outside his lab.”‘

“China Has a Controversial Plan for Brain-Computer Interfaces”

Emily Mullin discusses Chinese aspirations of cognitive enhancement in this Wired piece, explaining in part ‘“China is not the least bit shy about this,” he says, referring to ethical guidelines released by the Communist Party in February 2024 that include cognitive enhancement of healthy people as a goal of Chinese BCI research. A translation of the guidelines by CSET says, “Nonmedical purposes such as attention modulation, sleep regulation, memory regulation, and exoskeletons for augmentative BCI technologies should be explored and developed to a certain extent, provided there is strict regulation and clear benefit.”’

“The translated Chinese guidelines go on to say that BCI technology should avoid replacing or weakening human decisionmaking capabilities “before it is proven to surpass human levels and gains societal consensus, and avoid research that significantly interferes with or blurs human autonomy and self-awareness.”’

“The Czech Illegals: Husband and Wife Outed as GRU Spies Aiding Bombings and Poisonings Across Europe”

Michael Weiss, Roman Dobrokhotov, and Christo Grozev recently published this investigative piece in The Insider covering the work of Elena and Nikolai Šapošnikov’s support of GRU Unit 29155, explaining in part “While both Šapošnikov spouses engaged in espionage for Russia assisted GRU’s sabotage operations, the wife, Šapošnikova, 62, appears to have been directly integrated with Unit 29155, as evidenced both by findings by the Czech investigators and by The Insider’s independent discovery of documentary evidence. As such, Czech investigators have concluded, she likely directed and supervised her husband’s – and possibly their son’s – activities in support of Russian state interests. The family’s clandestine duties ranged from intelligence-gathering to logistical facilitation, providing safe havens, recruitment efforts, and even aiding in securing physical access for GRU operatives conducting sabotage missions.”

“UNSCR 1540 at 20 Years”

Christina McAllister and Annie Trentham recently published this commentary piece with the Stimson Center covering the first two decades since UNSCR 1540 was passed. They explain in their introduction, “United Nations (UN) Security Council Resolution 1540 marked a round birthday of 20 years on April 28, approaching its age of majority in a very different world to the one into which it was born two decades ago. Obligating all UN member states to implement measures preventing the proliferation of weapons of mass destruction (WMD), delivery systems, and related materials, particularly to non-state actors, its passage in 2004 was a historic achievement by an international community shaken by the 2001 terror attacks on the United States as well as the exposure of A.Q. Khan’s nuclear proliferation activities. It is hard to imagine such unified action today, amid the geopolitical tensions that consume so much valuable multilateral energy and resources. Yet while the international context has changed significantly since 2004, the need for Resolution 1540 has only grown, even while implementation challenges remain.”

First Issue of the UNSCR 1540 Compass

The UN Interregional Crime and Justice Research Institute (UNICRI) recently released the first edition of the UNSCR 1540 Compass. In a statement about the new publication, UNICRI Acting Director Leif Villadsen said “This new e-journal comprises one of the ways in which the Institute is committed to advancing the objectives of UNSCR 1540 and bolstering the global non-proliferation framework. The publication aims to shed light on the impact, challenges and INTRO 9 opportunities of UNSCR 1540, as well as the work of the 1540 Committee. It also seeks to establish a dynamic platform for international dialogue and knowledge exchange among Member States, experts, practitioners, and organizations involved in implementing UNSCR 1540. Moreover, it will enable us to stay abreast of emerging trends, threats and risks. I trust that it will generate informed discussions and actionable insights that can help us forge better collective understanding of the field of non-proliferation as it stands today.”

Read the first issue here.

NEW-H5N1 What Do We Know So Far?

From Boston University Center on Emerging Infectious Diseases: “Cases of the H5N1 strain of avian flu have been reported in US dairy cattle since March 2024. As we have seen avian influenza (or “bird flu”) has the ability to be transmitted from birds to mammals such as cows and humans. We know that this strain of avian flu is transmittable to humans; in April 2024 a case was reported in a dairy farm worker who had been in contact with infected cattle.”

“This begs the question, how concerned should we be about future spread of H5N1 from animals to humans? And how does the risk of infection vary for farmers compared to the general population? Based on experience with other strains of avian flu, how do experts foresee this strain potentially evolving?”

“Join Boston University’s Center on Emerging Infectious Diseases for a discussion with experts in epidemiology, infectious diseases, and veterinary medicine as we unpack these questions and more.”

This virtual event will take place on May 9 at 10 am EST. Learn more and register here.

NEW-Biosafety and the Origin of the COVID-19 Pandemic: Evidence and Policy Implications

From Brookings: “The world just lived through the COVID-19 pandemic, with more than 7 million reported direct deaths globally, more than 775 million reported cases, more than 14 million indirect excess deaths, and likely millions more unreported deaths. Despite the devastating effects on people and economies around the world, we still do not know with certainty how the pandemic originated, with the two most likely hypotheses either a natural spillover from an animal host or a research lab leak. Finding an answer to this question is not just a matter of doing justice to the millions of victims of COVID-19—it will have significant ramifications for policy implementation to help prevent the next pandemic.”

“Importantly, the catastrophic impact of the COVID-19 disease has shown us that preventing the next pandemic and biosafety in general should be top of mind for researchers, regulators, policymakers and public health officials, and it will likely require an array of measures by private, public, and nongovernmental organizations. This includes reconsidering our early warning systems for emergent diseases from the natural world, and taking a closer look at research with dangerous pathogens in biolabs. Identifying the origins of the recent pandemic can help target those efforts.”

“On May 14, the Brookings Center on Regulation and Markets will address these complex questions. First, Alina Chan, scientific advisor at the Broad Institute, and Alison Young, Curtis B. Hurley chair in public affairs reporting at the University of Missouri School of Journalism, will explain why the origin of the SARS-CoV-2 virus matters for public policy. Then, a balanced expert panel will debate the two most likely origins: natural spillover or a leak from a lab. A final panel of biosafety experts will discuss what measures would be best suited to improve biosafety and reduce the risks for research-related lab incidents as well as future pandemics. This event is a part of the CRM series on Reimagining Modern-day Markets and Regulations.”

This online event will take place on May 14 at 1:30 pm EDT. Learn more and access the event here.

3rd International Biosecurity Virtual Symposium

From ABSA: “The Symposium will bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge on diverse biosecurity topics. The Symposium will offer attendees an opportunity to learn the latest in biosecurity and have thought-provoking conversations about real-world biosecurity issues, concerns, and scenarios.”

This symposium will take place May 7-8. Learn more and register here.

Addressing the Challenges Posed by Chemical and Biological Weapons: Intensive Online Introductory Course for Students of Technical Disciplines

“SIPRI and the European Union Non-Proliferation and Disarmament Consortium (EUNPDC) invite graduate and postgraduate students of the technical or natural science disciplines to apply for an intensive online introductory course on chemical and biological weapons—their proliferation, the efforts to eliminate them, the various mechanisms used to control their spread—and endeavours underway to reduce the risk of chemical or biological agents in terrorist attacks. The course will take place online, during four half-days on 28–31 May 2024, 14:00 to 18:00 Central European Summer Time (CEST).”

“The course will cover the fundamentals of chemical and biological weapons as well as of missiles and other means of delivery; the history of chemical and biological warfare; the evolution of international norms against these weapons; the threats associated with potential terrorist uses of chemical and biological material; bioweapons and other related scientific advances; the current challenges posed by chemical weapons; arms control treaties; and mechanisms to curb the spread of dangerous substances, including export controls.”

“The course will also discuss the role of the EU institutions and industry to address the challenges mentioned above. The course will be instructed by renowned experts on non-proliferation, arms control, disarmament, export controls, verification and related subjects from SIPRI, other European research centres, think tanks and international organizations.”

Learn more and apply here.

Registration for GHS 2024 Now Open

Registration is now open for the Global Health Security 2024 conference in Sydney, Australia. This iteration will take place 18-21 June, 2024. The call for abstracts is also still open. “The mission of the Global Health Security conference is to provide a forum where leaders, researchers, policy-makers, and representatives from government, international organisations, civil society, and private industry from around the world can engage with each other, review the latest research and policy innovations, and agree solutions for making the world safer and healthier. To that end, our mission is to help foster a genuinely multidisciplinary community of practice that is committed to working collaboratively to enhance global health security and eliminate disease, irrespective of its origin or source.”

SBA.3 International Synthetic Biology, and Biosecurity Conference in Africa

“Join us for the SBA.3 International Synthetic Biology and Biosecurity Conference in Africa, a groundbreaking event that brings together experts, researchers, and enthusiasts in the field of synthetic biology. This in-person conference will take place at the Laico Regency Hotel from Wed, Jul 17, 2024 to Friday, Jul 19, 2024.”

“Get ready to dive into the exciting world of synthetic biology and explore its potential applications in Africa. From cutting-edge research to innovative solutions, this conference offers a unique opportunity to learn, network, and collaborate with like-minded individuals.”

“Discover the latest advancements, trends, and challenges in synthetic biology through engaging keynote speeches, interactive workshops, and thought-provoking panel discussions. Immerse yourself in a vibrant atmosphere where ideas flow freely and new connections are made.”

“Whether you’re a seasoned professional or just starting your journey in synthetic biology, this conference provides a platform to expand your knowledge, exchange ideas, and contribute to the growth of the field in Africa.”

“Don’t miss out on this extraordinary event that promises to shape the future of synthetic biology and biosecurity in Africa. Mark your calendars and join us at the SBA.3 International Synthetic Biology and Biosecurity Conference in Africa!”

Learn more and register here.

Pandora Report 4.26.2024

by dkellogg97, posted in Pandora Report

Happy Friday! This week’s edition of the Pandora Report covers Volodymyr Zelenskyy’s warning about Russia’s continued occupation of Zaporizhzhia Nuclear Power Plant on the 38th anniversary of the fateful explosion at Chernobyl Nuclear Power Plant, updates on the federal government’s sluggish response amid continued spread of H5N1 in the United States, and more.

On Chornobyl Disaster Anniversary, Zelensky Warns Russian Seizure of Zaporizhzhia Nuclear Power Plant Could Lead to Similar Disaster

Today, on International Chernobyl Disaster Remembrance Day and the 38th anniversary of the explosion at Chernobyl Nuclear Power Plant, Ukrainian President Volodymyr Zelenskyy highlighted the ongoing risk posed by Russia’s occupation of the Zaporizhzhia Nuclear Power Plant. Russia has occupied the plant since March 2022, and it briefly held the site in Chornobyl earlier in its invasion. Both incidents have sparked concern due to unsafe practices at both locations.

In his statement, Zelenskyy said “Radiation sees no borders or national flags. The Chornobyl disaster demonstrated how rapidly deadly threats can emerge. Tens of thousands of people mitigated the Chornobyl disaster at the cost of their own health and lives, eliminating its terrible consequences in 1986 and the years after…For 785 days now, Russian terrorists have held hostage the Zaporizhzhia NPP. And it is the entire world’s responsibility to put pressure on Russia to ensure that ZNPP is liberated and returned to full Ukrainian control, as well as that all Ukrainian nuclear facilities are protected from Russian strikes. This is the only way to prevent new radiation disasters, which the Russian occupiers’ presence at ZNPP constantly threatens.”

As of March this year, “The International Atomic Energy Agency (IAEA) board of governors resolution notes that the six-unit Zaporizhzhia nuclear power plant (ZNPP) has been under Russian military control for more than two years and “expresses serious concern about the unstable state of nuclear safety and security at the ZNPP, especially the lack of adequately qualified personnel at the site, gaps in planning and prevention work, the lack of reliable supply chains, the vulnerable state of water and electricity supply outside the site, as well as the installation of anti-personnel mines in the buffer zone between the internal and external perimeter of the installation”.” (World Nuclear News)

Another Game of Infectious Disease Chicken? Federal Government Under Scrutiny for Slow H5N1 Response

Veterinarians and other professionals in the United States and abroad are increasingly criticizing the federal government for what they describe as a delayed effort to share data on viral changes, spread, and milk safety as H5N1 continues to spread in several states. So far, 33 dairy cattle herds in eight states have tested positive. Following the announcement of a human case in Texas recently, concern among scientists and the general public has continued to grow, though authorities continue to emphasize the US milk supply is safe and the risk to the general public is low.

Source: USDA

However, 1 in 5 retail milk samples in the country now test positive for H5N1 fragments according to the FDA, leaving some even more weary. This comes as the Department of Agriculture recently announced that there is growing evidence the virus is spreading among cows, in addition to continued spread from birds to cows. Furthermore, officials in North Carolina have reported a herd tested positive while remaining asymptomatic, though USDA has yet to discuss this publicly. The USDA is currently not requiring farms to test their herds for infection, though it did announce it will begin reimbursing farms for testing cows that are not symptomatic in addition to those that are visibly ill.

As STAT News explains, “Three and a half weeks after first announcing the startling news that cows from a milking herd in Texas had tested positive for H5N1, the government agencies involved in the investigations have not yet revealed what research shows about whether pasteurization of milk kills this specific virus. And until Thursday, U.S. officials had not disclosed whether the now 29 affected herds in eight states form a single linked outbreak fueled by the movement of cattle from the Texas panhandle, where the first outbreak was discovered. At present, STAT was told, that does not appear to be the case.”

The same article continues: “Other countries are trying to determine whether this event is a strange one-off, or proof that the wily virus has evolved to be able to infect cattle more easily, and what risk their own herds — and potentially people — could face if the latter is true. But they are operating largely in the dark because the United States has released such sparse information, said Marion Koopmans, head of the department of viroscience at Erasmus Medical Center in the Dutch city of Rotterdam.”

As this all points to the outbreak being larger than previously thought, the USDA has implemented a rule requiring the testing of all lactating cows before they can be moved across state lines, though experts think this is probably not going to do much to contain transmission at this point. There have also yet to be cases in pigs, which is good because pigs have human and avian receptors, making them especially dangerous in the context of H5N1 spread. However, the US government’s slow reaction and hesitancy to share information is deeply concerning for several key reasons.

A lack of transparency now holds the potential to be incredibly damaging if H5N1 spreads much further, particularly if it does begin spreading in pigs or person-to-person. While the US government does have stockpiled antivirals and vaccines that should be effective against this virus, depending on these measures and continuing to act as if everything is fine is a very dangerous game. Public trust in relevant institutions and these tools is at a dangerous low, and the public is likely to be more susceptible to mis- and disinformation if the federal government continues to drag its feet on sharing information now. This is a major threat to global health, and action needs to be taken now to give everyone, not just the US, the best chance to respond appropriately if this problem does escalate.

Donna E. Shalala Named Co-Chair of Bipartisan Commission on Biodefense

Former Secretary of Health and Human Services Donna E. Shalala was named Co-Chair of the Bipartisan Commission on Biodefense this week following the passing of former Senator Joe Lieberman, a founding Co-Chair of the Commission, last month. She will serve alongside former Pennsylvania Governor and DHS Secretary Tom Ridge. The Commission’s announcement explains that “Dr. Shalala is Trustee Professor of Political Science and Health Policy at the University of Miami, where she served as president from 2001-2015. She served in the U.S. House of Representatives from 2018-2020, representing Florida’s 27th Congressional District. In 1993, President Clinton nominated her as Secretary for Health and Human Services, where she served for eight years. Most recently, Dr. Shalala was named interim president of The New School in New York City.”

‘“This issue of biodefense, of keeping us safe from biological weapons and pandemic-causing diseases, was of great importance to Joe as it is to each of us who continue this work,” said Dr. Shalala. “I thank Gov. Ridge for his steadfast leadership, and for welcoming me as his co-chair.”’

Michael Koeris Appointed Director of DARPA’s Biotechnologies Office

Michael Koeris, Professor of Bioprocessing and a member of the Amgen Bioprocessing Center at the Keck Graduate Institute, was recently tapped to lead the Defense Advanced Research Agency (DARPA) Biotechnology Office (BTO). Koeris has been influential in the field of synthetic biology for years, having recently led the NIH’s RADx initiative as a portfolio executive and serving as Senior Bio Advisor & Venture Partner to The Venture Collective. In this new role, Koeris will oversee DARPA’s efforts to prioritize advancements in synthetic biology, particularly as it relates to areas like AI and space.

Read more about Koeris’ background and path to DARPA’s BTO here.

“Reinforcing Global Biodefense: The Case for Amending the Biological Weapons Convention to Enhance International Law and Legitimacy”

Biodefense PhD Student Ryan Houser recently published this article in the Rutgers Law Record, explaining in his introduction “The BWC is the cornerstone of the biological weapons disarmament regime, but the treaty is having difficulty keeping up with changing threats due to its decision-making process and geopolitics. Fundamentally flawed, the BWC is “crippled by key compromises made by the great powers in pursuit of various self interested security objectives in the context of the Cold War.”5 In November 2022, over two years after the widescale emergence of COVID-19, the international community met to review the BWC for the ninth time. In early 2022, the prospects for strengthening the BWC were the best they had been in years as China, Russia, and the United States had articulated individual plans that reflected enough common ground to craft a workable compromise.6 This cautious optimism around the BWC’s improvement prospects were spoiled by Russia’s invasion of Ukraine in February of 2022. The illegal aggression of Russia undermined the rules-based international order that the BWC is intertwined with. As part of the invasion, Russia also deliberately fabricated allegations levied against Ukraine, the United States, and other partners7 which “stigmatizes and politicizes biosafety, biosecurity, and cooperative public health and life sciences research to the detriment of not just Ukraine, but global health security overall.”8 Efforts to misrepresent or undermine legitimate biosafety and biosecurity research and capacity building weaken the BWC and undermine international cooperation for peaceful purposes.”

“Bringing New Technologies to Bear for Biosurveillance”

Biodefense PhD program alumnus and Schar School adjunct faculty member Daniel M. Gerstein recently coauthored this piece for Food Safety Magazine, which explains in its introduction “Public health, agriculture, the environment, and the food supply could be severely affected by the presence of infectious agents that occur naturally, are the result of accidents, or are intentionally introduced. Yet today, the capability to detect these biological pathogens effectively and rapidly is lacking. This shortfall continues, despite recent key technological advances that could alter the biosurveillance landscape…The foundations of biosurveillance lie in the One Health concept, which the World Health Organization defines as “an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals, and ecosystems.”1 This approach acknowledges the direct relationship between the health outcomes of people, animals, and ecosystems. What affects one, affects all.”

“Teetering on the Edge: Retaliatory Strikes Between Iran and Israel”

Schar School faculty member Mahmut Cengiz recently published this article with Homeland Security Today, writing in his introduction “Once again, tensions are rising in the Middle East, and the continuous cycle of retaliatory strikes between Iran and Israel could lead to unintended consequences and jeopardize security in the region. The Hamas terrorist attacks on October 7, 2023, marked a significant turning point in the history of terrorism and its impact on regional dynamics in the Middle East. These attacks resulted in the deaths of more than 1,300 Israelis, prompting severe retaliatory measures from Israeli forces. However, Israel’s counterterrorism efforts have faced strong criticism due to the casualties of over 33,000 Palestinians and the destruction of thousands of buildings in Gaza. The disproportionate number of civilian casualties, particularly women and children, has sparked debate regarding the legitimacy of terrorist operations in the region. The Tehran regime has promptly engaged in the conflict to pursue regional and global opportunities.”

“Statement of the G7 Non-Proliferation Directors Group, G7 Italy 2024”

The G7 Non-Proliferation Directors Group recently released their statement ahead of the G7 meeting in Italy this June. Their statement covers numerous areas, including nuclear safeguards, conventional weapons, AI and emerging technologies, and more. On biological and chemical weapons, they explain in part “The G7 reaffirms its strongest commitment to effective multilateral actions against the proliferation of all weapons of mass destruction and their means of delivery. As such, we continue to stress the centrality of the Chemical Weapons Convention (CWC) and the Biological and Toxin Weapons Convention (BTWC), and the importance of ensuring their full and effective implementation and universalization.”

Read the entire statement here.

“Strengthening Global Biosecurity and Biosafety Efforts: The Role of the BWC National Implementation Database in Informing and Guiding National Policies”

Jaroslav Krasny recently authored this blog post for the National University of Singapore’s Centre for International Law, explaining in part “The Biological Weapons Convention National Implementation Database (“BWC Database”), developed collaboratively by the United Nations Institute for Disarmament Research (UNIDIR) and the Verification Research, Training and Information Centre or VERTIC, serves as a resource for understanding and supporting the implementation of the Biological Weapons Convention (BWC). This new database compiles information on how State Parties meet their obligations under the BWC. It is designed to assist a wide range of stakeholders, such as government officials, legal professionals, researchers, non-governmental organizations, international bodies, and the private sector, by providing access to detailed information on national implementation practices. The objective is to support compliance with the BWC and contribute to global efforts in biosecurity and biosafety by making relevant information accessible to all interested parties.”

“NTI Convenes the First International AI-bio Forum”

From the Nuclear Threat Initiative: “NTI | bio convened more than 25 high-level biosecurity professionals, AI experts, and policymakers for the inaugural meeting of the International AI-Bio Forum. Participants included representatives from industry, such as Anthropic and Google DeepMind, experts from China, India, Nigeria, the U.K., the U.S., and representatives from multilateral institutions. The virtual meeting was held on April 10-11 and focused on defining the scope, institutional structure, and initial priorities of the International AI-Bio Forum to position it for success in reducing risks associated with rapidly advancing AI-enabled capabilities to engineering living systems.”

Read more here.

“Fighting ‘Smart’ Pandemics: Mitigating Risks and Harnessing the Potential of AI for Biosecurity”

This report was produced by Foreign Policy Analytics with support from the Coalition for Epidemic Preparedness Innovations (CEPI): “Each year, FP Analytics (FPA) invites practitioners, experts, and thought leaders to participate in interactive, scenario-based simulations that foster dialogue and seek innovative solutions to pressing global issues. In February 2024, FPA partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) and the Munich Security Conference (MSC) to produce a simulation, “Fighting ‘Smart’ Pandemics.” The simulation built upon a multistakeholder roundtable discussion that FPA and CEPI co-hosted on the sidelines of the 2023 UN General Assembly, which highlighted the intersection of AI and biosecurity as a key priority area warranting deeper and sustained engagement from global leaders. CEPI, alongside the International Pandemic Preparedness Secretariat, has led a “100 Days Mission” to enable the design, testing, and development of pandemic countermeasures within 100 days of an epidemic or pandemic threat’s emergence, a goal supported by the G7 but not yet realized.”

“A National Security Insider Does the Math on the Dangers of AI”

This Wired piece covers an interview with Jason Matheny, CEO of the RAND Corporation, and his thoughts on AI advancement making it easier to create biological and other weapons. In it, he explains his transition from working in public health to focusing on national security and how this has shaped his thinking, saying in part “When I first started getting interested in biosecurity in 2002, it cost many millions of dollars to construct a poliovirus, a very, very small virus. It would’ve cost close to $1 billion to synthesize a pox virus, a very large virus. Today, the cost is less than $100,000, so it’s a 10,000-fold decrease over that period. Meanwhile, vaccines have actually tripled in cost over that period. The defense-offense asymmetry is moving in the wrong direction.”

“Strengthening Biosecurity in Southeast Asia”

DTRA’s Andrea Chaney recently authored this piece that covers the recently-concluded Southeast Asia Strategic Biosecurity Dialogue. She explains in part, “In the context of Southeast Asia’s increasingly complex biosecurity landscape, dialogue participants engaged in several roundtable discussions covering a range of biosafety and biosecurity topics. Participants brought a broad scope of expertise, including health, defense and law enforcement, biology and biotechnology, international relations, and non-proliferation. The discussions encompassed Southeast Asia’s regional biosecurity priorities; building resilience to future threats; laboratory biosecurity and biosafety; the convergence of biology and emerging technologies; medical countermeasures development, production, and stockpiling strategies; and the role of the military in biosecurity.”

“Emerging Biotechnology Capacity and Emerging Biosecurity Threats in Colombia and Chile”

Steve S. Sin recently published this section in a report from the Army War College, “Emerging Technologies and Terrorism: An American Perspective”: “With the onset of the COVID-19 pandemic, countries around the world came to recognize the importance of maintaining a national stockpile of biologics (for example, vaccines) and, if possible, possessing domestic capabilities to produce the biologics required to fight the spread of communicable diseases. In South America, Colombia and Chile at one point possessed robust vaccine production capabilities but abandoned them decades ago.1 Although some within these countries called for a renewal of their vaccine production capabilities, the calls went unheard—that is, until the COVID-19 pandemic. As the world weathered the pandemic and countries scrambled to secure the vaccines needed to combat it, Colombia and Chile decided they would return to producing biologics domestically as well as double down on their already-active biotechnology policies that had been designed to encourage public-private partnerships and attract foreign investments.”

“Biotech Matters: Public-Private Coordination of Biotechnology”

Richard Danzig recently authored this piece for CNAS, writing in part “The U.S. successes and failings during the COVID-19 pandemic, combined with perceptions that China vigorously coordinates its public and private sectors, generated calls for an American industrial policy that would further orchestrate biotechnology work in the United States. In this context, the natural tendency is to regard improved coordination as straightforwardly achievable through improved processes and enlightened leadership…The nation would be well advised, however, to recognize that the difficulties are more deeply rooted than simply failures of will, imagination, or efficiency. Three deep-seated problems impede progress.”

APIC Emerging Infectious Diseases HPAI Playbook

The Association for Professionals in Infection Control and Epidemiology regularly publishes playbooks for specific diseases, including a new one for Highly Pathogenic Avian Influenza: “To help infection preventionists quickly activate Highly Pathogenic Avian Influenza (HPAI) prevention efforts, APIC’s Emerging Infectious Diseases Task Force has created an HPAI Playbook that IPs can download and customize for use in their facilities. The Playbook is a concise workflow document that is designed to be user-friendly and operational for busy IPs.”

“The Viral Most Wanted: The Hantaviruses”

CEPI’s Kate Kelland recently authored this latest entry in CEPI’s Viral Most Wanted focused on the hantaviruses, writing in the work’s introduction: “The Albuquerque Journal, a newspaper in the U.S. state of New Mexico, ran an alarming headline in its May 27th edition in 1993: “MYSTERY FLU KILLS 6 IN TRIBAL AREA”. The article told a story that had first come to light two weeks earlier, when a 19-year-old man was rushed to the emergency department of the Indian Medical Centre in Gallup.”

“The man, a Native American from the Navajo tribe, had been travelling with his family to his fiancée’s funeral when he began struggling to breathe in the car’s back seat. The family veered off the road to call for an ambulance. Both the first responders and, later, the emergency room doctors tried to revive the victim with cardiopulmonary resuscitation, but their efforts were in vain. The young man’s lungs were flooded with fluid. He had effectively drowned.”

“The ER doctors were shocked, not only at the speed and dramatic nature of the man’s death, but by the similarity of the case to that of a young woman a few weeks earlier who had suffered the same symptoms and also died.” 

“Over the next few weeks, more than a dozen more people in the area contracted the deadly disease, many of them young Navajos.”  

“During the same period, doctors and public health officials tried desperately to identify what was causing the outbreak. On June 11th, 1993, the weekly Morbidity And Mortality report from the U.S. Centers for Disease Prevention and Control (CDC) revealed that the mystery pathogen was “a previously unrecognized Hantavirus”.” 

“The novel viral villain belonged to the Hantavirus family—a group of viruses normally carried by rats, mice and other rodents and known to cause severe disease in people. The Hantavirus family is one of The Viral Most Wanted.“

“Public Health Preparedness: Mpox Response Highlights Need for HHS to Address Recurring Challenges”

The Government Accountability Office recently published this report on HHS’ response to the mpox outbreak in the United States: “Health and Human Services was initially charged with coordinating the federal response to a 2022 global outbreak of mpox—a smallpox-related virus.”

“State and local jurisdictions cited challenges in the federal response such as difficulty accessing and using vaccines and tests, which may have led to unnecessary suffering. We added HHS’s leadership and coordination of public health emergencies to our High Risk List earlier in 2022 due to similar issues in past responses.”

“We recommended that HHS adopt a coordinated, department-wide program that incorporates input from external stakeholders to identify and resolve challenges.”

“Deadly Diseases and Inflatable Suits: How I Found My Niche in Virology Research”

Nikki Forrester recently authored this spotlight piece for Nature covering the career of  Hulda Jónsdóttir: “Virologist Hulda Jónsdóttir studies some of the world’s most pathogenic viruses at the Spiez Laboratory in Spiez, Switzerland. For her, highly pathogenic viruses are more often a source of curiosity than of concern. Jónsdóttir, who runs a research group at the Spiez Laboratory, regularly dons a giant, inflatable protective suit to research disinfectants and antiviral compounds to combat several lethal viruses, including Ebola virus and Lassa virus. Jónsdóttir spoke to Nature about carving her own path in virology research and why she chose to pursue a career in Switzerland and at the Spiez Laboratory, which is owned and funded by the Swiss government.”

What We’re Watching 🍿

IR Thinker, Chemical and Biological Weapons – Brett Edwards | 2024 Episode 7

“In this enlightening interview, Dr. Brett Edwards, an expert in chemical and biological weapons, describes the history, current capabilities, and future challenges associated with these formidable weapons systems. Dr. Edwards discusses the evolution of chemical and biological warfare, the verification processes for weapon destruction, and how these weapons integrate into national military strategies. He also addresses the ethical debates surrounding their use, international efforts to control such weapons, and the specific challenges posed by conflicts like the ongoing war in Ukraine.”

Watch here.

ICYMI-Oppenheimer: The Rest of the Story

Middlebury’s James Martin Center for Nonproliferation Studies recently hosted this event with Siegfried Hecker: “Christopher Nolan’s biopic Oppenheimer has captured the interest of nearly 100 million people around the world. Dr. Hecker will provide the back story to some key elements of the film and share his views on the legacy of Oppenheimer and the Manhattan Project, based on his more than five-decades associated with the laboratory Oppenheimer led.”

The event recording is available here.

3rd International Biosecurity Virtual Symposium

From ABSA: “The Symposium will bring together biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge on diverse biosecurity topics. The Symposium will offer attendees an opportunity to learn the latest in biosecurity and have thought-provoking conversations about real-world biosecurity issues, concerns, and scenarios.”

This symposium will take place May 7-8. Learn more and register here.

Addressing the Challenges Posed by Chemical and Biological Weapons: Intensive Online Introductory Course for Students of Technical Disciplines

“SIPRI and the European Union Non-Proliferation and Disarmament Consortium (EUNPDC) invite graduate and postgraduate students of the technical or natural science disciplines to apply for an intensive online introductory course on chemical and biological weapons—their proliferation, the efforts to eliminate them, the various mechanisms used to control their spread—and endeavours underway to reduce the risk of chemical or biological agents in terrorist attacks. The course will take place online, during four half-days on 28–31 May 2024, 14:00 to 18:00 Central European Summer Time (CEST).”

“The course will cover the fundamentals of chemical and biological weapons as well as of missiles and other means of delivery; the history of chemical and biological warfare; the evolution of international norms against these weapons; the threats associated with potential terrorist uses of chemical and biological material; bioweapons and other related scientific advances; the current challenges posed by chemical weapons; arms control treaties; and mechanisms to curb the spread of dangerous substances, including export controls.”

“The course will also discuss the role of the EU institutions and industry to address the challenges mentioned above. The course will be instructed by renowned experts on non-proliferation, arms control, disarmament, export controls, verification and related subjects from SIPRI, other European research centres, think tanks and international organizations.”

Learn more and apply here.

Registration for GHS 2024 Now Open

Registration is now open for the Global Health Security 2024 conference in Sydney, Australia. This iteration will take place 18-21 June, 2024. The call for abstracts is also still open. “The mission of the Global Health Security conference is to provide a forum where leaders, researchers, policy-makers, and representatives from government, international organisations, civil society, and private industry from around the world can engage with each other, review the latest research and policy innovations, and agree solutions for making the world safer and healthier. To that end, our mission is to help foster a genuinely multidisciplinary community of practice that is committed to working collaboratively to enhance global health security and eliminate disease, irrespective of its origin or source.”

SBA.3 International Synthetic Biology, and Biosecurity Conference in Africa

“Join us for the SBA.3 International Synthetic Biology and Biosecurity Conference in Africa, a groundbreaking event that brings together experts, researchers, and enthusiasts in the field of synthetic biology. This in-person conference will take place at the Laico Regency Hotel from Wed, Jul 17, 2024 to Friday, Jul 19, 2024.”

“Get ready to dive into the exciting world of synthetic biology and explore its potential applications in Africa. From cutting-edge research to innovative solutions, this conference offers a unique opportunity to learn, network, and collaborate with like-minded individuals.”

“Discover the latest advancements, trends, and challenges in synthetic biology through engaging keynote speeches, interactive workshops, and thought-provoking panel discussions. Immerse yourself in a vibrant atmosphere where ideas flow freely and new connections are made.”

“Whether you’re a seasoned professional or just starting your journey in synthetic biology, this conference provides a platform to expand your knowledge, exchange ideas, and contribute to the growth of the field in Africa.”

“Don’t miss out on this extraordinary event that promises to shape the future of synthetic biology and biosecurity in Africa. Mark your calendars and join us at the SBA.3 International Synthetic Biology and Biosecurity Conference in Africa!”

Learn more and register here.

Applied Biosafety Call for Papers, Special Issue: Biosafety and Biosecurity for Potential Pandemic Pathogens and Dual Use Research of Concern

“The fields of biosafety and biosecurity are crucial to managing risks associated with Potential Pandemic Pathogens (PPPs) and Dual Use Research of Concern (DURC), particularly as novel and reemerging pathogens increasingly impact global health. The Editors of Applied Biosafety are pleased to announce a forthcoming Special Issue focused on the myriad of risks associated with handling, transporting, and researching PPPs and DURC, as well as the measures needed to mitigate these risks effectively. This special issue aims to review and scrutinize existing and forthcoming government policies and regulations to identify gaps in addressing these concerns. It will also explore the integral role played by biosafety and biosecurity professionals in shaping policy and guidance.”

Learn more here.

Job Openings at the Institute for Progress

Senior Biotechnology Fellow

“Our biotechnology portfolio explores how we can advance policies that improve U.S. state capacity to accelerate and shape promising innovations in biotechnology and biotechnology governance. Innovations in biology may finally deliver cures to HIV, malaria, influenza, and some cancers. New AI models are unfolding the secrets of the molecular world before our eyes. Spurred by the urgency of the pandemic, we are now closer than ever before to developing technologies to prevent future such outbreaks.”

“Biotechnology fellows are expected to have a keen interest in these issues. Under the guidance of the IFP team, they will explore and become experts in specific biotechnology topics, both from a technology and policy perspective. Fellows will interact with policymakers, write articles and white-papers, and more. We encourage fellows to pursue creative routes that they think might have significant counterfactual policy impact.”

Biotechnology Fellow

“Biotechnology fellows are expected to have a keen interest in these issues and the ways the U.S. government supports and oversees them. Under the guidance of the IFP team, they will explore and become experts in specific biotechnology topics, both from a technical and policy perspective. Fellows will interact with policymakers, write articles and white papers, and more – we encourage fellows to pursue creative routes that they think might have significant counterfactual policy impact.”

Learn more and apply to these positions here.

Job Opening at Blueprint Biosecurity

“Blueprint Biosecurity is seeking a full-time Program Director to build and lead our portfolio of work on personal protective equipment (PPE). We are seeking a proactive leader who thrives in a dynamic and evolving environment. You will have a high degree of autonomy to design and steer a pioneering program that aims to advance the state of PPE for pandemic prevention. This effort will build on the roadmap for Pandemic Proof PPE, developing goals and objectives to translate our ambitious vision into tangible outcomes. A successful candidate will be excited about building an effort from the ground up and willing to pivot and iterate to find ways to succeed.”

“In this role, you will be working collaboratively with other teams within and external to Blueprint Biosecurity. The ideal candidate will have excellent interpersonal abilities and strong skills in project management, strategic prioritization, research, and analysis.”

Learn more and apply here.

Pandora Report 1.5.2024

by dkellogg97, posted in Pandora Report

Happy New Year! This week covers reports of over 450 chemical attacks by Russia since the invasion of Ukraine in 2022, the fifth anniversary of DHS’ CWMD Office, and several recent publications.

Ukraine Reports Hundreds of Chemical Attacks by Russia Since Start of Invasion

In late December, the Kyiv Post published an article explaining a post from Ukraine’s Armed Forces Support Forces Command, which “claims that Russian troops have conducted 465 chemical attacks in Ukraine since the initiation of the full-scale invasion, with over 80 such attacks in December 2023, including one grenade containing a new, unknown chemical agent…The command notes an escalating trend in the use of such weapons by Russian forces, highlighting eight chemical attacks on Dec. 19 alone.”

The article continues, explaining “The commonly used weapons include grenades like K-51, RGR, and Drofa-PM gas hand grenades dropped from unmanned aerial vehicles (UAVs). Additionally, improvised explosive devices equipped with irritant substances and artillery shelling containing chemically dangerous substances are being employed.”

“The report mentions that 28 cases involving dangerous chemicals were documented and forwarded for investigative actions as part of criminal proceedings by groups of radiation, chemical, and biological intelligence from the military units of the Support Forces Command, working in collaboration with the Security Service of Ukraine (SBU).”

In case you missed it: Last summer, the Royal United Services Institute published an article on this topic, exploring the reported limited use of riot control agents and broader deployment of CW by Russia could mean in this war. The piece offers insight into Russia’s potential ogic in using these kinds of weapons in Ukraine, making it helpful in understanding this latest reporting.

DHS Celebrates Five Years of the Countering Weapons of Mass Destruction Office

In late December, the Department of Homeland Security celebrated the fifth anniversary of the founding of the Countering WMD Office. In an email update from the Department, Assistant Secretary for the Countering Weapons of Mass Destruction Office, Mary Ellen Callahan, was quoted saying “The threat of weapons of mass destruction terrorism is real. Five years ago, in the face of a dynamic, evolving threat environment, legislators recognized that the U.S. needed a more holistic approach to countering chemical, biological, radiological, and nuclear threats to the Homeland…By authorizing CWMD, the legislators enabled us to enhance and coordinate the chemical, biological, radiological, and nuclear detection efforts of federal, state, local, tribal, and territorial governments to improve preparedness and response capabilities throughout the United States. We look forward to continuing this essential mission to protect the American people.”

The update further explained “Congress established the CWMD Office in 2018 to elevate, consolidate, and streamline DHS efforts to protect the Homeland from weapons of mass destruction (WMD) and chemical, biological, radiological, and nuclear (CBRN) threats. CWMD serves as the DHS nexus for WMD and CBRN coordination, which includes providing direct financial and operational support nationwide to government and industry partners for full-time biological detection, illicit nuclear material detection, training, and exercises. Additionally, as part of the President’s Executive Order on AI signed in October 2023, President Biden tasked CWMD with helping to evaluate and mitigate the potential for AI to be used to develop WMDs, such as through AI-enabled misuse of synthetic nucleic acids to create biological weapons. The President directed the CWMD Office to evaluate the potential for AI to lower the barriers to entry for developing WMD and to develop a framework to evaluate and stress test synthetic-nucleic acid screening, creating a standardized set of expectations for third parties that audit AI systems to prevent the risk of abuse and proliferation by malicious actors.”

Defense Dossier Issue 38: “Pandemic Preparedness and Biodefense”

The American Foreign Policy Council’s December Defense Dossier is focused on biodefense and pandemic preparedness, featuring an article-“Parsing the Great Gain of Function Debate”-co-authored by Biodefense PhD Program alumni Yong-bee Lim and Saskia Popescu. It also includes other articles like “China’s Evolving Thinking About Biotechnology,” and “Understanding the Cyberbiosecurity Threat.” Read here.

“Virology-the Path Forward”

Rasmusen et al. recently published this commentary article in the Journal of Virology. They write in their abstract, “In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.”

“Interpreting the Biological Weapons Convention – What Are “Necessary Measures” Under Article IV of the Convention?”

Sally Longworth recently published this report with the Swedish Defence Research Agency. She explains in her summary, “Article IV of the Biological Weapons Convention 1972 (BWC) requires States Parties to implement national implementation measures to prohibit and prevent the development, production, stockpiling, retention, acquisition, transfer, and use of biological agents, toxins and weapons in violation of the Convention. No definition of “national implementation measures” is included in the treaty, but there has been over 50 years of State practice in implementing this obligation, which can provide guidance on how States Parties interpret the obligations under Article IV. The Final Declarations agreed by consensus by States Parties at the Convention Review Conferences held every five years are particularly useful tools in understanding what measures are required and what, if any, development there has been in interpreting Article IV. Using legal methods to interpret international treaties, this memo first analyses the obligations set out in Article IV and then considers the interpretative value of the Final Declarations in relation to the BWC. It goes on to highlight a number of measures identified by the States Parties considered necessary in the implementation of the obligations contained in Article IV and important developments in what must be covered.”

“Vision, Needs, and Proposed Actions for Data for the Bioeconomy Initiative”

The National Science and Technology Council recently released this report from the Interagency Working Group on Data for the Bioeconomy. Its executive summary explains in part, “To realize a thriving bioeconomy, the Data Initiative identifies strategic investments and opportunities to leverage and build upon existing resources. The goal is to create an interwoven data fabric that connects data with the infrastructure and computational resources necessary to analyze, synthesize, and use those data for the widest audience. This vision depends on creation and adoption of community-driven standards, both for data and for repositories to enable interoperability and integration; training and education to build the bioeconomy data workforce of tomorrow; efforts to limit and mitigate security risks; and ongoing coordination to ensure efforts keep pace with transformations in data science, computing, biotechnology and biomanufacturing. While additional data are needed, government coordination and investment in infrastructure are also needed to make best use of the existing and anticipated data.”

Furthermore, in identifies seven Core Action areas the Data Initiative indicates requires “consistent whole-of-government coordination and investments”:

  1. Dedicated long-term funding mechanisms for data and computational resources and infrastructure;
  2. Standards to establish common best practices that foster and strengthen a shared U.S. bioeconomy data ecosystem;
  3. Biodata Catalog to identify extant data and metadata;
  4. Security practices and policies that secure the data landscape while supporting innovation;
  5. Workforce to drive U.S. leadership in the bioeconomy of the future;
  6. Strategically Targeted Areas for Rapid Transformation (START) to determine viability and impact and chart a course for larger investments; and
  7. Coordination of intergovernmental investments, efforts, and resources.

“FACT SHEET: Biden-⁠Harris Administration Releases Global Health Security Partnerships Annual Progress Report Demonstrating Results from United States Investments”

The White House recently released this fact sheet along with the release of its Global Health Security Partnerships Annual Progress Report. The fact sheet explains in its introduction, “The Biden-Harris Administration continues to prioritize global health security as a critical component of national biodefense.  The COVID-19 pandemic, as well as HIV/AIDS, Ebola, mpox and other outbreaks in recent years, has demonstrated the catastrophic impacts infectious diseases can have on health, economies, and societies, regardless of where they start.  The United States partners with countries around the world to build stronger global health security capacity – the ability to prevent, detect, rapidly respond to, and recover from new and emerging public health threats and prevent their spread across borders. Partnering with countries to stop infectious disease threats at their source, including by strengthening equitable health systems in their own countries and across regions, effectively protects the health of Americans and people across the world.”

“Exploring Actions for Epidemic and Pandemic Preparedness”

The National Academies recently released this Proceedings of a Symposium-in Brief: “Investing in pandemic preparedness ahead of disease outbreaks can greatly reduce the toll of epidemics and pandemics when they occur. Although several tools exist for assessing pandemic preparedness at an epidemiological and operational level, less information and fewer approaches are available to guide the prioritization of preparedness investments at the country level. The National Academies of Sciences, Engineering, and Medicine held an international, virtual symposium series in May and June 2023 to explore possible strategies for evidence-based prioritization of global health capabilities to prepare for future epidemics and pandemics. Speakers and participants discussed assessment tools for national action planning; country and organizational decision-making about funding priorities; effective approaches for disease surveillance and risk communication; governance structures that support robust and reliable systems for global health investments; and specific actions for tools and resource prioritization for preventing and preparing for future epidemics and pandemics. This publication summarizes the presentation and discussions of the symposium.”

“America Should Be More Like Operation Warp Speed”

Gary Hamel and Michele Zanini recently published this Ideas piece in The Atlantic focused on how OWS offers lessons for the rest of the government in achieving goals. They write in their introduction, “The U.S. government can achieve great things quickly when it has to. In November 2020, the Food and Drug Administration granted emergency-use authorization to the Pfizer-BioNTech vaccine for COVID-19. Seven days later, a competing vaccine from Moderna was approved. The rollout to the public began a few weeks later. The desperate search for a vaccine had been orchestrated by Operation Warp Speed, an initiative announced by the Trump administration that May. Developing, testing, manufacturing, and deploying a new vaccine typically takes a decade or more. OWS, which accomplished the feat in months, belongs in the pantheon of U.S. innovation triumphs, along with the Manhattan Project and the Apollo moon-landing program. It’s a case study in how the U.S. government can solve complex, urgent problems, and it challenges the narrative that public institutions have lost their ability to dream big and move fast.”

“Why the World Needs Its Own Immune System”

Atul Gawande, USAID’s Assistant Administrator for Global Health, recently published this opinion piece in The New York Times. He writes in part, “This is now the pattern: one emergency after another, often overlapping, diverting focus away from longer-term public health goals. And there’s no sign of this letting up. Displacement and activities like deforestation have increased contact between humans and wildlife — and thus the incidence of animal diseases leaping to humans. (The Ebola virus, for example, has been linked to bats as a possible source of spread.) The risk of outbreak-causing laboratory accidents is a significant concern as labs proliferate and safety measures lag. On average, between 1979 and 2015, more than 80 laboratory-acquired infections were reported per year, several involving transmission beyond those initially infected, and underreporting is rife. The growing field of synthetic virology has simultaneously generated lifesaving new treatments (mRNA vaccines, for example) and made it easier for bad actors to turn infectious diseases into weapons of mass destruction.”

“But we can break the pattern. Longer-range investment in local preparedness for such events — in building what I think of as a global immune system — could reduce the threat these crises pose and even reduce dependence on foreign aid to weather them. As dangers rise, so can our capacity to get ahead of them. With the right strategy, we could use the mishaps, malefactors and shocks we face to strengthen our capacity to adapt. This is not about developing resilience (the ability to recover from crisis) or robustness (the ability to resist crisis). It is about developing what the writer Nassim Nicholas Taleb has called antifragility — the ability to become stronger from crisis.”

“The OPCW and Civil Society: Considerations on Relevant Themes and Issues”

Alexander Ghionis recently published this working paper for CBWNet. He explains in its executive summary, “This paper explores some key elements of the relationship between the Organisation for the Prohibition of Chemical Weapons (OPCW) and civil society, with the specific and limited aim of supporting ongoing discussions being held within the OPCW regarding options and mechanisms to enhance that relationship. The paper is designed to be practical, providing readers from State Parties, the Technical Secretariat, civil society, and other stakeholders, with some initial perspectives, ideas, and considerations that could inform discussions.”

The paper addresses “The composition and focus of accredited civil society organisations (CSOs); How CSOs have engaged with the OPCW so far and what alternative modes of engagement may be beneficial; and, What foundational aspects can strengthen the relationship between the OPCW and civil society moving forward.”

“The Altered Nuclear Order in the Wake of the Russia-Ukraine War”

Rebecca Davis Gibbons, Stephen Herzog, Wilfred Wan, and Doreen Horschig recently published this research paper with the American Academy of Arts & Sciences. They explain in their executive summary: “On February 24, 2022, Russia invaded nonnuclear-armed Ukraine and leveraged threats with its nuclear arsenal as a “shield” to deter third-party intervention. The well-publicized horrors on the ground in Ukraine are, unfortunately, not the only consequences of Russia’s full-scale invasion of its neighbor. The war is having unmistakable effects on how governments, scholars, and the public think about nuclear arms. Not only has Moscow reintroduced the world to the often-unsavory realities of nuclear deterrence, but its suspension of the New Strategic Arms Reduction Treaty (START) and deratification of the Comprehensive Nuclear-Test-Ban Treaty (CTBT) have been setbacks for arms control and disarmament. Meanwhile, vulnerable states around the globe may be further incentivized to develop nuclear weapons or seek protection from nuclear-armed patrons to avoid being invaded like Ukraine.”

“Given these changing geopolitical circumstances, how might the Russian war on Ukraine affect the global nuclear order? The authors in this publication conclude that the United States and the broader international community must now more seriously engage with alternatives to traditional arms control, nonproliferation, and disarmament endeavors. Specifically, the authors discuss the increasing prominence of approaches such as the Treaty on the Prohibition of Nuclear Weapons (TPNW)—popularly known as the Nuclear Ban—and risk reduction measures. They assess whether these initiatives can have an impact in reducing nuclear dangers. Additionally, they examine temptations for states to pursue more forceful counterproliferation measures and describe the risks of doing so.”

NEW: “When Medicine Stops Saving Us: The Antimicrobial Resistance Crisis”

“Interim Dean Abel Valenzuela and the UCLA Division of Social Sciences present an exclusive screening of a new documentary from the team behind the award winning NETFLIX documentary, RESISTANCE. This genre-bending short film, HOLOBIOME, features the harrowing story of UCLA graduate Bradley Burnam’s personal encounter with a deadly superbug. Through a variety of creative elements, HOLOBIOME examines the need for innovation in AMR and questions the overall human relationship with infectious disease and the microbial world. The screening will be followed by an interdisciplinary panel discussing the looming AMR crisis through the lenses of sociology, public policy, industry, and public health.”

This event will be moderated by Biodefense PhD Program alumna Jomana Musmar. It will take place on January 22, at 5 pm PST. Learn more and register here.

NEW: AI Executive Order Report Card Reviewing the First 90 Days

“On October 30, 2023, the Biden Administration issued a call to action outlining a host of requirements and deliverables for U.S. government agencies on artificial intelligence. The executive order touched on a range of AI-relevant issues, including testing and evaluation of new AI systems, developing a healthy and capable U.S. AI workforce, and ensuring U.S. competitiveness in the years to come.”

“Join CSET researchers on January 31, 2024, for a discussion of what the U.S. Government has accomplished so far, what have we learned, and what’s left to do to complete the EO’s ambitious goals.”

This online event will begin at 12 pm EST. Learn more and register here.

International Conference, CBRNE Research & Innovation

“The last 40 years have demonstrated that both military and civilian populations could be exposed to highly hazardous CBRNE agents following conflicts, natural outbreaks and disasters, industrial incidents or terrorist attacks.”

“Worldwide, researchers, responders and industrial capacities have been commited to provide adapted response to these challenges.”

“Building on the success of the first 5 International Conferences « CBRNE Research and Innovation » which took place in Antibes (2015), Lyon (2017), Nantes (2019), on line (2021) and Lille (2022), we want to give you a new opportunity to build up or strengthen collaborative networks in Strabourg (March 19th – 21rst 2024).”

“The CBRNE R&I Conference is specifically devoted to scientific updates, responders’ feedbacks and expression of needs. It also includes workshops and demonstrations of innovative materials, technologies and procedures, according to the following themes: DETECTION – IDENTIFICATION, PROTECTION – DECONTAMINATION, MEDICAL COUNTERMEASURES, RISKS & CRISIS MANAGEMENT.”

“Looking forward to your proposals for communication and to welcoming you at Strasbourg in March 2024!”

Learn more here.

cbrne-ri-conference-2024-_-flyer-ppt-v06.11.2023-1Download

Registration for GHS 2024 Now Open

Registration is now open for the Global Health Security 2024 conference in Sydney, Australia. This iteration will take place 18-21 June, 2024. The call for abstracts is also still open. “The mission of the Global Health Security conference is to provide a forum where leaders, researchers, policy-makers, and representatives from government, international organisations, civil society, and private industry from around the world can engage with each other, review the latest research and policy innovations, and agree solutions for making the world safer and healthier. To that end, our mission is to help foster a genuinely multidisciplinary community of practice that is committed to working collaboratively to enhance global health security and eliminate disease, irrespective of its origin or source.”

Vote: 2023 Arms Control Person(s) of the Year Nominees

“Since 2007, the independent, nongovernmental Arms Control Association has nominated individuals and institutions that have, in the previous 12 months, advanced effective arms control, nonproliferation, and disarmament solutions and raised awareness of the threats posed by mass casualty weapons.”

“In a field that is often focused on grave threats and negative developments, the Arms Control Person(s) of the Year contest aims to highlight several positive initiatives—some at the grassroots level, some on the international scale—designed to advance disarmament, nuclear security, and international peace, security, and justice.”

“Voting will take place between Dec. 8, 2023, and Jan. 11, 2024. The results will be announced on Jan. 12, 2024. Follow the discussion on social media using the hashtag #ACPOY2023.”

Learn about the nominees and vote here.

Pandora Report 12.15.2023

by dkellogg97, posted in Pandora Report

This week covers the FDA’s ongoing investigation into contaminated applesauce, the passing of Gao Yaojie-an activist responsible for bringing to light the extent of China’s AIDS epidemic-, and more.

Biodefense MS Graduates Riley Flynn and Sophie Hirshfield at GMU’s 2023 Winter Commencement Ceremony

FDA Leadership Says Tainted Applesauce Pouches May Have Been Intentionally Contaminated

Cinnamon applesauce pouches available Weis, WanaBanana, and Schnucks have been pulled from shelves after they were found to be contaminated with lead. Dozens of children in the United States have been sickened by the tainted products. Now, the FDA’s Deputy Commissioner for Human Foods, Jim Jones, says they may have been intentionally contaminated.

In an interview with Politico, Jones said “We’re still in the midst of our investigation. But so far all of the signals we’re getting lead to an intentional act on the part of someone in the supply chain and we’re trying to sort of figure that out.” All of the pouches in question were linked to a manufacturing facility in Ecuador that the FDA is currently inspecting.

‘“My instinct is they didn’t think this product was going to end up in a country with a robust regulatory process,” Jones said. “They thought it was going to end up in places that did not have the ability to detect something like this.”’

Politico further explained that “The FDA continues to investigate a number of theories for how the pouches became contaminated, and has not drawn any conclusions about the way the lead was added, why or by whom. The FDA says it currently believes the adulteration is “economically motivated.” That generally refers to ingredients being altered in order to make products appear higher in value, often so companies can produce a cheaper item and sell it at an elevated price.”

“The agency and the Centers for Disease Control and Prevention have collaborated with state and local health authorities as well as Ecuadorian authorities to trace the origin of the cinnamon in the applesauce pouches, which is believed to be the source of the lead contamination. More than 60 U.S. children under the age of 6 have tested positive for lead poisoning after consuming the pouches — some at levels more than 500 times the acceptable threshold for lead, according to The Washington Post.”

Gao Yaojie, Chinese Physician and Self-Exiled AIDS Activist, Dead at 95

Gao Yaojie, a gynecologist and well-known AIDS activist, died on December 10 in New York City. Gao, formerly based in China’s Henan province, was famous for her work to expose the outbreak of HIV/AIDS in the country in the 1990s and 2000s. The outbreak was large in scale and primarily driven by the country’s Plasma Economy, which arose because of restrictions on foreign imports of blood products in the 1990s. This resulted in blood plasma donation becoming a way for rural populations to make money in government-supported plasma donation centers. However, unsafe practices like repeated use of unsterilized needles and pooling multiple donors’ blood during the plasmapheresis allowed HIV to spread widely.

Because of the Chinese government’s efforts to suppress reporting on this epidemic, poor rural populations were left largely unaware of the dangers of plasma donation and the public in general was unaware of the severity of the crisis. Gao was one of the first to speak publicly about the outbreak, helping draw the attention of media outlets. She later told documentary filmmakers about her motivations for doing this, saying, “My driving thought is: how can I save more people from dying of this disease? We each only live one life.”

It is estimated that at least one million Chinese were infected with HIV during this epidemic, highlighting the importance of Gao’s and others’ bravery. For this, she garnered praise from the United Nations, several Western organizations, and even Hillary Clinton. This rising fame led to her being placed under house arrest in 2007, with about 50 police preventing her from traveling to the United States to accept an award recognizing her work. In response to this, she told NPR “I think they feel I got in the way of their political achievements and their official careers…Otherwise, why would they put me under house arrest? What law did I break to warrant mobilizing all these police?”

NPR further explained her activities later in life in their article on her passing, writing: “Despite pressure from Henan provincial authorities to stop publicizing the AIDS crisis, she continued her work, using all the proceeds from her books and pamphlets to support AIDS families, especially children orphaned by the disease or the many suicides that it caused.”

“Restrictions on her movement began hindering in work in China, however, and in 2009, she abruptly fled to the US, after fearing she would be put under house arrest again. Many admirers continued to visit her apartment in West Harlem, including a group of young Chinese students who kept her company in the loneliness of exile.”

‘”Many Chinese regarded her as a hero, and when they came to New York, if they didn’t know how to contact her , [sic] they would ask me. I would ask them for an email written in Chinese and would forward it to her. So far as I know, she always wrote back to those people and welcomed them to come visit,” remembers Andrew Nathan, a political science professor at Columbia University who handled much of Gao’s affairs in New York.”

“The Biological and Toxin Weapons Convention in 2023: Glimmers of Progress Set Against a Troubled Geopolitical Landscape”

Experts at CSR’s Nolan Center, including Biodefense PhD Program alumna and current faculty member Saskia Popescu, recently authored this blog post focused on the BWC’s potential for success in verification, universalization and effective implementation in Africa, and the creation of an International Agency for Biological Safety. They explain in their introduction: “For nearly two decades, efforts to strengthen the Biological and Toxin Weapons Convention (BWC) were in stasis, with opportunities missed and States Parties unable to agree to definite action. States Parties arrived at the Review Conference last year facing a growing biological weapons threat—augmented by rapidly converging complimentary technologies—coupled with a status quo in the BWC that was insufficient for the task. Yet nations drove a breakthrough: the consensus achieved at last year’s Review Conference proved that action is still possible despite the challenging international security environment.”

“In a world in which biological threats and vulnerabilities are exceedingly complex, there is a critical need to reinforce relationships among global experts, national governments, and civil society. Over the past two weeks, these stakeholders have met to identify, examine, and develop specific and effective measures to strengthen the Convention. An unwavering theme throughout the Meeting of States Parties underscored that preparedness and resilience are investments, rather than costs, reinforcing the deterrence by denial efforts CSR continues to promote. Although the challenging international security environment continues to hinder progress there are glimmers of genuine progress across several fronts…”

“Biosecurity in the Americas: Regional Threat Assessment”

A new from UMD’s START, co-authored by Biodefense MS Program alumna Alexandra Williams: “This publication, currently available in Spanish, provides a breadth and depth of focuses as a high-level assessment of the Central and South America regions and introduction to key topics as:

  1. The needed expansion of understanding of the differences and areas of collaboration between the concepts of biosafety and biosecurity,
  2. Existing international obligations to biosecurity through the BWC and UNSC Resolution 1540,
  3. How biosecurity applies to and may differ in application across a variety of facility types that engage in biological research or production, whether private or public laboratories, agricultural or university-based facilities,
  4. Biosecurity risks that include proliferation, bioterrorism, agroterrorism, and biocrime,
  5. The five pillars and mechanisms of biosecurity,
  6. Lastly, the application of biosecurity in the Central and South American regions.”

“NTI|Bio Convenes Workshop on Disincentivizing State Bioweapons Development and Use”

From NTI: “A week ahead of the Biological Weapons Convention (BWC) Working Group meetings in Geneva, Switzerland, NTI | bio convened a workshop on “Disincentivizing State Bioweapons Development and Use.” This two-day workshop on November 29 and 30 brought together academics, diplomats, biosecurity experts, and government policy makers to begin developing a cross-disciplinary thought and practice community to explore and develop potential disincentivizing solutions. Current thinking and policy on disincentivizing bioweapons acquisition and use is underdeveloped—especially by comparison with the nuclear security field.”

‘“We launched this effort because we see the need for more rigorous thinking on effective approaches to making bioweapons unattractive to nation-states,” said NTI | bio Vice President Jaime Yassif. “NTI’s goal is to bridge theory and practical policy-relevant approaches to develop new ideas that can invigorate international efforts to reduce biological threats.”’

Biodefense Graduate Program Director Gregory Koblentz and Associate Professor Sonia Ben Ouagrham-Gormley both participated in this workshop. Read more about it here.

“Great Powers and the Norms of the BW Prohibition Regime”

A new working paper from CBWNet: “The United States of America and the Soviet Union were instrumental in creating the biological weapons prohibition regime more than 50 years ago. This has left the regime with a big gap in its normative structure related to the verification of treaty compliance. The working paper by Alexander Kelle and Eva Siegmann analyses great power involvement in several areas of regime implementation and concludes that none of the great powers, including China, has supported the addition of declaration and inspection norms. While recent US and Chinese initiatives could still lead to a strengthening of the regime in different areas, Russian policies, most notably false accusations against the US and others, threaten to undermine the regime.”

“AI and Biorisk: An Explainer”

A new explainer from Georgetown’s CSET: “Recent government directives, international conferences, and media headlines reflect growing concern that artificial intelligence could exacerbate biological threats. When it comes to biorisk, AI tools are cited as enablers that lower information barriers, enhance novel biothreat design, or otherwise increase a malicious actor’s capabilities. In this explainer, CSET Biorisk Research Fellow Steph Batalis summarizes the state of the biorisk landscape with and without AI.”

“Bio X AI: Policy Recommendations For A New Frontier”

Jeffrey et al. discuss the work of the Federation of American Scientists’ Bio x AI Policy Development Sprint in this piece, explaining in their introduction: “Artificial intelligence (AI) is likely to yield tremendous advances in our basic understanding of biological systems, as well as significant benefits for health, agriculture, and the broader bioeconomy. However, AI tools, if misused or developed irresponsibly, can also pose risks to biosecurity. The landscape of biosecurity risks related to AI is complex and rapidly changing, and understanding the range of issues requires diverse perspectives and expertise. To better understand and address these challenges, FAS initiated the Bio x AI Policy Development Sprint to solicit creative recommendations from subject matter experts in the life sciences, biosecurity, and governance of emerging technologies. Through a competitive selection process, FAS identified six promising ideas and, over the course of seven weeks, worked closely with the authors to develop them into the recommendations included here. These recommendations cover a diverse range of topics to match the diversity of challenges that AI poses in the life sciences. We believe that these will help inform policy development on these topics, including the work of the National Security Commission on Emerging Biotechnologies.”

“Push to Improve Biosecurity in the Age of Genetic Engineering”

Wilmot James recently authored this opinion piece for Business Day, explaining in part “The possibility of using AI to develop bioweapons raises additional concerns, and remains uncharted territory. While the intersection of AI and biotechnology holds immense potential for positive applications in healthcare, research and diagnostics, it also poses risks if misused. AI algorithms could be employed to analyse vast genetic data sets and identify specific sequences for manipulation. This could accelerate the process of genetic engineering, allowing for the creation of more efficient and potentially harmful pathogens…To safeguard against such threats, multilateral and public-private sector agreements and regulations to govern the ethical use of AI in science, emphasising the prohibition of bioweapon development, should be established, with strong oversight committees responsible for assessing the ethical implications at the intersection of AI and biotechnology. These committees should include experts in AI, virology, bioethics and global health security.”

“Sounding the Alarm on Anti-Science”

Margaret Winchester provides background and overview of Peter Hotez’s latest book-The Deadly Rise of Anti-Science-in this piece for Health Affairs: “In his book, The Deadly Rise of Anti-Science, Hotez, professor and dean of the National School of Tropical Medicine at Baylor College of Medicine, and co-director of the Center for Vaccine Development at Texas Children’s Hospital, paints a bleak picture of public science denial during the pandemic, embedded in historic context. He tells the story of systematic anti-science efforts from his view in the trenches—and as a personal target for anti-science activists. This book, and his commentary in our December issue of Health Affairs on global lessons from COVID-19, highlight the very real effects of this movement, including lives lost, undermined public health efforts, foregone vaccinations, social schisms, and more, that will be felt for generations to come. As he writes, “anti-science now kills more Americans than global terrorism, or other deadly societal forces and social determinants.” Drawing from multiple sources, he estimates that approximately 200,000 people needlessly died in the US after COVID-19 vaccines became widely available.”

EU vs Disinfo Disinformation Review

The most recent edition of EU vs Disinfo’s Disinformation Review is now available and features multiple sections focused on Russia’s continued use of alleged US biological weapons laboratories as a bogeyman. Be sure to check it out for fantastic lines such as “If the only tool that you have is a hammer, everything looks like a biolab,” and “At a staged event, Putin mumbled out an announcement to veterans and the wider public that his regime would continue to rule over Russia after an orchestrated ritual not to be confused with an event known as an ‘election’ in the free world.”

2023 State of the Bioeconomy

From BIOISAC: “We have a lot to celebrate as we close 2023 and just over 12 months since the Executive Order calling for a safe, secure bioeconomy. Join us as we recap the activity, publications, outcomes, and – we will of course share a glimpse of the “behind the scenes” conversations from our 3 regional events and our one-day “Closing the Knowledge Gaps” event, our two-day table top training and the resulting “Going Viral: Bioeconomy Defense TTX” report, and, of course, the industry-demanded outputs from our hardware/software device security workgroup report and supplements, “Fortifying the Bioeconomy” as well as the Bioeconomy Security Questionnaire and Instrument Disposal Guide. We also have a lot left to do! We plan to share a few of our goals for 2024 and our upcoming regional events schedule.”

“Join us December 19th at 2pm Eastern-US for a live discussion.” Register here.

Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Virtual Meeting

“The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provides advice, information, and recommendations to the U.S. Secretary of Health and Human Services (HHS Secretary). The council supports and evaluates U.S. government activities focused on fighting antimicrobial resistance (AMR) in human health, animal health, and environmental health. Using this One Health approach, members of the PACCARB have expertise from a range of backgrounds, including academia, industry, public health, advocacy, veterinary, and agricultural production.”

“The PACCARB was established under Executive Order 13676 and included in the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA). Since 2019, the President has given authority to the HHS Secretary as the primary recipient of PACCARB recommendations. Additional information on the authority and activities of the PACCARB can be found on the About Us page in the charter.”

“As a federal advisory committee, the PACCARB looks to engage with the public and all AMR stakeholders. The council holds several public meetings every year both in-person and live streamed on the HHS.gov website. These meetings are open to anyone with an interest in combating AMR. See how to get involved!”

This virtual meeting will take place on December 20 from 9-4 EST. Learn more here.

61st ISODARCO Course: Nuclear Order and International Security after Ukraine

“The war in Ukraine has had an enormous impact on global security, reviving nuclear fears, undermining the prospects for arms control, and shattering many of the norms and constraints that were the foundation of European security.  ISODARCO 2024 will examine the global nuclear order in light of the Ukraine war, focusing on the states, the policies and the technologies that will shape the future in a much more difficult environment.  How will we cope with this more dangerous world?”

This course will take place January 7-14, 2024, at the University of Trento. Learn more and register here.

International Conference, CBRNE Research & Innovation

“The last 40 years have demonstrated that both military and civilian populations could be exposed to highly hazardous CBRNE agents following conflicts, natural outbreaks and disasters, industrial incidents or terrorist attacks.”

“Worldwide, researchers, responders and industrial capacities have been commited to provide adapted response to these challenges.”

“Building on the success of the first 5 International Conferences « CBRNE Research and Innovation » which took place in Antibes (2015), Lyon (2017), Nantes (2019), on line (2021) and Lille (2022), we want to give you a new opportunity to build up or strengthen collaborative networks in Strabourg (March 19th – 21rst 2024).”

“The CBRNE R&I Conference is specifically devoted to scientific updates, responders’ feedbacks and expression of needs. It also includes workshops and demonstrations of innovative materials, technologies and procedures, according to the following themes: DETECTION – IDENTIFICATION, PROTECTION – DECONTAMINATION, MEDICAL COUNTERMEASURES, RISKS & CRISIS MANAGEMENT.”

“Looking forward to your proposals for communication and to welcoming you at Strasbourg in March 2024!”

Learn more here.

cbrne-ri-conference-2024-_-flyer-ppt-v06.11.2023-1Download

Registration for GHS 2024 Now Open

Registration is now open for the Global Health Security 2024 conference in Sydney, Australia. This iteration will take place 18-21 June, 2024. The call for abstracts is also still open. “The mission of the Global Health Security conference is to provide a forum where leaders, researchers, policy-makers, and representatives from government, international organisations, civil society, and private industry from around the world can engage with each other, review the latest research and policy innovations, and agree solutions for making the world safer and healthier. To that end, our mission is to help foster a genuinely multidisciplinary community of practice that is committed to working collaboratively to enhance global health security and eliminate disease, irrespective of its origin or source.”

WHO Announces Proposed Members of Technical Advisory Group on Response Use of the Life Sciences and Dual-Use Research

The WHO recently announced its proposed membership of its Technical Advisory Group on Responsible use of the life sciences and dual-use research (TAG-RULS DUR). According to WHO, “As per WHO processes, there will be now a two-week public consultation period for WHO to receive feedback on the proposed TAG-RULS DUR members and set in place the modalities for the TAG-RULS DUR’s first meeting, which is planned to take place following this consultation period…The final membership to the TAG-RULS DUR is subject to the above-mentioned public consultation period and relevant WHO practices and procedures.”

The proposed membership and instructions for providing commentary on the individuals included are both available here.

Vote: 2023 Arms Control Person(s) of the Year Nominees

“Since 2007, the independent, nongovernmental Arms Control Association has nominated individuals and institutions that have, in the previous 12 months, advanced effective arms control, nonproliferation, and disarmament solutions and raised awareness of the threats posed by mass casualty weapons.”

“In a field that is often focused on grave threats and negative developments, the Arms Control Person(s) of the Year contest aims to highlight several positive initiatives—some at the grassroots level, some on the international scale—designed to advance disarmament, nuclear security, and international peace, security, and justice.”

“Voting will take place between Dec. 8, 2023, and Jan. 11, 2024. The results will be announced on Jan. 12, 2024. Follow the discussion on social media using the hashtag #ACPOY2023.”

Learn about the nominees and vote here.

Pandora Report: 1.13.2023

by dkellogg97, posted in Pandora Report

Happy Friday! This week we cover DoD’s upcoming chem-bio defense changes, a recent accelerated preview from researchers at Boston University’s NEIDL, the arrest of an Iranian man in Germany on suspicion of planning an attack using ricin and cyanide, and more. We also include several new publications and podcasts, including our own Dr. Saskia Popescu’s piece about her experience catching COVID-19 as an epidemiologist working in infection prevention. We also have new events listed, including an upcoming Schar School graduate open house where you can learn more about the Biodefense Graduate Program. Stay safe and enjoy the MLK Day weekend!

Pentagon to Overhaul Chem-Bio Defense Despite Budget Trimming

Amid anticipation of the release of its first biodefense posture review, the Department of Defense (DoD) announced this week it is overhauling its approach to countering chemical and biological weapons. In a new document, “Approach for Research, Development and Acquisition of Medical Countermeasures and Test Products,” the Office of the Deputy Assistant Secretary of Defense for Chemical and Biological Defense explains that the Chemical and Biological Defense Program will expand the foci of its medical countermeasure development efforts. According to Politico, rather than continuing to focus on developing countermeasures for a specific list of threat agents, “Officials are launching a new plan to develop medical treatments, vaccines and personal protective equipment that can adapt to a range of evolving biological and chemical threats, said Ian Watson, DoD’s deputy assistant secretary for chemical and biological defense.”

Politico continued, quoting Deputy Assistant Secretary of Defense for Chemical and Biological Defense Ian Watson-“U.S. officials are particularly concerned about adversaries that already have advanced chemical and biological capabilities and have proven themselves willing to use them. Russia and China now have the technology necessary both to tweak current threats — from toxins to naturally occurring pathogens — to make them more deadly and to create new weapons, Watson said.”

“U.S. Sailors and Marines, assigned to the 31st Marine Expeditionary Unit (MEU), take part in a chemical, biological, radiological and nuclear (CBRN) mass casualty drill on the flight deck of the amphibious assault ship USS Wasp (LHD 1) East China Sea, Oct. 22, 2018. Wasp, flagship of Wasp Amphibious Ready Group, with embarked 31st MEU, is operating in the Indo-Pacific region to enhance interoperability with partners and serve as a ready-response force for any type of contingency. (U.S. Navy photo by Mass Communication Specialist 1st Class Daniel Barker)“

The same article referenced Biodefense Graduate Program Director Dr. Gregory Koblentz, explaining “Gregory Koblentz…said the decision by the administration to look more holistically at chemical and biological threats is a strategic national security decision — one that could help the U.S. keep pace with countries such as China, Russia and Iran.” Koblentz was quoted later, saying “There’s definitely a much higher kind of salience and appreciation of how nation-states are using these technologies,” Koblentz said. “Until fairly recently, the focus has mostly been on ISIS and Al Qaeda using chemical and biological terrorism. This [strategy] might be another kind of paradigm shift.”

However, this announcement comes amid cuts to DoD’s chem-bio program funding overall. Roll Call reported recently that the nearly $2 billion in funding dedicated to all these programs will be cut by about $126 million, even in light of their comparatively slow growth and concerns brought about by the COVID-19 pandemic. Furthermore, the Chemical Biological Defense Program received $1.26 billion in appropriations in the last omnibus spending bill-$66 million less than was requested.

Roll Call discussed these funding concerns with Andrew Weber, former Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs under President Obama, and David Lasseter, former Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction under President Trump and a visiting fellow at George Mason’s National Security Institute. Both indicated the funding for these programs needs to more than double, with Lasseter saying “Increasing the current investment to around $3 billion per year, while ensuring efficient and effective program execution, will enable the CBDP to develop cutting-edge capabilities like rapid, ruggedized point-of-care diagnostics, stand-off detection, predictive wearables, advanced protective suits and innovative platform technologies as well as stock and replenish existing medical countermeasures.”

It isn’t all doom and gloom, however. Check out this recent post from George Mason University about a Mason research team’s work to help USAMRIID find broad-spectrum therapeutics for to treat HFV infections-“Mason Collaboration Receives $3.2 million to Help Military Personnel Combat Hemorrhagic Diseases”

Months After Firestorm Surrounding SARS-CoV-2 Experiments, NEIDL Publishes Article on BA.1 Attenuation

In late October, news and social media were full of debate regarding a preprint authored by researchers at Boston University’s National Emerging Infectious Diseases Laboratories. As Science explained at the time of the controversy, “They took the gene for Omicron’s surface protein, or spike protein, which SARS-CoV-2 uses to enter cells and added it to the genome of a “backbone” virus—a variant of SARS-CoV-2 from Washington state that was identified soon after the pandemic first emerged in Wuhan, China, in early 2020. The objective was to tease apart whether Omicron’s spike protein explains why it is less pathogenic (meaning it causes less severe disease). The answer could lead to improved COVID-19 diagnostic tests and better ways to manage the disease, the preprint authors say.” As there had been no approval from NIAID, debates swirled over the benefits and safety of the research, and if it violated rules on NIH-funded gain of function (GoF) studies.

Now the same team has published an article that is available for accelerated preview in Nature, again attracting attention and sparking debate. This comes amid broader debates about risky research, including GoF research itself and calls to broaden definitions of what kinds of experiments require special reviews and safety measures. In April last year, Biodefense Graduate Program Director Dr. Gregory Koblentz delivered a statement addressing this topic to the NIH, highlighting the problems the term “gain of function” has brought in policy debates. In his remarks regarding the Department of Health and Human Services Framework for Guiding Funding Decisions about Proposed Research Involving Enhanced Potential Pandemic Pathogens, Koblentz said “The first positive aspect of the Framework is that it does not use the term “gain of function.” The introduction of this term into the discussions on dual-use research in 2011-2012 triggered a long and unproductive debate about how to define this category of research. Carving out “gain of function” as somehow distinct or separate from dual-use research muddied the debate and continues to cause confusion today.”

This topic recently garnered attention again as the omnibus appropriations bill progressed through Congress before being signed into law by President Biden. As we discussed last week, the new legislation also takes aim at GoF research, after GOP lawmakers pushed the administration to halt federally-funded GoF research, citing beliefs that such research is responsible for the COVID-19 pandemic. On page 3,354 of the more than 4,100 page bill, it reads, “(1) IN GENERAL.—Beginning not later than 60 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall not fund research conducted by a foreign entity at a facility located in a country of concern, in the estimation of the Director of National Intelligence or the head of another relevant Federal department or agency, as appropriate, in consultation with the Secretary of Health and Human Services, involving pathogens of pandemic potential or biological agents or toxins listed pursuant to section 351A(a)(1) of the Public Health Service Act (42 U.S.C. 262a(a)(1)).” It also requires the Office of Science and Technology Policy to review and update federal policy on potential pandemic pathogen research.

German Police Detain Iranian Man Accused of Plotting Attack, Acquiring Cyanide and Ricin

This week, Deutsche Presse-Agentur (DPA) reported that German police arrested a 32-year-old Iranian man on suspicion of planning an attack motivated by Islamic extremism. Police wearing protective gear entered the man’s apartment in Castrop-Rauxel, northwest of Dortmund, late Saturday night. According to Herbert Reul, State Minister for Internal Affairs, the police acted on a “serious tip” that prompted them to respond the very night they received it. News reports indicate that an allied intelligence service alerted Germany that the man was planning an attack. Though he is thought to have acquired cyanide and ricin, it is unclear how developed his plan was. However, Düsseldorf prosecutors later told DPA that “no toxic substances” were found in the initial search of the apartment.

Outgoing Eskom CEO Survives Cyanide Poisoning

Andre de Ruyter, the outgoing CEO of Eskom-South Africa’s state-owned electricity company-, reportedly survived an attempt to poison him with cyanide last month. De Ruyter, who will step down in March, fell ill after he was served a cup of coffee laced with the agent on December 12. According to Insider, “After drinking the coffee, De Ruyter became “weak, dizzy, and confused,” EE Business Intelligence reported, citing an unnamed source. He was shaking, vomiting, and eventually collapsed, the source said. The Financial Times reported sources as saying that De Ruyter was nauseous and became confused after the drinking the coffee. According to the FT, the coffee machine at Eskom’s office was out of order at the time of the incident, and he was served a coffee from a different source.”

The same news report also explained that, “Since taking over as CEO of Eskom, De Ruyter has attempted to crack down on corruption within South Africa’s energy sector, EE Business Intelligence reported. He has, however, also clashed with the country’s government, and in December, Eskom was accused of “actively agitating for the overthrow of the state” by South Africa’s energy minister Gwede Mantashe.”

Prison Colony Where Alexei Navalny is Held Suffers Flu Outbreak

Alexei Navalny, the prominent Putin critic who survived an attempted poisoning in 2020, is reportedly in worsening health amid a flu outbreak in the colony he is held in east of Moscow. Navalny claims that prison authorities intentionally placed a man sick with influenza next to him as a “bacteriological weapon,” and that he has been denied basic medications despite suffering a fever and cough. Last month, Navalny said he suffers from worsening back pain from long periods of time spent in the colony’s punishment cell and that he has been injected with multiple unknown drugs. He has also Tweeted through his lawyers that the authorities intentionally moved a mentally unstable man who howls at night into a cell near him.

Though his current symptoms are not life-threatening, there is speculation that this could be part of a deliberate attempt to make Navalny, Putin’s most out-spoken domestic supporter, die from natural causes. The Schar School’s Dr. Mark N. Katz, an expert on Russia, told Newsweek “”If Putin had wanted Navalny dead, he could have easily arranged for this.” He added “Putin may think he’ll be better off if Navalny dies from illness than directly at the hand of the state.” Russia denies any role in the 2020 attack against Navalny, which used a Novichok agent, a group of nerve agents developed in the Soviet Union. Navalny is currently serving an 11.5 year prison sentence on trumped up charges supporters say were created to silence him.

“Understanding Biosafety and Biosecurity in Ukraine”

Biodefense PhD student Ryan Houser, Biodefense Graduate Program Director Dr. Gregory Koblentz, and Dr. Filippa Lentzos of King’s College London recently published this piece in Health Security. Their abstract reads: “The Russian invasion of Ukraine in February 2022 was accompanied by unfounded Russian allegations of bioweapon activities in Ukraine conducted by the United States and its allies. While false, such allegations can cause substantial damage to disarmament efforts and international cooperation for strengthening disease surveillance and global health security. The purpose of this article is to describe Ukraine’s biosafety, biosecurity, and dual-use policies and to provide important context for understanding the unwarranted Russian allegations. Moreover, the analysis of Ukraine’s biorisk management system highlights some of the international efforts underway to ensure that life sciences research across the world is conducted safely, securely, and responsibly. With the help of international partners, Ukraine has strengthened its biorisk management governance, as well as identified areas for improvement that it is working to address.”

“When the Infection Prevention Epidemiologist Gets COVID-19”

In this piece for Infection Prevention Today, Biodefense PhD Program alumna and current Schar School Assistant Professor, Dr. Saskia Popescu, discusses what it was like to catch COVID-19 in late 2022 as someone working in infection prevention. She offers insights into the pressures and guilt that many professionals have grappled with throughout this pandemic, writing “Safety isn’t binary, but rather a spectrum of risk and choice, and ultimately, it’s important to consider those individuals around us. I wish I would have been more vigilant in masking but am grateful I had the resources and capacity to mask and isolate appropriately when symptoms began. A friend recently joked that I had lost my street “cred” as an infection preventionist, which was both comical and a bit eye-opening. Mostly, it highlights much of the guilt or even shame many of us experience when we feel as if we’ve failed at the very thing we specialize in. I still beat myself up at times for getting COVID-19 and knowing better as an infectious disease specialist, but I also don’t want to associate any sense of shame with an infectious disease. We have all learned lessons during this pandemic, and a sustainable approach to COVID-19 will likely be one of the most important in the greater context of public health and infectious disease response.”

“Building the CDC the Country Needs”

The Center for Strategic & International Studies recently published this report by Drs. J. Stephen Morrison and Tom Inglesby discussing the current state of CDC and the findings of the CSIS Commission on Strengthening America’s Health Security’s review of the agency. They explain, “This CSIS report enumerates the essential, concrete, near-term steps that will return CDC to a pathway of high performance: clarifying and better integrating CDC’s core domestic and global missions; enhancing CDC’s leadership and transparency by bolstering its communications and federal engagement capacities; creating a much stronger competency in Washington; and bolstering its operational and surge capabilities through updated frontline engagement, workforce development, data analysis, and budget flexibility. Across all reforms, greater attention to equity and accountability will be essential.”

“The Global Risks Report 2023”

In the 18th edition of the Global Risks Report, the World Economic Forum discusses the findings of the latest Global Risks Perception Survey. The report addresses current crises, risks that are likely to be severe in the next decade, and mid-term future challenges centered around natural resource shortages. It finds that the cost of living will continue to dominate global risks in the next two years while failure to mitigate climate change will be the defining issue of the next decade, leading a formidable list that includes other issues like geoeconomic confrontation and widespread cybercrime and cyber insecurity.

What We’re Listening To 🎧

The BWC Global Forum: Biotech, Biosecurity & Beyond

This podcast series from the Johns Hopkins Center for Health Security aims to “…support BWC States Parties, policymakers and policy experts, and scientists understand advancements in biology and biotechnology and their impact on the Biological & Toxin Weapons Convention (BWC).” Currently, episodes include “De-Extinction Technologies”, “Human Genome Editing”, and “Wastewater Surveillance”. Learn more and listen here.

The Retort Episode 7-Toxin and Bioregulator Weapons

In this latest episode of the Retort, the University of Bath’s Dr. Brett Edwards discusses toxin and bioregulator weapons with Drs. Lijun Shang and Malcolm Dando. Check it out here.

George Mason Arlington Graduate Open House

Join us for the Graduate Open House on Thursday, January 19, from 5-7 p.m. on George Mason University’s Arlington Campus to learn more about the Biodefense Program and 40+ other programs from the Schar School of Policy and Government, the School of Business, and the Carter School for Peace and Conflict Resolution. At the in-person event, explore your graduate school options, connect with our representatives, and find out where a Mason graduate degree can take you next. Come early and work on your application with us! A computer lab is reserved starting at 4:30 p.m. for you to start your application and staff members will be on hand to answer your questions. Register today!

Opportunities, Threats and Proliferation Challenges Deriving from Bio-Technology and Bio-Engineering

“The International Affairs Institute (IAI) of Rome and the Vienna Center for Disarmament and Non Proliferation (VCDNP) cordially invite you to attend the next Young Women and Next Generation Initiative (YWNGI) public webinar event entitled: “Opportunities, Threats and Proliferation Challenges deriving from Bio-Technology and Bio-Engineering” which will be held on 16th January 2023 from 3:00 to 4:30 p.m. Central European Time (CET) via Zoom.

The webinar will feature remarks by Dr Angela Kane, former UN High Representative for Disarmament Affairs and Senior Fellow at the Vienna Center for Disarmament and Non Proliferation (VCDNP); Dr Filippa Lentzos, Associate Professor in Science & International Security at King’s College London; and Dr James Revill, Head of the WMD and Space Security Programmes at the United Nations Institute for Disarmament Research (UNIDIR).” Learn more and register here.

Wastewater-Based Disease Surveillance for Public Health Action

“The National Academies’ Water Science and Technology Board and Health and Medicine Division invite you to a public release webinar of “Wastewater-Based Disease Surveillance for Public Health Action,” on Thursday, January 19, 2023 from 2-3 p.m. ET. The report explains how community-based wastewater disease surveillance has been useful during the COVID-19 pandemic in helping to inform important public health decisions. It also examines the value of wastewater surveillance applications for other infectious diseases, and presents a vision for the future of wastewater surveillance on a national scale.” Learn more and register here.

Closing the Knowledge Gaps

“BIO-ISAC, in partnership with the Department of Homeland Security and Johns Hopkins Applied Physics Laboratory, will host a one-day event (with remote participation available) on January 24, 2023.”

“This gathering of thought leaders across the industry and its partners will address knowledge gaps about the bioeconomy itself. The event is expected to deliver recommendations that demonstrate the scope and breadth of industry impacts, identify specific safety needs and goals, and carve the path forward for a secure future.” Learn more and register here.

Novel Applications of Science and Technology to Address Emerging Chemical and Biological Threats

For the first time since 2019, this Gordon Research Conference is back, this time in sunny Ventura, CA. “The Chemical and Biological Defense GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.” The conference will be held March 19-24, 2023. Learn more and apply here by February 19.

Special Call for Papers-Journal of Science Policy & Governance

The Journal of Science Policy & Governance recently announced a special call for papers “and competition to provide policymakers with a new perspective on how scientific expertise could be useful to the complex brew of 21st foreign policy and national security challenges, resulting in a special issue on Policy and Governance on Science, Technology and Global Security.” The journal invites “students, post-doctoral researchers, policy fellows, early career researchers and young professionals from around the world to submit op-eds, policy position papers and other articles addressing foreign policy and national security challenges. These include concerns about the use of nuclear or radiological weapons driven by the war in the Ukraine, hypersonic weapons, immigration driven by climate change, and emerging threats in cybersecurity and biosecurity.” The deadline for submission is April 30.

Additionally, there will be a science policy writing workshop on January 30 in addition to two webinars on February 20 and March 30 (one on Policy and Governance on Science and Technology and one on Foreign Policy and National Security, respectively) to help prospective authors prepare their submissions. Learn more about these events and register here.

Weekly Trivia Question

You read the Pandora Report every week and now it’s time for you to show off what you know! The first person to send the correct answer to biodefense@gmu.edu will get a shout out in the following issue (first name last initial). For this week, our question is “In 1980, a Frenchman entered a cave while visiting Mount Elgon National Park, Kenya. A week later he became seriously ill, eventually dying in a Nairobi hospital. Which cave did he enter and what disease killed him?”

Shout out to Stephen M. for winning last week’s trivia! The correct answer to “Before perpetrating the infamous Tokyo subway sarin attack in 1995, this Japanese cult attempted to disseminate botulinum neurotoxin and Bacillus anthracis, among other agents. What was the name of this cult prior to its split/name change in 2007?” is Aum Shinryko.